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ABSTRACT 
The significance of endocrine-disrupting compounds (EDCs) in the environment has only 
recently come to the forefront of scientific research, policy debates, water utilities management 
and public awareness. EDCs have the ability to interfere with the normal functioning of the 
endocrine system of humans and other animals. Numerous chemicals are included in the class 
of compounds known as EDCs, and exposure is widespread. These compounds are found in a 
variety of environmental matrices (e.g., marine and freshwater systems, sediment, soil), 
transported there primarily through sewage effluent discharge and recycling of sewage sludge 
for topical fertilizer use. This transport to the environment serves as the primary route of 
exposure for aquatic and terrestrial organisms living there. Furthermore, these compounds are 
also found in consumer products, food and drinking water—which serve as the exposure source 
for human beings. Multiple examples of endocrine disruption have been documented in humans 
and animals, and certain EDCs have been implicated in each case. The future of public and 
environmental health will depend upon mitigating the effects of these chemicals.   
This purpose of this dissertation is to provide an initial understanding of EDC occurrence in 
the Tampa Bay region of south Florida, and to complement the existing body of EDC research 
with regards to marine systems. It focuses on estrogenic EDCs, specific compounds which 
target the estrogen axis of the endocrine system. Six estrogenic EDCs were chosen based on 
their documented prevalence in the environment, prevalence in sewage, and for their suspected 
endocrine-disrupting effects: estrone, 17β-estradiol, estriol, 17α-ethinylestradiol, bisphenol-A 
and nonylphenol. These compounds were verified to be amenable to and detectable by gas 
chromatography-mass spectrometry analysis.  
ix 
 
Since the occurrence of EDCs in aquatic environments of the Tampa Bay region had not 
been previously characterized, the initial phase of the research focused on quantification of the 
six estrogenic EDCs in Tampa Bay area water, sediment, and sewage influent and effluent. All 
targeted EDCs were present in 89% of sewage samples, while 100% of the samples contained 
at least one or more EDCs. The concentrations of EDCs in marine aqueous and sediment 
samples tended to decrease with increasing distance from the wastewater treatment plant 
discharge site. The ubiquitous presence of these estrogenic EDCs in the Tampa Bay area is 
cause for concern with respect to endocrine disruption in local terrestrial and aquatic wildlife. 
Since the Tampa Bay region is home to a wide variety of marine organisms, constant exposure 
to EDCs could result in ecosystem-level effects, as these compounds can impair reproductive 
fitness and lead to other adverse health effects. This research also served to enlarge the 
existing scientific literature on EDC occurrence, as many marine and freshwater systems 
continue to be characterized globally. 
The very basis for expecting to find EDCs in the Tampa Bay area had come from the fact 
that the main source of environmental contamination is typically the effluent discharge from area 
wastewater treatment plants. Conventional wastewater treatment plant processes are designed 
to reduce the amount of organic matter, pathogens and nutrients from the incoming influent. 
However, the processes are not as effective in removing micropollutants, including EDCs. 
These compounds notoriously evade traditional wastewater treatment technologies and are 
found even in tertiary-treated effluent. For this reason, the second phase of the research 
assessed an electro-chemical technique for the removal of the same six EDCs. The removal 
technique was tested on a laboratory scale and has a commercial-sized counterpart which can 
be integrated at the level of the wastewater treatment plant. In order to test the removal 
efficiency, samples of influent and tertiary-treated effluent were spiked with the six EDCs. The 
mean concentration of each EDC component was statistically lower after treatment (removal 
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range = 42% - 98.2%), demonstrating the effectiveness of this electro-chemical process for 
EDC removal from both raw and treated sewage. The significance of the results lies in the fact 
that if this method is implemented, then future wastewater treatment plant effluent discharge 
(similar to that of the Tampa Bay region) could be less impacted by EDCs and therefore cleaner 
for the environment into which it is being discharged.  
For the final phase of the research, the use of computational techniques to simulate human 
endogenous estrogen binding to its receptor was started as a foundation for future models to 
eventually predict endocrine-disrupting potential of different chemical compounds. We built an 
estradiol-human estrogen receptor model, and used molecular dynamic simulations to 
determine the binding free energy. The calculated total binding free energy of estradiol bound to 
the ligand binding domain of the human estrogen receptor was found to be -16.85 kcal/mol, 
which is in range of the experimental value of -12.40 kcal/mol. Humans are chronically exposed 
to low doses of EDCs every day, which makes endocrine disruption a considerable public health 
issue. Human exposure to EDCs is completely different from marine organism exposure, but the 
adverse effects are no less significant. The successful completion of this model serves as a 
platform for 1. Testing the human model against endocrine-disrupting compounds, 2. 
Subsequent models that will be developed for different species, including marine species 
important to Tampa Bay.  
Substantial data exist regarding the exposures and health risks associated with EDCs in 
humans and wildlife on a global scale. As the pressing issues of climate change and carbon 
emissions are at the top of the list of environmental concerns, it is important to note that 
mitigating the effects of EDCs should not be overlooked and will be an important responsibility 
of regulatory agencies in the near future. 
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CHAPTER ONE: INTRODUCTION 
 
1.1 The Endocrine System 
The endocrine system is the network of glands that regulates many vital body functions 
including development and growth, sexual maturation, reproduction, metabolism, brain function, 
gender behavior, thyroid function, stress response, immune and cardiovascular function. Found 
in all animal phyla, the endocrine system communicates throughout the body via chemical 
messengers known as hormones (deFur 2004). Endocrine glands release these hormones 
which then coordinate and control the functions of multiple organ systems throughout the life 
cycle.  
The specific actions of individual hormones often change throughout the development 
and lifetime of an organism. In addition, hormone actions may be different in males and females 
and they may be mediated by different receptors which are expressed in different tissues or at 
different life stages (Andrade et al. 2006, Zoeller et al. 2012). Because they act through 
receptors, hormones exert very specific effects on development and adult physiology which 
contribute to the complexity and delicacy of the endocrine system as a whole. The functions and 
responses of the endocrine system change over the lifetime of an individual (Zoeller et al. 2012, 
Gore et al. 2013). There are critical windows of development (especially during fetal/neonatal 
development) where hormones have crucial command over extremely rapid cell division and 
differentiation, leading to the development of tissues (Arcand-Hoy and Benson 1998, Newbold 
2010, Schug et al. 2011). Hormone actions during development are often permanent. Any 
disruption of this delicate hormone balance can have irreversible effects on the tissues of the 
endocrine system--both reproductive and non-reproductive tissues such as the brain, lungs, 
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colon, prostate, cardiovascular system and intestines (Shanle and Xu 2011, Gore et al. 2013). 
The consequences of disruption can be life-long, although some may not be apparent until the 
individual reaches adulthood (Newbold 2010, Zoeller et al. 2012).   
 
1.2 Endocrine-Disrupting Compounds (EDCs) 
The term “endocrine disruptor” was coined in 1991 at a working session where 21 
scientists from 17 different disciplines came together to discuss concerns over their endocrine-
related findings (Vandenberg et al. 2013). As defined by the Endocrine Society, an EDC is an 
exogenous (i.e., introduced from the environment or diet) chemical, or mixture of chemicals, that 
interferes with any aspect of hormone action (Zoeller et al. 2012). This definition of an EDC 
focuses on the compound’s ability to interfere with hormone action rather than its ability to 
cause adverse effects. In contrast, the World Health Organization’s definition further specifies 
that the chemical compound must cause adverse health effects in order to be considered an 
EDC (World Health Organization 2013). Since there is still considerable debate on what should 
be included as an EDC and what should not, scientific consensus on a standardized definition is 
needed, as this definition will be especially important when attempting to identify new chemicals 
as EDCs (Snyder et al. 2001, Zoeller et al. 2012).  
The mechanisms by which EDCs may disrupt hormone action can be quite complex 
(Shanle and Xu 2011, Zoeller et al. 2012): 
 They may bind to endogenous hormone receptors and exert direct agonist or 
antagonistic actions. 
 They may exert indirect agonist or antagonistic actions (e.g., through transcription 
factors). 
 They may interfere with the enzymes that are critical for normal hormone synthesis, 
metabolism or degradation (e.g., aromatase). 
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 They may interfere with hormone transport (e.g., serum binding proteins). 
In assessing adverse effects, it is essential to consider at which developmentally-sensitive stage 
the EDC exposure occurred. In humans, windows of susceptibility include prenatal, neonatal, 
pre-pubertal, pubertal and sexual maturity/pregnancy (Miller et al. 2002). Prenatal exposures 
can lead to diseases in childhood or adulthood, while childhood or pubertal exposures can lead 
to diseases later in life (latency of exposure). Similar outcomes have been demonstrated in 
terrestrial, marine and freshwater organisms (Newbold 1995, Jobling et al. 1998). EDCs are 
active at very low doses so it is possible for even low-dose EDC exposure to cause permanent, 
irreversible effects. (Zoeller et al. 2012, Gore et al. 2013).  
Compounds from many different groups are included in the EDC category: pesticides, 
plasticizers, PCBs, flame retardants, PAHs, pharmaceuticals, personal care products, 
phytoestrogens and natural hormones (Esplugas et al. 2007). While certainly not all 
pharmaceuticals and personal care products are EDCs (and vice versa), there are compounds 
that overlap several of these different groupings (Snyder et al. 2007). Additionally, compounds 
with endocrine-disrupting potential may have little in common structurally with one another 
(Depledge and Billinghurst 1999). Many different molecular structures have turned out to be 
estrogenic and the list continues to grow.  
There are 5 key issues regarding EDCs in the environment (Auriol et al. 2006, Olea and 
Fernandez 2007):  
 Removal from wastewater treatment plants utilizing conventional techniques is 
incomplete and, therefore, EDCs are continuously discharged to the 
environment.  
 EDCs follow non-traditional dose-response dynamics, where high and low doses 
have different effects.  
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 Environmental exposure is rarely due to single EDC, but rather a complex 
mixture of EDCs.  
 Adverse effects from exposures earlier in life may not manifest until later in life. 
 EDCs have the ability to cause trans-generational effects through epigenetic 
factors.  
These issues will be discussed thoroughly throughout the dissertation.  
 
1.3 History of EDC Research 
As early as the 1930s, scientists were aware that certain chemical compounds had the 
ability to mimic endogenous estrogens (Snyder et al. 2007). By the 1940s, one of these 
compounds, bisphenol-A (BPA), was being developed as a possible drug for hormone treatment 
after it was discovered that it behaved like estrogen in lab animals. In the 1950s, studies were 
published on chemical compounds which had the ability to mimic estrogen (Burlington and 
Lindeman 1950, Levin et al. 1951, Fisher et al. 1952).  In 1965, one of the first reports on 
human hormones not being degraded at the level of the wastewater treatment plant (and 
therefore discharged into the aquatic environment) was published by Stumm-Zolinger and Fair 
(1965). Since that report, studies in the 1970s and 1980s revealed the presence of these (and 
other) steroid hormones in the environment, and appearing coincidentally were reports revealing 
the presence of pharmaceutical compounds in the environment as well. However, for both the 
steroid hormones and the pharmaceutical compounds, the fact that they were acting as 
environmental contaminants did not receive a great deal of attention until a link was established 
between these compounds and adverse effects on exposed wildlife. This link was firmly 
established in the 1990s, when numerous papers were published on the adverse effects of 
these environmental pollutants on aquatic wildlife (Kim et al. 2007, Snyder et al. 2007). Most 
studies to date have focused on the effects of estrogenic EDCs due to the fact that many of the 
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endocrine effects seen in wildlife seem to have resulted from disruption of this particular axis 
(Guillette et al. 2000, Jobling et al. 2004).  
Endocrine disruption in humans has been more challenging to correlate due to the lack 
of satisfactory experimental systems (Falconer et al. 2006). In the early 1990s, Skakkebaek led 
a pioneering study examining the decreasing quality of semen in men from 1938 to 1990 
(Carlsen et al. 1992). The statement that a reduction in sperm count and semen volume was 
occurring in humans (and that such changes most likely had an environmental cause rather 
than a genetic one) proved to be controversial. However, other scientists confirmed this 
decrease to be real, and more importantly it was shown to not be an isolated phenomenon. A 
recent study by Schiffer et al. (2014) was the first to show a direct link between exposure to 
EDCs and potential adverse effects on human fertilization through defective sperm functions.  
Endocrine disruption in humans and other animals has only recently received an 
exceptional amount of attention. The presence of EDCs in the environment, the exposures to 
these compounds and their potential to cause adverse health effects are some of the challenges 
faced today by scientists, government organizations, regulators, water utilities and even the 
public. Scientists in the fields of endocrinology, toxicology, immunology, developmental biology, 
computational science, ethics, engineering and many others have all contributed to the current 
groundwork of information regarding endocrine disruption, and they continue to research new 
avenues that will promote public and environmental health. Although many studies have 
focused on endocrine disruption in freshwater systems, fewer studies have investigated these 
issues in marine systems.  
 
1.4 The Estrogen Receptor  
Hormones exert their physiological actions through hormone receptors. Estrogens are 
naturally-occurring steroid hormones which regulate target tissues through the estrogen 
receptor (ER) (Sarath Josh et al. 2013). In humans, the physiological effects of estrogen are 
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manifested through two estrogen receptors: human estrogen receptor alpha (hERα) and human 
estrogen receptor beta (hERβ) (Kumar et al. 2011). The ER is a ligand-inducible nuclear 
transcription factor that mediates the biological effects of estrogens through gene regulation. 
When estrogen binds to the ligand-binding domain (LBD) of the estrogen receptor, the ER 
undergoes a conformational change that facilitates chromatin binding (the receptor binds DNA 
at estrogen response elements) and the regulation of gene expression (Matthews et al. 2000, 
Shanle and Xu 2011). Transcription of target genes can be up-regulated or down-regulated 
(Brzozowski et al. 1997, Kumar et al. 2011). 
With respect to endocrine disruption, ERs have relatively large ligand-binding domain 
pockets and are indiscriminate in terms of binding exogenous chemicals, including EDCs. Even 
though estrogenic EDCs can function through multiple mechanisms, many will influence ER 
signaling by directly binding with the ER ligand-binding domain (Shanle and Xu 2011). It is 
important to note that estrogenic EDCs are imperfect ligands of estrogen receptors and should 
be expected to interact with them in ways that do not perfectly replicate the actions of the 
endogenous estrogen hormone 17β-estradiol (Zoeller et al. 2012). 
 
1.5 Effects of EDCs on Wildlife 
Thousands of published studies have reported the health effects of EDCs on wildlife 
including invertebrates, amphibians, reptiles, fish, birds and mammals (Gore et al. 2013). Health 
effects include abnormal blood hormone levels, decreased fertility, decreased hatching success, 
feminization of males, induction of blood vitellogenin in males, masculinization of females, 
imposex, intersex (presence of both female and male gonadal tissues), abnormal thyroid 
function and alteration of immune system function (Colborn et al. 1993).  
EDCs can enter waterways by many routes (Falconer et al. 2006):  
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 Direct discharge into water (point source pollution including surface water 
discharge of wastewater treatment plant effluent as well as aquaculture 
applications). 
 Discharge from diffuse sources such as land runoff, precipitation, drainage, 
seepage or application of reclaimed water (non-point source pollution). 
 Accidental manufacturer spills and release of chemical compounds. 
 Improper disposal of unused, unwanted or expired medications by domestic 
households or industry. 
Natural mammalian hormones, including estrogens, can be released into the environment via 
sewage effluent (humans excrete them in urine and feces) and from sources such as animal 
feedlots and animal waste (Falconer et al. 2006). Since waterways serve as homes to many 
animals, wildlife worldwide are exposed to these ubiquitous contaminants through these point 
and non-point sources.  
One of the best-documented cases of endocrine disruption in invertebrate wildlife comes 
from field studies on mollusks.  Oyster (Crassostrea gigas) populations in Arcachon Bay, 
France, were exposed to organotin compounds (in particular tributyl tin) found in antifouling 
paints in the late 1970s/early 1980s (Depledge and Billinghurst 1999). The exposure of oyster 
culture areas to tributyl tin resulted in reduced growth and survival of the oyster larvae, a 
complete absence of spatfall (settling and attachment of young bivalves to the substrate) in 
certain years, and chambering of the oyster shell. Economically, the total losses in revenue by 
the Arcachon oyster industry between 1977 and 1983 was estimated to be almost $147 million 
(Alzieu 1991). Tributyl tin was later discovered to also cause imposex (the imposition of male 
sex organs on the female gastropod) in female snails (Jobling et al. 2004).  
One of the strongest examples of endocrine disruption in vertebrate wildlife is that of the 
American alligators (Alligator mississippiensis) in Lake Apopka (Central Florida). Although Lake 
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Apopka showed signs of anthropogenic eutrophication as early as the 1950s, it was 
contaminated by a spill of the miticide dicofol (derived from the pesticide DDT) in 1980 (Guillette 
et al. 2000). Throughout the 1980s, the number of alligators in Lake Apopka’s once dense 
population fell due to reduced egg hatchability and reduced viability of offspring. Eggs collected 
from Lake Apopka nests were translucent (no blood flow) and a high percentage of egg clutches 
were found completely lifeless. Contaminants were suspected to be the major contributor to the 
reduced egg viability which dropped to just 3.9% in 1988 (Guillette et al. 1994). Although during 
the 1990s egg mortality decreased and juvenile recruitment increased, several non-lethal 
problems continued at Lake Apopka (Guillette et al. 2000).  In observing the adults on the lake, 
the male alligators had low testosterone levels, similar to what one would find in a female 
alligator. Since the sex hormone testosterone plays a central role in male sexual development, 
the male alligators had malformed and/or smaller gonads—sometimes only 1/3 of their normal 
size. Female alligators also showed modified gonadal morphology including abnormal ovarian 
morphology with large numbers of polyovular follicles and polynuclear oocytes. Further, 
circulating sex steroid concentrations in both male and female alligators from Lake Apopka were 
significantly different when compared to a reference population (from Lake Woodruff) (Guillette 
et al. 1994). The alterations in plasma hormone concentrations have still not resolved and have 
been repeatedly observed (Guillette and Edwards 2008). This example is a painful reminder of 
how exposure to EDCs can bring about devastating population-level effects in wildlife.  
The transfer of EDCs throughout the food chain will in part depend on the compound’s 
bioconcentration and bioaccumulation factors (Touraud et al. 2011). Uptake of EDCs may be 
from diet (bioaccumulation), or directly across the body surfaces (bioconcentration) (Depledge 
and Billinghurst 1999). Most EDCs are stored in body fat where they may be slowly metabolized 
and excreted (Cappiello et al. 2014). As females go through pregnancy, they transfer the 
bioaccumulated contaminants to their young, likely putting embryonic development and 
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reproductive potential at risk (Guillette 1995). Contaminants may be biomagnified through the 
food chain when one organism (e.g., top predator) consumes prey that is already contaminated.  
 
1.6 Effects of EDCs on Humans 
The human population is chronically exposed to low doses of EDCs (Zoeller et al. 2012). 
These compounds are found in electronics, clothing, furniture, bedding, food packaging, toys, 
cosmetics and other personal care products. There may be an association between these low-
dose exposures and the health effects observed in humans. Men today face infertility, 
decreased sperm counts, testicular cancer, prostate cancer and birth defects including 
cryptorchidism (undescended testicles) and hypospadias (deformation of the penis). Women 
today face an increased incidence of estrogen-responsive cancers (vaginal, cervical, 
endometrial and breast) as well as ectopic pregnancies and miscarriages (Colborn et al. 1993). 
Both genders face an increased incidence of medical problems such as metabolic disorders 
(e.g., obesity and diabetes) and neurobehavioral disorders (e.g., autism spectrum disorder and 
ADHD) (Colborn et al. 1993, Barha et al. 2009, Vogel 2009, Newbold 2010).  
Even though cause and effect conclusions are hard to draw with respect to humans, 
there have been cases of pharmacologic dosing, accidental exposure or occupational exposure 
which allow retrospective insight into the adverse effects of EDC exposure (Falconer et al. 
2006). A case of documented endocrine disruption in humans occurred with exposure to the 
potent synthetic estrogen diethylstilbestrol (DES). For the purpose of preventing miscarriages, 
DES was prescribed to millions of pregnant women worldwide between 1947 and 1971 (Janex-
Habibi et al. 2009, Newbold 2010). Prenatal exposure to DES resulted in vaginal clear-cell 
adenocarcinoma in female offspring and testicular lesions in male offspring (Giusti et al. 1995). 
DES was banned in 1971 by the FDA and, due to its potential carcinogenicity in humans, DES 
was also banned from use in cattle and sheep (since it was being used in beef cattle and sheep 
for growth, efficiency and lean meat promotion) in 1979 by the U.S. FDA (Preston 1999).  
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1.7 Fate of EDCs in the Environment 
When micropollutants are released into the environment, they are subjected to various 
processes such as distribution between different phases (e.g., sorption), biological degradation 
and abiotic degradation (e.g., photolysis, hydrolysis) (Mompelat et al. 2009, Virkutyte et al. 
2010). The accurate determination of an organic contaminant’s physico-chemical properties is 
critical for predicting its fate in the environment (Pontolillo et al. 2001). Table 1.1 lists some of 
the important physico-chemical parameters for six different estrogenic EDCs that will be 
discussed in this dissertation. 
 
Table 1.1 Selected physico-chemical parameters for six estrogenic endocrine-disrupting 
compounds (EDCs) 
EDC MW 
(g/mol) 
log Kow log Koc S (mg/L) pKa 
17β-estradiol 272.4 4.01 3.5 13 10.4  
Estrone 270.4 3.13 3.5 13 10.3  
Estriol 288.4 2.45-2.81 3.5 13 10.4  
17α-
ethinylestradiol 
296.4 3.67-4.15 3.8 4.8 10.4 - 10.5  
Bisphenol-A 228.2 2.2-3.4  2.5-3.2 120 9.6-10.2  
4-nonylphenol 220.4 4.48-6.19 4.0; 5.6 5.43 ~10.7  
MW = molecular weight; log Kow = octanol-water partition coefficient; log Koc = organic carbon-
water partition coefficient; S = aqueous solubility; pKa = acid dissociation constant. Data 
obtained from Belfroid 2002, Yoon 2003, Huber 2003, Ivashechkin 2004, Snyder 2007, Ying 
2009, Silva 2012. 
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Sorption is a physical process that is based on the uptake of the chemical contaminant from the 
aqueous phase onto a solid phase or sorbent (Silva et al. 2012). This process becomes 
important in assessing the movement of contaminants throughout the environment. Sorption is 
generally defined by partition coefficients, two of which are listed in Table 1 (Caron et al. 2010). 
These partition coefficients are utilized to assess and predict the distribution of a contaminant 
between two phases. The parameter used to characterize the affinity of a compound to organic 
matter is the octanol-water partition coefficient, Kow. The greater this coefficient, the higher the 
affinity for nearby organic matter (Ivashechkin et al. 2004). Higher log Kow values suggest that 
the compound will be removed more readily from the aqueous phase and sorb mainly onto the 
organic portion of sediments or particles (Lai et al. 2000, Takigami et al. 2011). The soil organic 
carbon-water partition coefficient, Koc, is the ratio of the mass of a chemical that is adsorbed in 
the soil/sediment per unit mass of organic carbon in the soil. It is useful in soils where sorption 
to organic carbon dominates. However, the use of Koc is somewhat limited as the presence of 
organic carbon is not a prerequisite for sorption and there are some model soils/sediments with 
zero organic carbon content that will still adsorb EDCs (Lai et al. 2000, Ivashechkin et al. 2004). 
Aqueous solubility (S) is defined as the equilibrium distribution of the solute between water and 
solute phases at a given temperature and pressure (Pontolillo et al. 2001). 
Most EDCs possess similar (and relatively high) log Kow values which places them in the 
class of hydrophobic compounds and predicts similar adsorption behavior (Ivashechkin et al. 
2004). However, bisphenol-A, estrone and estriol have slightly lower log Kow values, which 
means that binding to sediment or sewage sludge will dominate less than for the other 
compounds. 
Sorption of contaminants to sediments and soils will limit the processes of 
photodegradation and biodegradation (Mompelat et al. 2009).  Sorption is not, however, just a 
matter of hydrophobicity. Many important interactions (e.g., electrostatic interactions) and 
environmental variables (e.g., salinity, sediment binding sites) are neglected through exclusive 
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use of partition coefficients (Lai et al. 2000, Mompelat et al. 2009).  However, sorption 
coefficients are a good way to at least initially predict the behavior of a contaminant in the 
environment. 
 
1.8 Fate of EDCs in Wastewater Treatment Plants: Current Removal Techniques 
Conventional wastewater treatment plant (WWTP) processes are designed for the 
removal of organic matter, nitrogen and phosphorus (C, N and P) (Auriol et al. 2006). Because 
conventional treatment processes in WWTPs have not been designed for the removal of 
micropollutants (including EDCs), new approaches in wastewater treatment are needed to 
reduce or entirely eliminate these contaminants (Wintgens et al. 2004, Snyder et al. 2007, 
Virkutyte et al. 2010, Sui et al. 2010, Wu et al. 2011). Current treatment technologies and their 
effectiveness in removing EDCs are discussed here.  
 
1.8.1. Activated Sludge 
Activated sludge (AS) is the principal biological process used to purify sewage (Silva et 
al. 2012). AS treatment is based on the natural role of microorganisms to break down organic 
matter, and is effective against those compounds which are readily biodegradable (Kim et al. 
2007). However, more recalcitrant compounds (including some EDCs) tend to just adsorb to the 
microbial sludge (Esplugas et al. 2007). This removes them from the aqueous phase in the 
WWTP, but it limits any further degradation. Although some studies have reported efficient 
biodegradation of natural hormones during AS treatment (Ternes et al. 1999a, Ternes et al. 
1999b), others caution that sorption may be playing a greater role in their removal due to the 
low solubility and biodegradability of steroid estrogens (Silva et al. 2012). The settleable solids 
that accumulate from this process form the waste sludge of the system, and this sludge can be 
discharged directly to drying beds in order to recycle the product for fertilizer re-use.  
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1.8.2. Sorption 
Rogers et al. (1996) proposed a mobility guide for organic contaminants during the 
WWTP process based on the compound’s octanol-water partition coefficient (Kow) and its 
tendency to sorb onto sludge solids. If log Kow <2.5, the compound has low sorption potential; if 
log Kow is between 2.5 and 4, the compound has medium sorption potential; if log Kow > 4, it has 
high sorption potential. Referring to Table 1.1, most EDCs will have medium to high sorption 
potential based on their log Kow values. 
 
1.8.3. Membrane Technology 
Membrane technology is an advanced wastewater treatment option. Generally, micro- 
and ultrafiltration membranes do not act as a reliable barrier to EDCs (Wintgens et al. 2004, 
Snyder et al. 2007). Membrane treatments which have demonstrated efficient removal of EDCs 
include membrane bioreactors, reverse osmosis (RO) and nanofiltration (NF) (Wintgens et al. 
2004). The degree of removal is directly related to the membrane characteristics (e.g., 
membrane material, membrane surface charge, permeability and membrane pore sizes) as well 
as the physico-chemical properties of the chemical contaminant (Weber et al. 2004, Snyder et 
al. 2007, Virkutyte et al. 2010). Challenges to the application of membrane filtration include the 
requirement that the water be nearly without particles or biomass (Weber et al. 2004), the high 
pressure required for RO/NF (energetically expensive), brine stream disposal (disposal of 
retentate) for RO/NF and fouling in any membrane separation (Snyder et al. 2007, Sui et al. 
2010). 
 
1.8.4. Activated Carbon 
The role of carbon adsorbents in the treatment of wastewater has been increasing 
(Virkutyte et al. 2010). Activated carbon (AC) is commonly applied to a wastewater stream as a 
powder (PAC) or in a granular form (GAC). For PAC, doses and contact times will vary, and 
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reports have demonstrated a dose-response relationship with greater contact times leading to 
significantly greater removal (Snyder et al. 2007). For GAC, surface area, surface chemistry and 
pore and particle size distribution are major factors affecting adsorption (Fuerhacker et al. 
2001). AC treatment has demonstrated good potential for the removal of micropollutants, 
however it is crucial to consider the characteristics of the water being treated, the adsorption 
isotherms of the contaminants and the concentration of the contaminants. Because PAC dose 
and GAC regeneration/replacement will be critical for exceptional removal, it is important to find 
the most efficient combination of dose and contact time (Fuerhacker et al. 2001, Snyder et al. 
2007).  
A disadvantage of AC is that its efficacy is greatly reduced by the presence of organic 
matter. For example, Kim et al. (2007) report that a low concentration of natural organic matter 
in river water resulted in less competition for the binding sites of AC. However, WWTPs which 
operate with higher organic loads may saturate AC binding sites, resulting in lower removal 
efficiency for micropollutants. Additionally, carbon regeneration for GAC can be expensive 
(Grover et al. 2011) and disposal issues with PAC are problematic (Snyder et al. 2007).  
 
1.8.5. Conventional Ozone and Advanced Oxidative Processes 
In conventional ozonation, oxidation of organic contaminants occurs through reactions 
with ozone, O3 (von Gunten 2003). It has been suggested that treatment with ozone oxidizes 
the phenolic moieties of the steroid estrogens, which are crucial for binding to the estrogen 
receptor (Huber et al. 2003, Maletz et al. 2013). The phenol group of bisphenol-A and 
nonylphenol is also expected to be the ozone-reactive moiety (Huber et al. 2003). The ozone 
dosage and contact time can vary, so it is important to find the most efficient combination. 
However, Maletz et al. (2013) found that ozone treatment of effluent actually increased estradiol 
levels, possibly because of stimulation of aromatase activity. Additionally, oxidation reactions 
with ozone are highly selective and reactivity is dependent on a compound’s pKa value as well 
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as the pH of the water matrix (Huber et al. 2003). The formation of undesired by-products (e.g., 
bromate) is also a disadvantage of conventional ozone treatment.  
 In advanced oxidative processes (AOPs), oxidation of organic contaminants occurs 
primarily through reactions with hydroxyl radicals (Silva et al. 2012). Even ozone itself can 
decompose into hydroxyl radicals, which are the strongest oxidants in water. The nature of the 
hydroxyl radical is very nonselective, so it reacts very quickly with many dissolved compounds 
in water (von Gunten 2003). Photolysis is an example of an AOP that uses ultraviolet irradiation 
to photodegrade micropollutants. AOPs have been found to be effective in removing 
micropollutants (Huber et al. 2003, Sui et al. 2010), but disadvantages include the formation of 
oxidative by-products which may be equally toxic (and/or estrogenic) or more toxic (and/or 
estrogenic) than the parent compound (Silva et al. 2012).  
 
1.9 Outline of the Dissertation 
The research presented in this dissertation is divided into three separate and 
independent chapters (2 through 4). Each of these chapters deals with estrogenic EDCs but 
from entirely different perspectives. The objectives of each study are listed in the separate 
chapters, and are outlined briefly here:  
 Chapter 2 presents baseline data for the presence of estrogenic EDCs in the Tampa Bay 
region, both in several regional wastewater treatment plants and in seawater and 
sediments of the Tampa Bay area.  
 Chapter 3 examines a removal mechanism (electrocoagulation) for EDCs from samples 
of sewage influent and effluent. Cost-effectiveness is discussed. 
 Chapter 4 explores a molecular model built for the estradiol-human estrogen receptor 
alpha complex. Molecular dynamic simulations were run and the binding free energy of 
this model is compared to published values in the literature of similar models. Future 
development of analogous models for marine species are discussed.  
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Chapter 5 presents conclusions of the dissertation, and Chapter 6 comments on current 
challenges and future directions for research. 
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CHAPTER TWO: QUANTIFICATION OF ESTROGENIC ENDOCRINE-DISRUPTING 
COMPOUNDS IN THE TAMPA BAY REGION  
 
2.1 Introduction 
Contaminants of emerging concern (CECs) include the insidious endocrine-disrupting 
compounds (EDCs), which are found at low concentrations (ng/L to µg/L range) throughout the 
environment (Noppe et al. 2007, Pojana et al. 2007). The potential harm to humans and animals 
was the incentive behind Congress directing the U.S. Environmental Protection Agency (EPA) 
to form the Endocrine Disruptor Screening Program (EDSP) in 1996 (Zoeller et al. 2012). 
Endocrine systems are found in all animal phyla at varying levels of sophistication 
(deFur 2004). The endocrine system is the network of glands that regulates many of the body’s 
functions including tissue development and growth, metabolism and reproduction. Endocrine 
glands secrete and utilize hormones to coordinate and control the functions of multiple organ 
systems throughout life (Zoeller et al. 2012). Various agencies worldwide (U.S. EPA, World 
Health Organization, European Union) have slightly different definitions for an EDC, but The 
Endocrine Society defines an EDC as an exogenous chemical, or mixture of chemicals, that 
interferes with any aspect of hormone action (Zoeller et al. 2012). An estrogenic EDC, then, 
specifically targets and interferes with estrogen signaling. This can occur either by way of the 
estrogen receptor (ER) itself, by way of transcription factors or by altering the balance of any of 
the enzymes necessary for estrogen synthesis or metabolism (Shanle and Xu 2011).  EDCs are 
a diverse group of compounds that includes various pharmaceuticals, personal-care products, 
industrial chemicals, pesticides, phytoestrogens and the endogenous hormones of humans and 
other animals (Kim et al. 2007, Shanle and Xu 2011).  
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Wastewater treatment plants (WWTPs) are one of the most significant sources of EDCs, 
as their discharged effluents contribute to the transport of EDCs to freshwater, marine and 
terrestrial environments (Wintgens et al. 2004). Stumm-Zollinger and Fair (1965) used the 
presence of steroid hormones in wastewater as a basis for testing the biodegradation of these 
compounds, similar to what occurs during activated sludge (secondary) treatment at a 
wastewater treatment plant. They concluded that because biological removal in the WWTP is 
incomplete, steroid hormones are then transported with wastewater into natural surface and 
ground water. Since that study, the presence of EDCs in raw sewage and treated effluent has 
been well documented (Wintgens et al. 2004, Wu et al. 2011, Baynes et al. 2012, Nie et al. 
2012). The transport of EDCs through the WWTP and into marine and freshwater environments 
(Kim et al. 2007, Pojana et al. 2007) as well as their accumulation in sediments (Braga et al. 
2005, Bertin et al. 2011, Grund et al. 2011) has also been well documented.  
The primary concern with the presence of EDCs in the environment is that the exposure 
of aquatic and terrestrial wildlife to these contaminants can potentially disrupt the organisms’ 
endocrine systems, thereby affecting reproductive success. Numerous studies have illustrated 
the physiological effects of endocrine disruption in wildlife: altered steroidogenesis, imbalanced 
plasma-hormone concentrations, malformed gonads, feminization in males, intersex and 
reduced viability of offspring (Guillette et al. 1994, Kidd et al. 2007, Baynes et al. 2012). To 
assess ecological risk, Kidd et al. (2007) conducted a 7-year, whole-lake study (Ontario, 
Canada) where fathead minnow were exposed to 5-6 ng/L of the synthetic estrogen, 17α-
ethinylestradiol, to test whether chronic exposure to low-level traces of an endocrine disruptor 
would adversely impact the sustainability of a wild fish population. After only two seasons of 
adding the synthetic estrogen to the lake, the fathead minnow population collapsed due to loss 
of offspring. This demonstrated the ecological implications of EDC exposure to a short-lived fish 
species.   
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The occurrence of EDCs in the aquatic environments of the Tampa Bay region has yet 
to be characterized. The Tampa Bay estuary, located on the central west Florida coast (Fig. 
2.1), is surrounded by Pinellas, Hillsborough and Manatee counties (Weisberg and Zheng 
2006b) which serve a combined population of almost 2.6 million. One of the most biologically-
diverse estuaries in the U.S. and the largest estuary in Florida, Tampa Bay supports a wide 
variety of marine organisms (Schmidt et al. 2004). Tampa Bay is divided into four sub-regions 
(Lower Tampa Bay, Middle Tampa Bay, Old Tampa Bay and Hillsborough Bay) and is generally 
shallow, with typical depths being less than 5 meters (Hu et al. 2004). Estuarine circulation in 
Tampa Bay is driven by rivers, tides and winds, with an estimated residence time of 100 days 
(Weisberg and Zheng 2006a). 
Estrogenic EDCs typically fall into 3 groups: 1. Natural estrogens (includes endogenous 
estrogens and phytoestrogens), 2. Synthetic pharmaceutical estrogens (specifically 
manufactured to produce a therapeutic, estrogenic effect), 3. Industrial compounds which mimic 
estrogen (not intended to produce an estrogenic response, yet still have estrogenic properties). 
Estrone (E1), 17β-estradiol (E2) and estriol (E3) are natural steroid hormones responsible for 
the development of female characteristics (Fig. 2.2, page 26). E2 is the most potent natural 
estrogen as well as the predominant estrogen in young, premenopausal, non-pregnant women 
(Hedge et al. 1987, Barha et al. 2009). E1 is a slightly weaker estrogen and the most prominent 
estrogen in post-menopausal women. E3 is a relatively weaker estrogen that is produced in 
small amounts in non-pregnant women, but because it is secreted by the placenta, it is the 
major estrogen of pregnancy (Hedge et al. 1987, Barha et al. 2009). 17α-ethinylestradiol (EE2) 
is the synthetic estrogen component of all estrogen-progestin oral contraceptive pills in the 
United States, as well as some transdermal patch and vaginal ring formulations (Spencer et al. 
2009). 
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Fig. 2.1. Tampa Bay estuary. Map illustrates raw sewage and effluent sampling locations. Raw 
sewage samples were taken at the headworks of the plant. Effluent samples were taken after 
dechlorination. 
 
Industrial compounds mimicking estrogen include bisphenol-A and nonylphenol, which have no 
structural relation to estradiol yet are capable of producing estrogenic effects. Bisphenol-A 
(BPA) is one of the highest volume chemicals manufactured in the world with over 2.7 billion 
kilograms (6 billion pounds) produced globally every year and continued growth is expected 
from the BPA market (Vogel 2009, Mendum et al. 2010). BPA in polycarbonate plastics allows 
the production of clear, shatter-proof constituents used in electronics, automobiles, safety 
equipment and food containers. BPA is also used extensively in the production of epoxy resins 
which line the interior of food cans, form protective coatings on metal equipment and are used 
as adhesives in dental sealants (Vogel 2009). The use of BPA in thermal paper (widely used in 
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point of sale receipts and labels) has also been studied as a quick route of exposure via surface 
to skin contact (Mendum et al. 2010).  Nonylphenol (NP) is the final degradation product of non-
ionic surfactants called nonylphenol polyethoxylates (NPEs). NPEs are used in the preparation 
of household and industrial detergents, lubricating oils, latex paints, plastics and emulsifiers. 
Even though various voluntary bans and phase-out agreements have reduced the use of NPEs 
in commercial detergents and cleaners, they are still used in certain industrial applications 
(Jobling and Sumpter 1993, Fuerhacker et al. 2001). 
 
 
 
 
Fig. 2.2. Structures of target estrogenic endocrine-disrupting compounds. The top row (E1, E2 
and E3) includes natural endogenous estrogens. The bottom row includes the synthetic 
estrogen EE2 and the industrial compounds BPA and NP, which mimic endogenous estrogens. 
 
 
In this study, we explore the hypothesis that these six estrogenic EDCs will be found in 
quantifiable amounts in Tampa Bay area water and sediment, as well as in the influent and 
effluent of regional WWTPs. The major objective of this study is to establish baseline 
occurrence data of EDCs in sewage, sediment and aqueous samples of the Tampa Bay region.  
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2.2 Materials and Methods 
 
2.2.1. Study area  
Raw sewage and effluent: Raw sewage and effluent samples were collected between 2012 
(April and October) and 2013 (June) from four regional WWTPs: Howard F. Curren Advanced 
Wastewater Treatment Plant, South Cross Bayou Water Reclamation Facility, City of St. 
Petersburg Southwest Water Reclamation Facility and Manatee County Southwest Water 
Reclamation Facility (WRF) (Fig. 2.1). Raw sewage samples were taken at the headworks while 
the effluent samples were taken after dechlorination. All of these WWTPs have standard 
primary and secondary treatment while also incorporating advanced treatment technologies 
(Table 2.1).  
Aqueous and sediment: Aqueous and sediment samples were collected from three locations in 
the Tampa Bay region (Fig. 2.3, page 29) concomitant with the raw sewage and effluent 
sampling. Sampling locations were chosen based on known influences of WWTP effluent 
discharge.  
Table 2.1 
Characteristics of the wastewater treatment plants (WWTPs) sampled during the current study. 
MGD = million gallons per day. 
WWTP 
Size of 
population 
served 
Average flow 
per day (MGD) 
Wastewater 
origin 
Highest level of 
treatment 
Howard F. 
Curren 
AWWTP 
~ 346,037 56 
97.5% 
domestic 2.5% 
industrial 
Advanced Tertiary 
(Denitrification 
filters) 
South Cross 
Bayou WRF 
~260,000 20 
85% domestic 
<15% industrial 
Advanced Tertiary 
(Denitrification 
filters) 
City of St. 
Petersburg 
SWWRF 
~104,000 20 100% domestic 
Advanced 
secondary 
(Advanced 
backwash filters)  
Manatee 
County 
SWWRF 
~315,000 (for 3 
facilities) 
21.4 
99% domestic 
<1% industrial 
 
Advanced 
secondary 
(Advanced 
backwash filters) 
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 Tampa location: The Howard F. Curren Advanced Wastewater Treatment Plant (Tampa, 
Florida) discharges its treated effluent directly into Hillsborough Bay.  
 St. Petersburg location: The Albert Whitted Water Reclamation Facility (St. Petersburg, 
Florida) employed surface water discharge into Middle Tampa Bay until 1992, at which 
time the facility switched to deep-well injection. 
 Clearwater location: The Marshall Street Advanced WWTP (Clearwater, Florida) 
discharges its treated effluent directly into Stevenson Creek (Wateratlas 2007). 
Twelve stations (GPS coordinates recorded in Appendix A) at the Tampa and St. Petersburg 
locations and thirteen stations at the Clearwater location were sampled in order to determine the 
distribution of EDCs in water and sediment at that specific site. A reference location (station R) 
with similar physico-chemical characteristics as the sampling locations, but without wastewater 
discharge impacts, was also chosen for comparison.  
 
2.2.2 Sampling procedure 
Raw sewage and effluent: Raw sewage and effluent were collected in 20-liter Nalgene high-
density polyethylene carboys and transported immediately to the University of South Florida 
(USF) College of Marine Science. In the laboratory, the samples were preserved by adding 5 
mL/L of a 20% sodium azide (NaN3) aqueous solution and refrigerated at 4°C until processed.  
Aqueous: One liter aqueous samples were collected from a motorized boat with a hand-
operated marine bilge pump. The extraction tube was 1 meter in length which allowed sample 
collection from approximately one meter below the water surface. Samples were stored in pre-
cleaned amber glass jars with Teflon-faced polyethylene-lined caps and transported on ice to 
USF. In the laboratory, samples were preserved with 5 mL of a 20% NaN3 aqueous solution and 
refrigerated at 4°C until processed. 
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Fig. 2.3. (a-c) Aqueous and sediment sampling locations. (a) Hillsborough Bay (b) Middle 
Tampa Bay (c) Stevenson Creek. A reference location (R) at the mouth of Tampa Bay was 
sampled for comparison. 
 
Sediment: Surface sediment samples (top 5-10 cm) were collected from a motorized boat with a 
Ponar Grab and transferred to pre-cleaned, glass sediment collection jars. Samples were 
transported on ice to USF. Triplicate Ponar grabs were taken at every 6th station to ensure 
consistency of the sampling procedure. In most cases, the replicates were within ±0.04 ng/g of 
each other.  
 
2.2.3 Chemicals  
Analytical standards E1, E2, E3, EE2, BPA, NP and 5α-androstanol (internal standard) 
were purchased from Sigma-Aldrich (St. Louis, USA). Methanol (HPLC grade), acetone (HPLC 
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grade) and pyridine (certified ACS) were purchased from Fisher Scientific (Pittsburg, USA). N, 
O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (TMCS) was 
purchased from Regis Technologies (Morton Grove, USA). Ultrapure (DI) water was acquired 
from a US Filter PureLab Plus system at the USF College of Marine Science.  
 
2.2.4 Sample Processing 
Raw sewage and effluent: One liter effluent samples were processed via solid phase extraction 
(SPE). An Evolute ABN (Acid, Base, Neutral) column (6 mL/200mg, Biotage, USA) was 
conditioned with methanol and equilibrated with ultrapure water. The effluent sample was then 
loaded onto the column at a flow rate of 15 mL/min using a large volume extraction tank 
(Biotage, USA) and an SPE vacuum pump (Waters, USA). EDCs retained in the column matrix 
were eluted with 6 mL of methanol. The eluate was spiked with 5 µg internal standard and 
evaporated to dryness under a gentle stream of nitrogen. Recoveries of all compounds were 
documented and accounted for in the final quantification. Raw sewage samples were filtered 
through a Whatman 934-AH glass microfiber filter (particle retention 1.5 µm) to yield a final 
filtrate volume of one liter which was then processed via SPE consistent with the methods for 
the effluent samples outlined above. The filter and suspended solids (which corresponded with 
each liquid sample) were loaded into an 11-mL accelerated solvent extraction (ASE) cell 
(Dionex ASE 200), spiked with 5 µg internal standard and the residual volume of the cell was 
filled with solvent-cleaned sand. Acetone:methanol (1:1 v/v ) was used to statically extract the 
sample under elevated temperature (100°C) and pressure (2000 psi) for 5 minutes. The purge 
time was 60 seconds and flush volume was 60% of extraction cell volume. This cycle was 
repeated 3 times (Richter et al. 1996, Noppe et al. 2007). The ASE extract was evaporated to 
dryness under a gentle stream of nitrogen in preparation for derivatization.  
Aqueous: Target EDCs were extracted from one liter marine aqueous samples via SPE 
consistent with the methods for the effluent samples outlined above.  
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Sediment: Sediment samples were homogenized and approximately 30 g transferred to a pre-
labeled Whirl-Pak bag. Samples were then frozen in preparation for freeze-drying. Samples 
were freeze-dried for approximately 72 hours until the sample was completely friable. All 
weights were recorded and percent dry weight determined (Appendix B). Five grams of the 
freeze-dried sediment were loaded into an 11-mL ASE cell, spiked with 5 µg internal standard 
and the residual volume of the cell was filled with solvent-cleaned sand. The ASE protocol was 
consistent with the methods for the raw sewage filters outlined above.  
 
2.2.5 Sample analysis  
Sample extracts were derivatized to their trimethylsilyl (TMS) ethers in 8-mL vials by 
adding 250 μL of BSTFA + 1% TMCS and 250 μL of pyridine, followed by heating in a 60°C 
water bath for 40 minutes in order to drive the derivatization reaction to completion. Samples 
were then transferred to a 2-mL vial for analysis by gas chromatography-mass spectrometry 
(GCMS). The GCMS system (Bruker, Fremont, USA) consisted of a Varian 3800 gas 
chromatograph coupled with a Varian 320 mass spectrometer. The GCMS was equipped with a 
30 m x 0.25 mm (internal diameter) ZB-5MS (Phenomenex, USA) fused silica capillary column 
coated with a 5% phenyl arylene/95% dimethylpolysiloxane stationary phase (film thickness 
0.25 μm). Helium (high purity) was used as the carrier gas at a flow rate of 1 mL/min. The GC 
oven temperature was programmed to begin at 150°C with an initial hold time of 2 minutes, 
followed by a temperature ramp of 6°C/minute until reaching 310°C (a 5 minute solvent delay 
was set). The final hold time was 6 minutes for a total run time of 35 minutes. MS data 
acquisition was performed in selected ion monitoring (SIM) mode with a 7-group program for the 
detection of target ions during different time windows, specified by the corresponding retention 
times. The MS was operated in electron impact (EI) ionization mode at 70 electron volts (eV). 
The dwell time per atomic mass unit (amu) was 0.5 seconds, and the quantitative and 
confirmatory ion fragments are outlined in Table 2. All GCMS samples were injected in triplicate 
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and the results were calculated based on an internal standard method relative to 5α-
androstanol.  
Total estrogenicity of each sample, represented by the estradiol equivalent quotient 
(EEQ), was calculated from the concentration data of the six EDCs obtained following GCMS 
analysis according to Beck et al. (2006): 
 
EEQ = ∑ EEF(i) x c(i) 
 
Where EEQ = total estrogenicity, EEF = estradiol equivalent factor, i = individual EDC 
compound, c = concentration. The EEF reflects the estrogenic potency of the individual EDC 
relative to estradiol, and the values were obtained from Beck et al. utilizing a recombinant yeast 
estrogen screen assay. Based on the results of the assay, the EEF for each individual EDC was 
calculated by dividing the EC50 for E2 by the EC50 of the compound: 
 
EEF(i) = EC50(E2) 
              EC50(i) 
 
 The EEQ parameter highlights more about the samples in terms of estrogenic potency than the 
individual compounds do, and allows one to observe the individual contribution of each EDC to 
the overall sample estrogenicity.  
 
2.2.6 Method Detection Limits 
Method detection limits (MDLs) were based on standard deviate protocol (Ripp 1996) 
and were evaluated using GCMS at a signal-to-noise ratio between 5 and 10. Nine replicates 
were spiked near the detection limit (S/N between 5 and 10) and carried through the entire 
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analytical procedure. Based upon the variability of the replicates, the MDL for each compound 
was calculated as the standard deviation multiplied by the t-value for 9 observations (8 degrees 
of freedom; t-value = 2.896). MDLs were in the range of 1 to 3 ng/L (Table 2.2).  
 
2.2.7 Statistical analysis  
SAS version 9.3 (SAS Institute Inc.; Cary, NC, USA) was used for statistical analyses on 
data retrieved following GCMS analysis. Because our sewage sampling process did not follow a 
specific influent mass through the WWTP system, the influent and effluent were treated as 
independent samples. If a normal probability distribution was justified, parametric testing was 
performed using a 2-tailed t-test (test statistic t) in order to assess a significant difference in the 
mean EDC concentration before (influent) and after (effluent) wastewater treatment. If a normal 
probability distribution could not be justified, non-parametric testing was performed using the 
Wilcoxon Rank Sum test (test statistic S). The criterion for statistical significance was set at 
α=0.05. 
For the environmental (marine aqueous and sediment) data, we had to consider the 
following issues: 1.The data exhibit heterogeneous (i.e., nonconstant) variance, 2. Clustered 
data are likely to be spatially correlated, 3. Repeated measurements taken at the same location 
inherently result in temporal correlations between time series. In order to account for the effects 
of correlation and heterogeneous variance, a linear mixed model (LMM) was set up with a 
random effects statement (which models statistical correlation directly). Location was included 
as a random effect, while campaign (the different times the samples were taken) was included 
as a fixed effect. Separate models were performed for each of the six estrogenic EDCs (the 
dependent variable), as well as for the total estrogenicity of each sample. Post-hoc analyses 
were run utilizing mixed models with pairwise comparisons.  
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Table 2.2 
Characteristics of estrogenic endocrine-disrupting compounds and internal standard. 
Compound Type 
Retention 
time (min) 
Quantitative 
ion 
Confirmatory 
ion(s) 
MDL  EEF 
Nonylphenol 
(NP) 
Industrial 
compound 
11.8 292 179,180 2 ng/L 0.000018 
Bisphenol-A 
(BPA) 
Industrial 
compound 
16.2 357 358, 372 1 ng/L 0.00012 
5α-androstanol 
Internal 
standard 
18.0 333 258  n/a 
Estrone (E1) 
Natural 
estrogen 
21.9 342 218, 257 2 ng/L 0.25 
17β-Estradiol 
(E2) 
Principal 
natural 
estrogen 
22.4 416 129, 285 1 ng/L 1 
17α-
Ethinylestradiol 
(EE2) 
Synthetic 
estrogen 
23.8 425 440 1 ng/L 1.25 
Estriol (E3) 
Natural 
estrogen 
24.8 504 386 3 ng/L 0.0059 
MDL = method detection limit; EEF = estradiol equivalent factor (obtained from Beck et al., 
2006). 
 
2.3 Results  
 
2.3.1 Raw sewage and effluent  
The mean influent (raw sewage) and mean effluent concentrations of six estrogenic 
EDCs were determined across four WWTP study locations over fourteen months (raw data 
supplied in Appendix C). Influent values correspond to the added concentrations of the 
suspended solids (filter) and the aqueous sample.  
In April 2012, the natural hormones (E1, E2 and E3) had consistent removals 
(differences between the raw sewage and influent) above 90% at all locations (Fig. 2.4) except 
for one (Manatee), where the removal of E1 was 29% (not significant) and the removal of E2 
was 89% (Fig. 2.4d). During October, the removals at all locations fell somewhat and nearly 
always showed removals less than 90%. One location (City of St. Petersburg) showed a higher 
E3 effluent concentration (39 ng/L) than in the influent (17 ng/L) (Fig. 2.4c). In 2013, the removal 
rates rose again and ranged from 14 to 99%.  
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For the synthetic pharmaceutical EE2, concentrations ranged from 4.1 ng/L to 9.8 ng/L 
in the influent, and from 1.0 ng/L to 4.3 ng/L in the effluent (Fig. 2.4). The removal range in April 
2012 was from 29% (Manatee) to 76% (South Cross Bayou). All removals were statistically 
significant. In October 2012, the removal was more consistent, from 83% (City of St. 
Petersburg) to 89% (South Cross Bayou), and all removals were again statistically significant. In 
2013, the removal was the most variable, from 21% (Manatee) to 76% (City of St. Petersburg). 
One of the samples (Manatee) was not significant in terms of removal.  
For the industrial compound BPA, the concentrations ranged from 117 ng/L to 48.5 µg/L 
in the influent and from 1.0 ng/L to 372.0 ng/L in the effluent (Fig. 2.5a). For NP, the 
concentrations ranged from 64 ng/L to 858 ng/L in the influent and from 2 ng/L to 88 ng/L in the 
effluent (Fig. 2.5b). The April 2012 sampling campaign showed high removal (above 90% and 
significant) except for 2 cases where NP was only removed by 58 – 59% (yet still significant). In 
October, the removal was more variable, with a low of 18% (BPA at City of St. Petersburg) and 
a high of 94% (NP at City of St. Petersburg). Interestingly, the Howard F. Curren plant had an 
effluent concentration of BPA that was approximately the same as the influent concentration. In 
2013, the removals went up again, ranging from 84% (NP at Manatee) to 99% (BPA at 
Manatee).  
Regarding total estrogenicity, in April 2012, the EEQ concentrations ranged from 52.9 
ng/L to 100.1 ng/L in the influent and from 6.2 ng/L to 15.2 ng/L in the effluent (Fig 2.6). The 
removal ranged from 71% (Manatee) to 93% (South Cross Bayou), and all removals were 
significant. In October 2012, the EEQ concentrations ranged from 44.0 ng/L to 58.2 ng/L in the 
influent and from 7.7 ng/L to 24.5 ng/L in the effluent. The removal rate dropped compared to 
April, and ranged from 58% (Howard F. Curren) to 83% (City of St. Petersburg). It is important 
to note that at one location (Howard F. Curren) the removal was not significant. In June 2013, 
the EEQ concentrations ranged from 56.2 ng/L to 100.8 ng/L in the influent and from 2.8 ng/L to 
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34.8 ng/L in the effluent. The removals were more variable, ranging from 53% (Manatee) to 96% 
(City of St. Petersburg), although all were significant.  
 
 
 
Fig. 2.4. Mean concentrations (ng/L) of the four steroid estrogens (E1, E2, EE2 and E3) in raw 
sewage (gray bars) and effluent (outlined white bars). (a) Howard F. Curren AWWTP (b) South 
Cross Bayou WRF. Error bars represent standard deviations from the average for sample 
replicates. For method detection limits, refer to Table 2.2.  
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Fig. 2.4. (continued) Mean concentrations (ng/L) of the four steroid estrogens (E1, E2, EE2 and 
E3) in raw sewage (gray bars) and effluent (outlined white bars). (c) City of St. Petersburg 
SWWRF (d) Manatee County SWWRF. Error bars represent standard deviations from the 
average for sample replicates. For method detection limits, refer to Table 2.2. 
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Fig. 2.5. Mean concentrations (µg/L) of the industrial compounds (BPA and NP) in raw sewage 
(gray bars) and effluent (outlined white bars). (a) BPA concentrations across the four 
wastewater treatment plant locations. (b) NP concentrations across the four wastewater 
treatment plant locations. Error bars represent standard deviations from the average for sample 
replicates. For method detection limits, refer to Table 2.2. 
 
 
 
 
 
Fig. 2.6. Total estrogenicity (ng/L) in raw sewage (gray bars) and effluent (outlined bars). Graph 
depicts the total estrogenicity (EEQ) across the four wastewater treatment plant locations. Error 
bars represent standard deviations from the average for sample replicates. 
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2.3.2 Aqueous and sediment 
The distribution of six estrogenic EDCs as well as total estrogenicity in marine aqueous 
and sediment samples was determined across three study locations over fourteen months (raw 
data supplied in Appendices D and E) and is illustrated in the box-and-whisker plots of Figures 
2.7 through 2.20. The length of the box represents the interquartile range (the distance between 
the 25th and 75th percentiles). The diamond symbol in the box interior represents the group 
mean, while the horizontal line in the box interior represents the group median. The vertical lines 
(whiskers) issuing from the box extend to the most extreme points in the groups that lie within or 
equal to the fences. The upper fence is defined as the third quartile (represented by the upper 
edge of the box) plus 1.5 times the interquartile range (IQR). The lower fence is defined as the 
first quartile (represented by the lower edge of the box) minus 1.5 times the interquartile range. 
 
 
Figure 2.7. Distribution of aqueous estrone (E1) concentrations by location (shown at top) and 
campaign in Tampa Bay region aqueous samples. For method detection limits, refer to Table 
2.2. 
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Figure 2.8. Distribution of aqueous estradiol (E2) concentrations by location (shown at top) and 
campaign in Tampa Bay region aqueous samples. For method detection limits, refer to Table 
2.2. 
 
 
 
Figure 2.9. Distribution of aqueous estriol (E3) concentrations by location (shown at top) and 
campaign in Tampa Bay region aqueous samples. For method detection limits, refer to Table 
2.2. 
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Figure 2.10. Distribution of aqueous ethinylestradiol (EE2) concentrations by location 
(shown at top) and campaign in Tampa Bay region aqueous samples. For method 
detection limits, refer to Table 2.2. 
 
 
 
Figure 2.11. Distribution of aqueous bisphenol-A (BPA) concentrations by location 
(shown at top) and campaign in Tampa Bay region aqueous samples. For method 
detection limits, refer to Table 2.2. 
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Figure 2.12. Distribution of aqueous nonylphenol (NP) concentrations by location 
(shown at top) and campaign in Tampa Bay region aqueous samples. For method 
detection limits, refer to Table 2.2. 
 
 
 
Figure 2.13. Distribution of aqueous total estrogenicity (EEQ) concentrations by location 
(shown at top) and campaign in Tampa Bay region aqueous samples. For method 
detection limits, refer to Table 2.2. 
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 Figure 2.14. Distribution of sediment estrone (E1) concentrations by location (shown at 
top) and campaign in Tampa Bay region sediment samples. For method detection limits, 
refer to Table 2.2. 
 
 
 
Figure 2.15. Distribution of sediment estradiol (E2) concentrations by location (shown at 
top) and campaign in Tampa Bay region sediment samples. For method detection limits, 
refer to Table 2.2. 
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Figure 2.16. Distribution of sediment estriol (E3) concentrations by location (shown at 
top) and campaign in Tampa Bay region sediment samples. For method detection limits, 
refer to Table 2.2. 
 
 
 
Figure 2.17. Distribution of sediment ethinylestradiol (EE2) concentrations by location 
(shown at top) and campaign in Tampa Bay region sediment samples. For method 
detection limits, refer to Table 2.2. 
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Figure 2.18. Distribution of sediment bisphenol-A (BPA) concentrations by location 
(shown at top) and campaign in Tampa Bay region sediment samples. For method 
detection limits, refer to Table 2.2. 
 
 
 
Figure 2.19. Distribution of sediment nonylphenol (NP) concentrations by location 
(shown at top) and campaign in Tampa Bay region sediment samples. For method 
detection limits, refer to Table 2.2. 
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Figure 2.20. Distribution of sediment total estrogenicity (EEQ) concentrations by location 
(shown at top) and campaign in Tampa Bay region sediment samples. For method 
detection limits, refer to Table 2.2. 
 
 
Regarding the marine aqueous samples, the effect of campaign (i.e., the different times 
the sampling took place) for the endogenous estrogens E1 and E2 was significant (p <0.0001). 
However, for E3, because the limit of detection was added to those data points where E3 was 
not detected, and because there were so many repeats of the same detection limit value, the 
convergence criteria was not met. For the synthetic estrogen EE2, the effect of campaign was 
significant (p <0.0001). For the industrial compounds, the effect of campaign for both BPA and 
NP was significant (p <0.0001). Finally, for EEQ, the effect of campaign was also significant (p 
<0.0001).  
Regarding the sediment samples, there was no significant difference between the 
sampling campaigns for the endogenous estrogen E1 (p = 0.6588). For E2, the effect of 
campaign was significant (p <0.0001). For E3, again, the data did not converge due to the 
repeated detection limit values. For EE2, the sampling campaign was not significant (p = 
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0.0854). For both BPA and NP, the effect of campaign was significant (p <0.0001). Finally, for 
EEQ, the effect of campaign was significant (p = 0.0007).  
If the fixed effect of campaign was significant, post-hoc analyses were subsequently run 
in order to determine which pairs of sampling campaigns were statistically different. The results 
yielded an adjusted p-value based on the three pairwise comparisons (Table 2.3).  
For E1 and E2 concentrations in marine aqueous samples, all campaigns were 
significantly different from one another. For EE2, the April 2012 campaign was not significantly 
different from October 2012. However, April 2012 was significantly different from June 2013, 
and October 2012 was significantly different from June 2013. For BPA, all campaigns were 
significantly different from one another. For NP, the April 2012 campaign was not significantly 
different from October 2012. However, April 2012 was significantly different from June 2013, but 
the model did not yield results for the October 2012 vs. June 2013 campaign due to infinite 
likelihood (i.e., nonpositive matrix). 
 
Table 2.3.  
Post-hoc analyses for significant effect of campaign.  
  Aqueous   Sediment  
 April 2012 
v. Oct. 
2012 
April 2012 
v. June 
2013 
Oct. 2012 
v. June 
2013 
April 2012 
v. Oct. 
2012 
April 2012 
v. June 
2013 
Oct. 2012 
v. June 
2013 
E1 Sig. (p 
<0.0003) 
Sig. (p = 
0.003) 
Sig. (p 
<0.0003) 
n/a n/a n/a 
E2 Sig. (p 
<0.0003) 
Sig. (p = 
0.0006) 
Sig. (p 
<0.0003) 
Sig. (p 
<0.0003) 
Sig. (p = 
0.002) 
Sig. (p = 
0.001) 
EE2 Not sig. (p 
= 0.988) 
Sig. (p = 
0.020) 
Sig. (p 
<0.0003) 
n/a n/a n/a 
BPA Sig. (p 
<0.0003) 
Sig. (p = 
0.001) 
Sig. (p 
<0.0003) 
Not sig. (p 
= 0.433) 
Sig. (p 
<0.0003) 
Sig. (p 
<0.0003) 
NP Not sig. (p 
= 0.752) 
Sig. (p = 
0.011) 
infinite 
likelihood 
Sig. (p 
<0.0003) 
Sig. (p = 
0.021) 
Not sig. (p 
= 0.920) 
EEQ Sig. (p 
<0.0003) 
Not sig. (p 
= 0.074) 
infinite 
likelihood 
Sig. (p = 
0.008) 
Sig. (p = 
0.033) 
Not sig. (p 
= 0.062) 
Sig. = significant; n/a = not applicable. 
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Finally, for EEQ, the only significant difference was between the April 2012 and October 
2012 campaigns. The model did not yield results for the October 2012 vs. June 2013 campaign 
since an infinite likelihood was detected.  
For sediment samples, the E2 concentration was significantly different across all three 
sampling campaigns. For sediment BPA concentrations, the April 2012 campaign was not 
significantly different from the October 2012 campaign, but the other campaign pairs were 
significantly different. For NP, there was no significant difference between October 2012 and 
June 2013, but the other pairs were significantly different. Finally, for EEQ, there was no 
significant difference between October 2012 and June 2013, but the other pairs were 
significantly different.  
For the reference location (Figure 2.3), all EDCs were below the limit of detection.  
 
2.4 Discussion 
 
2.4.1 Raw sewage and effluent 
89% of the influent and effluent samples taken from regional WWTPs contained all six 
EDCs. The concentration of the EDCs in the influent was nearly always higher than in the 
effluent (Figures 2.4 and 2.5), illustrating the fact that although modern WWTPs are typically 
designed for carbon (organic matter), nitrogen and phosphorus removal, partial EDC removal is 
achieved simultaneously (Auriol et al. 2006). Since the total raw sewage concentration of EDCs 
was the sum of both the aqueous and suspended solids (particulate retained on filter) phases, 
we assessed, per compound, what percentage of the total raw sewage concentration was in 
each phase (Table 2.4). The results match well with the log Kow partition coefficients given in 
Table 1.1. The compounds with high log Kow values (EE2, NP) were detected in the suspended 
solid (particulate) phase of the raw sewage sample, while those compounds with low log Kow 
values (E3 and BPA) were detected most often in the aqueous phase. The compounds with log 
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Kow values in the middle (E1 and E2) showed the largest range of variability, indicating that 
sorption can play an important role, yet the polar groups on these compounds allow them to 
remain soluble in aqueous phases as well. 
Table 2.4  
Raw sewage percent composition of aqueous and particulate phases.  
  E1 E2 EE2 E3 BPA NP 
April 
2012 
Aqueous 17-81% 20-34% 23-45% 52-81% 91-99% 4-61% 
 Particulate 19-83% 66-80% 54-76% 19-48% 1-9% 39-96% 
        
October 
2012 
Aqueous 17-69% 19-78% 34-44% 59-91% 64-88% 23-44% 
 Particulate 31-83% 22-81% 56-66% 9-41% 12-36% 56-77% 
        
June 
2013 
Aqueous 77-
100% 
64-92% 16-40% 98-
100% 
92-
100% 
12-54% 
 Particulate 0-23% 8-36% 60-84% 0-2% 0-8% 46-88% 
 
During the April 2012 (spring) campaign, the percent removal of the natural estrogens 
was high and mostly above 90% (See Appendix C). However, it appears that E1 at the Manatee 
location was not well removed (the influent concentration was 34 ng/L and the effluent 
concentration was 24 ng/L). Because E1 is a metabolite of E2, E2 is rapidly degraded to E1 in 
the secondary (biological) step of wastewater treatment. The accumulated E1 is then slowly 
transformed further, but this conversion (oxidation) reaction could explain why the E1 removal 
appears to be extremely low. During October (autumn), the percent removal of the natural 
estrogens fell somewhat, keeping in mind that conversion reactions could be occurring during 
this season as well. In June 2013 (summer), the percent removal increased again although 
there may still be conversion from E1 to E2 occurring. The observation of much higher 
concentrations of E2 in the influent than the effluent is consistent with the rapid biodegradation 
of E2 into E1 under aerobic conditions during the course of secondary (biological) wastewater 
treatment (Lee et al. 2004). Another significant phenomenon is deconjugation of the natural 
steroids. Natural estrogens are excreted by both males and females, and prior to excretion, the 
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metabolic system of humans and other animals conjugates these hormones to glucuronides, 
sulfates or acetates (Komori et al. 2004, Esperanza et al. 2007). Conjugation serves to 
inactivate hormonal action and increase water solubility so the hormones can be excreted via 
urine. When estrogen hormones enter the WWTP, they may still be conjugated. Upon exposure 
to bacteria producing the enzyme β-glucuronidase (as in activated sludge treatment), the 
estrogen conjugates are cleaved and the free estrogen is released. The fact that the free 
estrogen is tied up in conjugated form may explain why the mean concentrations of natural 
estrogens in raw sewage sometimes seem to be comparable to or even lower than the effluent. 
This phenomenon certainly depends on the amount of conjugated estrogens entering the plant 
at any point in time, since a lower fraction of conjugates entering the plant would not produce 
the same effect. This may also vary between WWTPs due to differing hydraulic retention time 
(HRT), solids retention time (SRT) or advanced treatment technologies. Longer HRT and SRT 
allows for increased efficiency in EDC removal, as do additional advanced treatment processes. 
In this study, we observed that E1 and E2 concentrations decreased after wastewater treatment 
100% of the time. The observed amounts of endogenous estrogen hormones (E1, E2, E3) in 
this study is consistent with other published studies (Ternes et al. 1999, Komori et al. 2004, 
Kanda and Churchley 2008).   
Mean EE2 influent concentrations ranged from 4.1 ng/L to 9.8 ng/L, and these values 
are consistent with values in the published literature. Previously reported concentrations of EE2 
in influent from the United States, Europe and Canada are in a range similar to that of our study 
(Baronti et al. 2000, Cargouët et al. 2004, Kumar and Xagoraraki 2010, Atkinson et al. 2012, 
Ziels et al. 2014). The amount of EE2 entering a WWTP depends, in large part, on the 
proportion of the population using products with EE2 as an active ingredient and then excreting 
it unchanged into the wastewater system. The mean EE2 effluent concentrations ranged from 
1.0 ng/L to 4.3 ng/L, and are also consistent with values in the published literature. Purdom et 
al. (1994) state that only 0.1 ng/L of EE2 is enough to cause induction of vitellogenin (a 
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biomarker for estrogenic endocrine disruption) in fish when compared to a control (Table 2.5). 
This illustrates that although significant removal is occurring at the WWTP, endocrine disruption 
is still a concern since the EE2 effluent values are well above 0.1 ng/L.  
 
Table 2.5  
Endocrine-disruptive levels of select EDC compounds.  
 Level at 
which 
disruption 
occurs 
Species Developmental 
Stage 
Endocrine-
disrupting 
effect 
Single 
compound 
or mixture 
exposure 
Reference  
E2 1 ng/L Male Rainbow 
trout 
(Oncorhynchus 
mykiss) 
Adult primary 
fish cells 
(hepatocytes)  
Induction 
of VTG 
Single Hansen et 
al. (1998) 
EE2 0.1 ng/L Male Rainbow 
trout 
(Oncorhynchus 
mykiss) 
Adult Induction 
of VTG 
Single Purdom et 
al. (1994) 
EE2 25 ng/L Mollusk 
(Potamopyrgus 
antipodarum) 
Adult Embryo 
production 
Single Jobling et 
al. (2002) 
EE2 1 ng/L Fathead 
minnow 
(Pimephales 
promelas) 
Adult Induction 
of VTG/egg 
production 
Single Jobling et 
al. (2002) 
BPA 5 µg/L Mollusk 
(Potamopyrgus 
antipodarum) 
Adult  Embryo 
production 
Single Jobling et 
al. (2002) 
BPA 25 µg/L Male Rainbow 
trout 
(Oncorhynchus 
mykiss) 
Adult primary 
fish cells 
(hepatocytes)  
Induction 
of VTG 
Single Hansen et 
al. (1998) 
NP 14 µg/L Male Rainbow 
trout 
(Oncorhynchus 
mykiss) 
Adult primary 
fish cells 
(hepatocytes)  
Induction 
of VTG 
Single Hansen et 
al. (1998) 
 
 
Regarding industrial compounds, in October 2012 the HFC plant had an effluent 
concentration of BPA that nearly equaled the influent concentration. BPA is also subject to 
conjugation before excretion, and the nearly identical concentrations in both influent and effluent 
could be a reflection of deconjugation occurring at the WWTP which releases free BPA, 
especially since the influent concentration is relatively low. For NP, sorption may play a more 
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important role in its fate than biodegradation. Our NP concentrations in both influent and effluent 
were lower than those found by Janex Habibi et al. (2009) yet comparable to the NP 
concentrations found in other studies (Johnson et al. 2005, Soares et al. 2008). 
Regarding total estrogenicity (EEQ), although all removals were statistically significant 
except one, the remaining estrogenicity of the sample is still of interest with respect to endocrine 
disruption. EE2, with its high EEF, is typically the main contributor to the estrogenicity of a 
sample, and as stated above, the EE2 concentrations in the effluent were high enough to cause 
vitellogenin induction alone. Total estrogenicity takes into account the contributions from all 
other compounds as well.   
When it comes to the behavior of organic compounds in the various stages of the 
WWTP, partitioning coefficients become very important. The octanol-water partition coefficient, 
Kow, is the ratio of the concentration of a chemical in octanol and water at equilibrium at a 
specified temperature. This is an important parameter in that it can be used to predict other 
properties such as sorption or bioconcentration factors (Pontolillo et al. 2001). The base-10 
logarithm is commonly used to characterize its value since the raw values cover an extremely 
wide range. The greater the log Kow of a compound, the more hydrophobic it is and the more 
likely sorption is to play an important role in the compound’s movement (Chang et al. 2002). 
Since estrogens are hydrophobic organic compounds, sorption could play an important role in 
the movement of these compounds from the aqueous phase to the particulate phase. The two 
compounds with the highest log Kow values, EE2 and NP, can be expected to sorb strongly to 
sludge, limiting their degradation and increasing their half-lives in sewage. However, the two 
compounds with the lowest Kow values, E3 and BPA, can be expected to rely less on sorption as 
they are more hydrophilic. The advantage is that these compounds typically favor the aqueous 
phase, making them susceptible to either biological degradation (secondary treatment) or 
tertiary treatment processes. As seen from our data, the removal of E3 and BPA was 
consistently high. This is also reflected in Table 2.4 where these compounds reflect this very 
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behavior in raw sewage samples. Desorption of estrogenic EDCs from sewage sludge has been 
demonstrated, but typically occurs when the pH is higher than the pKa of the compound—for 
example, during sludge conditioning (Ivashechkin et al. 2004). 
A potential limitation of this study is the fact that sludge was not sampled from the 
WWTPs. The sludge matrix is an important part of assessing the distribution of EDCs between 
the solid and liquid phases. Sorption to sludge can be predicted from partitioning coefficients 
and calculations, but a more accurate approach would be to incorporate samples of both sludge 
and liquid phases into the study (Carballa et al. 2007). 
 
2.4.2 Aqueous and sediment  
Because campaign was a fixed factor, differences between campaigns were of interest 
and were statistically evaluated through post-hoc analyses. Looking at the aqueous distribution 
of the 6 EDCs (Figures 2.7 through 2.12), most of the location groups (between the vertical 
dashed lines) exhibit an interesting inverted V-shaped pattern where the October 2012 
campaign had higher levels of EDCs than the campaigns surrounding it (April 2012 and June 
2013). When evaluating the post-hoc analyses, the tests showed that there were indeed 
statistical differences between the different campaigns (Table 2.3). The advantage of using 
random effects analyses is that the results regarding the effect of campaign can be generalized 
to the greater population of locations influenced by WWTP discharge. From our results, we 
conclude that monthly (seasonal campaign) differences will likely occur in a location subjected 
to WWTP discharge, with Fall (October) seasonality showing lower removal rates and higher 
discharge levels to the environment than the Spring (April) or Summer (June) months. 
Additional seasonal and annual sampling must be conducted to confirm this trend. In the 
WWTP, conditions must be favorable for the microbial community of the activated sludge 
system to grow. A major factor is temperature, which has a significant effect on the growth rate 
and metabolism of microorganisms. With increasing temperature (to a point), an increase in 
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growth rate and metabolism is observed. In summer months, wastewater temperature is 
typically high (>20°C), which results in increased biodegradation efficiency (Henze 2008). This 
temperature-induced change in microbial metabolic rates can possibly account for the inverted 
V-shaped pattern we observe in the boxplots. In the cooler temperatures in Fall (October), the 
microbial degradation rate may have decreased, leading to higher compound concentrations 
being discharged to the environment. The opposite would be true for Spring and Summer 
months where the increased temperature would lead to greater degradation efficiency and thus 
lower compound concentrations being discharged to the environment. To support this 
observation, a study by Manickum (2014) of the occurrence of EDCs in South African 
wastewater showed that lowest removals for E2 occurred in the Spring season while the highest 
removals occurred in the winter season. Because South Africa is in the southern hemisphere 
(and the seasons are reversed), these observations support those of our study.  
Regarding the sediment distribution of the 6 EDCs (Figures 2.14 through 2.19), we 
noticed the same inverted V-shaped pattern for most of these samples. The linear mixed model 
(LMM) results showed that for E1 and EE2, there was no significant difference in their 
concentration between sampling campaigns. For the compounds with a significant effect of 
campaign, post-hoc analyses disclosed, similar to the aqueous samples, exactly where the 
significant differences were (Table 2.3).   
The Clearwater site was the only location out of the three where samples were taken in 
a linear pattern downstream of the discharge point. We expected the concentration of the six 
EDCs to decrease with increasing distance from the site, and representative plots of the 
aqueous samples from April 2012 show that this was indeed the case (Figure 2.9 through 2.11).  
Environmental conditions (e.g., pH, salinity, sediment concentration, particle size, 
presence of colloid particles) can affect the sorption and/or the degradation of these compounds 
(Bowman et al. 2002). For seawater, Braga et al. (2005) determined that steroid estrogens sorb 
to fine effluent particles which, on contact with higher ionic strength seawater, settle to the 
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seafloor. The anoxic conditions of marine sediments do not promote degradation, and therefore 
the half-lives of steroid estrogens in sediments are on the order of many days to months. 
Though not steroidal in nature, BPA and NP can be degraded by aerobes in seawater (usually 
after a lag phase to allow the microorganisms to become acclimated to the chemicals), but 
under the anoxic conditions of marine sediment, limited biodegradation is also observed 
(Cajthaml et al. 2009). Environmental biodegradation of these compounds is likely to occur via 
degradation intermediates before complete remineralization (Lee and Liu 2002, Danzl et al. 
2009, Vega-Morales et al. 2010).  
 
 
 
Figure 2.21. Illustration of the decreasing aqueous concentrations of steroid endocrine-
disrupting compounds (EDCs) with increasing distance from the discharge point.  
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Figure 2.22. Illustration of the decreasing aqueous concentration of bisphenol-A (BPA) with 
increasing distance from the discharge point. 
 
 
 
Figure 2.23. Illustration of the decreasing aqueous concentration of nonylphenol (NP) with 
increasing distance from the discharge point. 
 
 
For the sediment samples (during the April 2012 campaign), we did not observe the 
same pattern of decrease as in the aqueous samples. Distribution in the sediments was much 
more random than found in the aqueous samples. Possible reasons for this include the fact that 
water quality issues in Stevenson Creek (Clearwater, FL) have historically been attributed to 
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urban storm water runoff and discharges from the Marshall Street Advanced WWTP (Parsons 
2001). However in 2010, a federal dredging project was contracted but the project stalled in that 
same year. We began sampling in 2012, and earlier that year the dredging was restarted only to 
be stalled again. The dredging is likely to cause resuspension and redistribution of the 
contaminants from the upper layers of the sediment, which could explain why the sediment 
distributions were more cluttered than they were linear.  
The use of graduated-symbol maps can help illustrate the distribution of a parameter 
along a specific geographic site. We constructed eighteen maps which show the distribution of 
total estrogenicity (EEQ) for the three sites across three sampling campaigns and both 
environmental matrices (i.e., marine aqueous and sediment). Representative maps for the 
Clearwater site from April 2012 are shown here (Fig. 2.24 and 2.25), and the remaining maps 
can be found in Appendix F. As can be observed from the aqueous map (Fig. 2.24), the total 
estrogenicity was highest near the discharge point (refer to Figure 2.3c for location of the 
discharge point), and decreased with increasing distance from this site. However, the sediment 
map shows a different trend, with total estrogenicity showing no direct change with increasing 
distance. This pattern can again be possibly attributed to the dredging that had just occurred 
prior to the April 2012 sampling trip. The dredging project was to remove accumulated sediment 
and muck from Stevenson Creek in order to restore it to pre-polluted conditions. Any EDCs 
(which contribute to the total estrogenicity) stored in the top layer of the sediment would 
potentially have been resuspended and transported away due to the brief dredging activity. The 
Clearwater aqueous samples from the October 2012 and June 2013 campaigns showed the 
same trend as the April 2012 samples-- total estrogenicity decreased with increasing distance 
from the discharge site (Appendix F). Likewise, the Clearwater sediment samples from the 
October 2012 and June 2013 campaigns showed similar trends to the April 2012 samples—total 
estrogenicity was nearly constant with increasing distance from the discharge site.  
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Figure 2.24 Graduated-symbol map for the Clearwater site. The map illustrates the difference in 
total estrogenicity in aqueous samples from April 2012 as Stevenson Creek flows northwest. 
EEQ units = ng/L. Refer to Figure 2.3c for the discharge point. 
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Figure 2.25. Graduated-symbol map for the Clearwater site. The map illustrates the difference 
in total estrogenicity in sediment samples from April 2012 as Stevenson Creek flows northwest. 
EEQ units = ng/g. Refer to Figure 2.3c for the discharge point. 
 
 
The St. Petersburg site consisted of sampling stations that form a radiating “X” pattern 
(Appendix F) and the four arms radiate out from the remnant discharge point. The EEQ 
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concentrations during the October 2012 and June 2013 campaigns were twice that of the April 
2012 campaign. As can be observed from the three sampling campaigns, no consistent pattern 
emerges since the total estrogenicity was higher towards the east in April, the west in October 
and the northwest in June. The dynamic movement of water in Middle Tampa Bay could 
potentially account for these findings. Regarding the St. Petersburg sediment concentrations, 
the October campaign had the highest estrogenicity of the three, yet within each campaign the 
differing stations seem to have fairly consistent concentrations along each arm. These findings 
in both the water and sediment of the St. Petersburg site are significant due to the fact that the 
Albert Whitted Water Reclamation Facility switched to deep-well injection in 1992. At the time of 
our sampling it had been nearly twenty years since the Albert Whitted facility stopped surface 
water discharge, yet the presence of EDCs in our samples illustrate the pervasive and 
ubiquitous nature of these compounds.  
The Tampa site consisted of sampling stations that form a chromosome-like shape, and 
the arms radiate out from the central discharge plume. For the aqueous samples, the October 
campaign had the highest EEQ concentrations of the three, and the only consistent pattern 
observed across the three campaigns is the northeast arm having high estrogenicity. Again, the 
dynamic movement of Hillsborough Bay would account for this variance, being that the water of 
Tampa Bay is highly subject to tides and currents. The Tampa sediment samples showed the 
highest estrogenicity concentrations of all three sites. The Howard F. Curren Advanced 
Wastewater Treatment Plant serves nearly 347,000 people, and we expected the effluent 
discharge to contain compounds which contributed significantly to the total estrogenicity. Within 
the three campaigns, October had the highest EEQ concentrations.    
 
2.5 Conclusions 
Even though conventional WWTP processes can achieve partial removal of EDCs, there 
is still detectable estrogenicity documented in the final effluent at levels which could still result in 
61 
 
significant biological effects (Purdom et al. 1994).  To avoid potential risks caused by EDCs in 
aquatic environments, their removal from sewage at the level of the WWTP, before final release 
into the environment, must be improved (Weber et al. 2004, Silva et al. 2012). Municipalities 
worldwide are anticipating future requirements for the removal of EDCs in treatment plants 
(Cicek et al. 2007). The ultimate goal of elimination needs to focus on (re)mineralization of the 
EDCs, not just adsorption onto sewage sludge. The nonpolar and hydrophobic nature of many 
EDCs allows them to adsorb onto sludge, but consequently the use of digested sludge as a 
fertilizer (which contains essential nutrients) may then cause contamination of soil and ground 
water (Auriol et al. 2006). Identifying removal processes that are cost effective will continue to 
be an important area of research in the field of marine pollution.  
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CHAPTER THREE: REMOVAL OF SIX ESTROGENIC ENDOCRINE-DISRUPTING 
COMPOUNDS (EDCs) FROM MUNICIPAL WASTEWATER USING ALUMINUM 
ELECTROCOAGULATION  
 
3.1 Introduction 
Micropollutants are chemical contaminants found in the aquatic environment in the µg/L 
(ppb) or ng/L (ppt) concentration range and are considered to be potential threats to 
environmental ecosystems (Clara et al. 2005b, Virkutyte et al. 2010). Both domestic and 
industrial wastewaters contain micropollutants which are not entirely removed by conventional 
wastewater treatment plant (WWTP) processes and are therefore continually discharged into 
the aquatic environment (Auriol et al. 2006). The contamination origin of micropollutants is 
predominantly anthropogenic and the aquatic environment becomes the final resting place for 
the majority of these chemical compounds (Mompelat et al. 2009, Hester and Harrison 2011).  
 Endocrine-disrupting compounds (EDCs) are an important class of micropollutants that 
are defined as exogenous chemicals, or mixtures of chemicals, that can interfere with any 
aspect of hormone action (Zoeller et al. 2012). EDCs are a particularly troublesome subset of 
micropollutants, due to their diverse nature, persistence in the environment and ability to cause 
metabolic and reproductive disturbances at very low concentrations. EDCs can enter the 
aquatic environment directly (e.g., through effluent discharge) or indirectly (e.g., storm-water 
runoff), but the major transport of EDCs to the aquatic environment is through WWTP (effluent) 
discharge to rivers, streams and surface waters (Clara et al. 2005b, Falconer et al. 2006). 
Potable water resources include both surface water and groundwater, and contamination can 
occur through surface water discharge or deep-well injection of WWTP effluent which transports 
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EDCs to groundwater supplies (Mompelat et al. 2009). Effects of EDCs on wildlife 
(invertebrates, fish, amphibians, reptiles, birds and mammals) include abnormal blood hormone 
levels, altered gonadal development (e.g., imposex and intersex), induction of vitellogenin 
(VTG) gene and protein expression in juveniles and males (the physiological production of VTG 
is specific to females—it is usually a silent gene in males), masculinization/feminization, 
hermaphroditism and decreased fertility and fecundity (Jobling et al. 2004, Kidd et al. 2007, 
Janex-Habibi et al. 2009, Nadzialek et al. 2010).  
 Estrogenic EDCs specifically target estrogen signaling. These include natural steroidal 
estrogens, synthetic estrogens and industrial compounds which mimic estrogen. 17β-estradiol 
(E2) is the primary natural estrogen and has the greatest potency. Estrone (E1), a metabolite of 
E2, is a slightly weaker estrogen. Estriol (E3), considered to be the final metabolite, is the 
weakest natural estrogen, with only 10% of E2’s potency. 17α-ethinylestradiol (EE2) is the 
synthetic steroidal estrogen component of combined oral contraceptive pills (i.e., those which 
contain an estrogen and a progestin) as well as transdermal patches and vaginal ring 
formulations (Spencer et al. 2009).  The overall estrogenicity of EE2 in effluent overshadows 
that of both E1 and E2 combined, due to its high estrogenic potency (Cicek et al. 2007). 
Bisphenol-A (BPA) is a monomer used in the resin and polycarbonate plastic industry to 
produce lacquers, food-can liners and thermal paper (Danzl et al. 2009). It has high water 
solubility and enters WWTPs through industrial discharges and leaching from BPA-based 
products. Nonylphenol (NP) is the final product of the biodegradation of the non-ionic surfactant 
nonylphenol ethoxylate (NPEO). NP is more persistent and more toxic than the ethoxylated 
form. NP also has estrogenic activity, unlike the parent compound (Gultekin and Ince 2007).  
 Conventional WWTP processes are designed for organic matter, nitrogen, phosphorus 
and pathogen removal. As seen in Chapter 2 of this dissertation, the effluent from conventional 
WWTPs still contains EDCs at levels ranging from a few ng/L to several µg/L--sufficient to cause 
endocrine disruption in some species. The concentrations of EDCs in WWTP influent clearly 
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vary according to geographic location and population served. The removal of EDCs during 
treatment, and thus EDC concentration in the final effluent, will also vary according to the 
WWTP processes employed (Fernandez et al. 2009). Some wastewater treatment processes 
are more effective than others for EDC removal as evidenced by monitoring studies.  
The activated sludge (AS) process (i.e., biological treatment) is effective against those 
compounds which are readily biodegradable or which bind to sludge solids (Kim et al. 2007). 
The AS process can provide a high removal of natural steroid hormones (>90% in some cases) 
as well as BPA, but it is highly dependent on the sludge retention time (SRT), with SRTs over 
10 days demonstrating better results (Clara et al. 2005a). However, even with an SRT over 10 
days, the removal is still not complete, and measured effluent concentrations (even at such low 
concentrations as ng/L) can still be sufficient to cause endocrine disruption. This then opens the 
door for additional techniques to reduce the contaminant levels even lower (Lee et al. 2004, 
Janex-Habibi et al. 2009). As discussed in Chapter 1, many treatments beyond the AS process 
are available to further clarify secondary effluent, but they tend to be limited by expense, 
maintenance and variable efficacy.  
For the above reasons, and because one single process is not sufficient to remove 
EDCs, additional technologies that are effective at reducing EDC concentrations at the level of 
the WWTP are becoming very important. Electrocoagulation (EC) technology removes 
contaminants by passing an electrical current through a water sample. EC is based on the in 
situ generation of coagulant precursors by electrolytic oxidation of sacrificial anode material—
usually aluminum or iron. During the EC process, amorphous insoluble polymeric metal 
hydroxides and oxides are formed which adsorb pollutants (particulate and dissolved) during 
precipitation, making them easily separable (Mollah et al. 2001, Rodriguez et al. 2007). The 
most widely used electrode materials, aluminum and iron, are both inexpensive and effective 
against a wide range of pollutants, including soluble organic pollutants (Canizares et al. 2007). 
Patented over a century ago, EC has a long history as a water treatment technology. However, 
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EC was abandoned by the 1930’s due to high operation costs as well as due to the chemicals 
for chemical coagulation treatment being readily available and inexpensive (Holt et al. 2005). 
Recent technical and design improvements, combined with a growing need for cost-effective 
water treatment processes, have led to a re-evaluation of EC technology (Holt et al. 2005). The 
purpose of the present study was to test the removal efficiency of a laboratory-scale 
electrocoagulation unit with respect to six estrogenic endocrine-disrupting compounds in WWTP 
influent and tertiary-treated effluent. 
 
3.2 Materials and Methods 
 
3.2.1 Preliminary tests and optimization of parameters 
The parameters used for this laboratory-scale study were chosen based upon a series of 
tests performed to evaluate EDC removal efficiency using different EC conditions and 
configurations (Appendix G). The optimal parameters used for this study were as follows: 
aluminum blades as the sacrificial electrodes, 3-lead arrangement of electrical connections, 
sample retention time of 2 min/L in the EC reaction chamber, volts held in the range of 85 to 98 
and amperes held in the range of 8.5 to 15.5. Inclusion of a precise cleaning step was important 
in the preliminary testing, as EDCs were found to ‘stick’ to the walls of the unit and tubing. 
Cleaning the instrument properly between replicate runs (described below) was experimentally 
tested and used in our EC processing procedure.  
 
3.2.2 Electrocoagulation unit 
The EC unit (Fig. 3.1) is a 110-volt demonstration unit manufactured and supplied by 
Powell Water Systems, Inc. (Centennial, Colorado, USA; United States patent number 7211185 
B2). The power source is a 110-volt alternating current (AC) to direct current (DC) power 
converter (allowing direct line voltage to be converted from AC to DC) with voltage control. The 
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pump is a Cole-Parmer® Masterflex Peristaltic Pump System (Vernon Hills, IL, USA) equipped 
with a 1/20-horsepower unidirectional motor and a separate single-turn speed control. The EC 
unit chamber (35.6 cm x 5.4 cm x 2.5 cm) is made of a non-conductive acrylic resin and has a 
total volume of 487.5 ml. Nine aluminum reaction blades (30.5 cm x 2.5 cm x 0.3 cm) were 
arranged vertically inside the chamber with an electrode gap of 3.18 mm. This vertical 
arrangement promotes a vertical flow of liquid through the chamber. The volume of one blade is 
24.6 cm3 and the volume of all nine blades equals 221.2 cm3, leaving a residual chamber 
volume of 266.3 ml. The EC unit was operated with a 3-lead arrangement of electrical 
connections (power attached to blades 1, 5 and 9; Fig. 3.2) which results in a configuration of 
two anodes and one cathode. The inflow tube measures 1.2 m. 
 
3.2.3 Chemical standards 
Analytical standards E1, E2, E3, EE2, BPA, NP and 5α-androstanol (internal standard) 
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Methanol (HPLC grade and Certified 
ACS) and pyridine (Certified ACS) were purchased from Fisher Scientific (Pittsburg, PA, USA). 
N, O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (TMCS) was 
purchased from Regis Technologies (Morton Grove, IL, USA). Ultrapure (DI) water was 
acquired from a US Filter PureLab Plus system at the University of South Florida College of 
Marine Science.  
 
3.2.4 Wastewater 
 Wastewater samples for the experiment were collected from South Cross Bayou Water 
Reclamation Facility, a tertiary treatment plant located in St. Petersburg, Florida (USA) which 
serves a population of approximately 260,000. The average wastewater flow per day is 20 
million gallons (rated for 33 MGD), and 85% of the wastewater is domestic in origin, while less 
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than 15% is industrial in origin. South Cross Bayou’s wastewater treatment processes follow the 
graphic in Fig. 3.3 (page 74).  
 
 
Fig. 3.1. Schematic of laboratory-scale electrocoagulation unit. 
 
Fig. 3.2. Diagram and close-up picture of the nine aluminum blades showing the electrical 
connections to blades 1, 5 and 9. The (+) represents the two anodes and the  (-) represents the 
one cathode. The arrows show the flow of electrons through the system.  
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Fig. 3.3. Illustration of South Cross Bayou’s wastewater treatment process. Sludge is processed 
and converted into fertilizer pellets sold commercially for agricultural use. Stars indicate 
collection points of influent and effluent samples for the experiment.  
 
 
3.2.5 Blanks 
 Field blanks were taken at the sample site. Laboratory blanks (DI water spiked with 
internal standard) were extracted with each batch of samples. GCMS instrument blanks (blank 
solvent injections) were performed every 8 samples. All EDCs were undetectable in the blank 
samples. Specifically regarding the DI water blanks that were run through the EC unit in 
between replicate runs, the amount of EDCs was undetectable, illustrating the effectiveness of 
the solvent cleaning step performed between runs. 
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3.2.6 Experimental design/electrocoagulation processing 
Both raw WWTP influent and tertiary-treated effluent were tested in this study in order to 
determine not only if the effectiveness of EC for removing EDCs is matrix-dependent, but also to 
assess the possibility of using EC as a post-treatment in traditional WWTPs. Samples were 
collected the morning of the experiment in methanol-cleaned, 20 L high-density polyethylene 
carboys. Influent samples were taken at the headworks of the plant while effluent samples were 
collected after dechlorination. After sampling, the carboys were immediately transported to USF 
and refrigerated at 4°C until processing. In the lab, 8 spiked-wastewater replicates (outlined 
below) were created for both the influent and effluent. Half of the spiked-wastewater replicates 
(n=4) went straight to analysis (pre-EC) and the other half (n=4) were processed via 
electrocoagulation (post-EC).  
Due to the threat of BPA leaching from different products used in the experiment, BPA 
removal assays were conducted separately from the remaining EDCs. Preliminary experiments 
indicated elevated levels of BPA in the EC-treated samples which likely originated from leaching 
of the plastic holding containers which were used to collect the EC effluent. Because the EC 
effluent can reach high temperatures (measured average temperature 69°C), this likely induced 
leaching from the containers into the sample itself.  The current experiment utilized pre-cleaned 
glass containers to capture the EC-treated effluent in order to reduce BPA contamination. The 
only part of the EC experiment that could not be substituted was the inflow tube, which was 
manufactured with BPA in the Tygon material (discussed below).  
Since background concentrations in the WWTP influent and effluent were too low to 
demonstrate significant removal potential by the EC unit, it was necessary to spike both with 
EDCs. Stock standards were made up in methanol and, due to the low water solubility of 
steroids, were added to the pre-EC sample via methanol (250 µL). Three liters of WWTP 
influent were spiked with approximately 5 µg each of estrone (E1), estradiol (E2), estriol (E3), 
ethinylestradiol (EE2) and approximately 20 µg nonylphenol (NP) after being filtered through a 
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1.5 µm pore size, glass microfiber filter (Whatman 934-AH).  Similarly, 3 L of WWTP effluent 
were spiked with the aforementioned EDCs.  
In order to test the removal efficiency of the EC unit, 3 L of spiked WWTP influent (n=4) 
and effluent (n=4) were separately processed through the EC unit via a recirculation method, 
where the original sample was passed through the unit, discharged from the unit and then 
circulated back through the unit. The pump speed was set at 8 which corresponded to a 
retention time of 2 min/L in the EC chamber. The voltage fluctuated between 85 - 98 and the 
ampere readings fluctuated between 9 – 15.5 during EC treatment. Once the sample was 
collected from the EC unit, it was allowed to sit while coagulation began. After approximately 20 
minutes, the EC-treated sample was filtered through two, Whatman Grade 1 filters (pore size 11 
µm) in order to separate the flocculent (sludge phase) from the treated water (aqueous phase). 
The final volume captured for analysis was 1.0 L. 
For the BPA assays, 3 L of WWTP influent (n=4) and effluent (n=4) were spiked with 
approximately 20 µg of BPA and processed through the EC unit via a one-time flow-through 
method where the sample would not retouch the Tygon inflow tube (manufactured with BPA). 
Since the temperature of the EC effluent could get as hot as 69°C, a one-time flow-through 
method was essential in order to prevent BPA leaching from the Tygon inflow tube. The pump 
speed was set at 2.2 which still corresponded to a retention time of 2 min/L. The voltage 
fluctuated between 94 – 98 and the ampere readings fluctuated between 8.5 – 14.5. The post-
EC sample was collected as previously described after the flocculent was separated from the 
treated water.  
To ensure against cross-contamination between reported replicates, the EC unit was 
cleaned in between each run to remove any residual EDCs. The EC unit was cleaned by first 
removing the blades and rinsing the unit with tap water. The blades were scrubbed with steel 
wool in order to remove the build-up of the oxidizing layer. The scrubbed blades were then reset 
and the unit was flushed with 1 L ACS methanol to remove residual EDCs and 2 L DI water to 
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rinse the unit of residual methanol. Once the unit was cleaned, DI water laboratory blanks were 
passed through the unit (no power) to ensure that no EDCs were caught and/or remaining in the 
unit. Polarity reversal of the electrodes was implemented between runs to help prevent the 
build-up of an oxidizing layer on the blade surface.  
 
3.2.7 Solid phase extraction 
In order to determine the concentration of EDCs, the pre-EC and post-EC 1 L samples 
were processed via solid phase extraction (SPE) within 24 hours and subsequently analyzed via 
gas chromatography-mass spectrometry (GCMS). An Evolute ABN (Acid, Base, Neutral) 
column (6 mL/200 mg, Biotage; Charlotte, NC, USA) was conditioned with methanol and 
equilibrated with DI water. The sample was then loaded onto the column at a flow rate of 15 
mL/min using a large volume extraction tank (Biotage, USA) and an SPE vacuum pump. EDCs 
retained in the column matrix were eluted with 6 mL methanol. The eluate was spiked with 5 μg 
internal standard and evaporated to dryness under a gentle stream of nitrogen. Recoveries of all 
compounds were documented and accounted for in the final quantification.  
 
3.2.8 Determination of EDC concentrations  
Samples were derivatized to their trimethylsilyl (TMS) ethers by adding 250 μL of BSTFA 
+ 1% TMCS and 250 μL of pyridine, followed by heating in a 60°C water bath for 40 min in order 
to drive the derivatization reaction to completion. Samples were then transferred to a 2 mL vial 
via low volume insert for analysis by GCMS. The GCMS system (Bruker; Fremont, CA, USA) 
consisted of a Varian 3800 gas chromatograph coupled with a Varian 320 mass spectrometer. 
The GCMS was equipped with a 30 m x 0.25 mm (internal diameter) ZB-5MS (Phenomenex; 
Torrance, CA, USA) fused silica capillary column coated with a 5% phenyl arylene/95% 
dimethylpolysiloxane stationary phase (film thickness 0.25 μm). Helium (high purity) was used 
as the carrier gas at a flow rate of 1 mL/min. The GC oven temperature was programmed to 
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begin at 150°C with an initial hold time of 2 min, followed by a temperature ramp of 6°C/min until 
reaching 310°C. The final hold time was 6 min for a total run time of 35 min. The MS was 
operated in selected ion monitoring (SIM) mode for quantitative analysis using electron impact 
(EI) ionization at 70 electron volts (eV). The dwell time per atomic mass unit (amu) was 0.5 
seconds, and the quantitative and confirmatory ion fragments are outlined in Table 3.1.  
Table 3.1 
Characteristics of estrogenic endocrine-disrupting compounds and internal standard.  
Compound Type Retention time 
(min) 
Quantitative ion Confirmatory 
ion(s) 
Nonylphenol (NP) Industrial 
estrogen mimic 
11.8 179 180, 292 
Bisphenol-A (BPA) Industrial 
estrogen mimic 
16.2 357 358, 372 
5α-androstanol Internal standard 18.0 333 258 
Estrone (E1) Natural estrogen 21.9 342 218, 257 
17β-Estradiol (E2) Principal natural 
estrogen 
22.4 416 129, 285 
17α-
Ethinylestradiol 
(EE2) 
Synthetic 
estrogen 
23.8 425 440 
Estriol (E3) Natural estrogen 24.8 504 386 
 
 
3.2.9. Statistical Analysis  
SAS version 9.3 (SAS Institute Inc.; Cary, NC, USA) was used for statistical analysis of 
data retrieved from GCMS analysis.  All values are reported as mean±SD. If a normal 
probability distribution was justified, parametric testing was performed using a 2-tailed t-test 
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(test statistic t). With equality of variances, the Pooled method was used. With unequal 
variances, the Satterthwaite approximation was used. If a normal probability distribution could 
not be justified, non-parametric testing was performed using the Wilcoxon Rank Sum test (test 
statistic S). The criterion for statistical significance was set at p≤0.05.  
 
3.3 Results and Discussion 
  
3.3.1 EC removal of EDCs from spiked-WWTP influent 
 The removal achieved for each of the six EDCs from spiked-WWTP raw influent samples 
is illustrated in Fig. 3.4. The removal efficiency ranged from 56.2% (estriol, E3) to 80.5% 
(nonylphenol, NP). Furthermore, each EDC post-EC had a statistically lower mean 
concentration than pre-EC (Table 3.2, page 81). NP showed the greatest removal at 80.5%. 
Other studies (Ciorba et al. 2002, Martins et al. 2006) have investigated the removal of 
nonylphenol ethoxylates (NPEOs), but to our knowledge this is the first study to test the removal 
by electrocoagulation of the estrogenic breakdown product, NP.  
 
Figure 3.4. Endocrine-disrupting compound concentration in spiked raw influent samples, 
showing the difference pre- and post-electrocoagulation treatment. Error bars for E1, E2, EE2 
and E3 are within the thickness of the bar graph outline. 
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A significant finding was the removal of EE2 at 63.8%, which is important for two 
reasons: 1) this synthetic component of contraceptive products exhibits potent estrogenicity in 
the environment, with evidence of endocrine disruption at concentrations as low as 0.1 ng/L to 1 
ng/L (Purdom et al. 1994, Kidd et al. 2007) and 2) the recalcitrant nature of this compound has 
led to poor removal with regards to other treatment processes (Cicek et al. 2007). 
E3 showed the lowest removal (56.2%) of all the compounds, which could be explained by its 
physico-chemical properties and its lower affinity for sorption onto organic solids. The octanol-
water partition coefficient (Kow) describes the partitioning behavior of a compound between 
water and organic phases. The higher the Kow, the more hydrophobic the compound and the 
more likely it is to be removed from solution. Most EDCs possess similar log Kow values which 
places them in the class of hydrophobic compounds. They readily adsorb onto sludge solids and 
therefore sorption plays an important role in their removal from the aqueous phase (Ivashechkin 
et al. 2004). However E3, with its three hydroxyl groups, is only weakly hydrophobic (Table 1.1) 
and is therefore less apt to bind to sludge (Chang et al. 2002). Because of this, E3 likely does 
not have the same affinity for the flocculent produced during EC treatment. With more E3 in the 
aqueous phase (i.e., not bound to the EC flocculent), more of it withstands filtration and passes 
into the EC-treated water sample.  
Estrone (E1) and estradiol (E2) had similar removals at 61.1% and 62.9%, respectively. 
Of the natural estrogens, E2 has the greatest potency yet E1 still retains high estrogenicity. For 
this reason, it is important that both of these natural estrogens are removed to a significant 
extent at the level of the WWTP. Auriol et al. (2006) suggested that E1 is the most important 
natural EDC due to the fact that the amount of E1 discharged from WWTPs is greater than ten 
times that of E2, and that E1 retains important estrogenicity. 
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Table 3.2  
Removal of endocrine-disrupting compounds from spiked-WWTP raw influent samples,  
showing percent reduction and statistical significance (p<0.05). 
EDC 
 
Mean Pre-
EC Conc. ± 
SD (µg/L) 
Mean Post-
EC Conc ± 
SD (µg/L) 
 
Test Statistic 
 
p value 
 
% reduction 
 
E2 4.70 ± 0.22 1.74 ± 0.09 
 
t = 25.07 
 
<.0001 
 
62.9 
 
E1 6.95 ± 0.25 
 
2.70 ± 0.10 
 
S = 26.00 
 
0.0286 
 
61.1 
 
E3 6.23 ± 0.21 
 
2.73 ± 0.12 
 
t = 29.4 
 
<.0001 
 
56.2 
 
EE2 4.70 ± 0.13 
 
1.70 ± 0.07 
 
t = 41.91 
 
<.0001 
 
63.8 
 
BPA 23.04 ± 1.35 
 
7.80 ± 3.64 
 
t = 7.85 
 
0.0002 
 
66.2 
 
NP 16.84 ± 1.81 
 
3.28 ± 0.97 
 
t = 13.24 
 
<.0001 
 
80.5 
 
 
BPA was reduced by 66.2% which is important since it is one of the most highly 
produced chemicals in the world. BPA enters the WWTP at levels in the low ug/L range 
(concentration can be greatly increased if industrial discharges contribute to WWTP influent). 
Our findings support those of Govindaraj et al. (2012) who achieved 65% removal of BPA from 
aqueous solutions using aluminum electrocoagulation. Compared with NP, BPA is a more polar 
compound which explains its lower removal. BPA does not tend to adsorb to sludge 
particles/sediment as much as NP. 
 
3.3.2 EC removal of EDCs from spiked-WWTP tertiary-treated effluent 
 The removal achieved for each of the six EDCs from tertiary-treated effluent samples is 
illustrated in Fig. 3.5. The removal efficiency ranged from 42% (BPA) to 98% (NP), and again 
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each EDC post-EC had a statistically lower mean concentration than pre-EC (Table 3.3, page 
83).  
EE2 was removed to a high extent, 67.7%, which again is important considering the 
potent estrogenicity of this compound in the environment as well as its recalcitrant behavior 
concerning most treatment processes. Estriol was removed by 53.4% which is comparable to 
the raw influent. A lower removal was seen with BPA (42%) than in the raw influent samples. 
Estrone and estradiol were similarly reduced (62% and 59.6%, respectively) as in the raw 
influent samples. Because the combination of E1 and E2 contribute largely to the estrogenicity 
of a sample, their removal is of considerable importance in water treatment processes.  
 
 
Figure 3.5. Endocrine-disrupting compound concentration in spiked tertiary-treated effluent 
samples, showing the difference pre- and post-electrocoagulation treatment. Error bars for E1, 
E2, EE2 and E3 are within the thickness of the bar graph outline.  
 
A higher removal was achieved for NP (98.2%) than in the raw influent samples. An 
important point to consider is, even with 98.2% removal, the amount of NP in the final treated 
sample may still lead to detectable estrogenicity. This will be an important question in future 
testing of EC against environmentally-relevant concentrations. The amount of NP in our post-EC 
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spike. However, if 98.2% removal is still achieved at environmentally-relevant concentrations, it 
will be important to determine if the post-EC concentration is estrogenic or not. In-vitro 
bioassays have the advantage of screening for estrogenicity without a priori knowledge of the 
pollutant present, and this will be a useful tool in future EC testing. 
 
Table 3.3  
Removal of endocrine-disrupting compounds from spiked-WWTP tertiary-treated 
effluent samples, showing percent reduction and statistical significance (p<0.05). 
EDC 
 
Mean Pre-EC 
Conc ± SD 
(ug/L) 
 
Mean Post-
EC Conc ± SD 
(ug/L) 
 
Test Statistic 
 
p value 
 
% reduction 
 
E2 4.88 ± 0.09 
 
1.97 ± 0.07 
 
t = 51.03 
 
<.0001 
 
59.6 
 
E1 7.13 ± 0.10 
 
2.71 ± 0.19 
 
t = 42.14 
 
<.0001 
 
62.0 
 
E3 6.99 ± 0.15 
 
3.25 ± 0.10 
 
t = 41.42 
 
<.0001 
 
53.4 
 
EE2 5.04 ± 0.09 
 
1.63 ± 0.06 
 
t = 64.28 
 
<.0001 
 
67.7 
 
BPA 25.47 ± 0.18 
 
14.77 ± 2.71 
 
t = 6.84 
 
0.0203 
 
42.0 
 
NP 20.49 ± 2.43 
 
0.37 ± 0.10 
 
t = 16.54 
 
0.0005 
 
98.2 
 
 
3.3.3 Cost considerations 
Regarding the EC unit in a real-world application, the question of cost-effectiveness will 
be determined from the energy consumption and consumable parts. Electrical energy 
consumption is a very important economical parameter in the EC process (Akbal and Camcı 
2011). The typical range of electrical use with a commercial EC unit is 2 to 7 kilowatt hours 
(kWh) per 3.8 m3 (1000 gallons) treated wastewater (or ~0.5-1 kWh per m3). This is 
comparable to the electric costs determined by other electrocoagulation studies (Akbal and 
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Camcı 2011, Attour et al. 2014). Electricity is purchased from the electric company in kWh, with 
the typical industrial electrical cost in the contiguous United States ranging from $0.05 to $0.14 
per kWh (U.S. Energy Information Administration 2014).  The electrodes (blades) can be made 
of any conductive material.  The most common materials are aluminum and iron. The 
commercial units are designed to utilize standard factory dimensions of the blade material. The 
sheet metal can be purchased wholesale or through a metal shop (prices range from $0.45 to 
$1.11 per kilogram for iron—the cost of aluminum is slightly higher), and the metal is cut into the 
proper dimensions for the unit. A typical commercial EC system contains 217 blades, two of 
which are connected to the electricity (the ‘power blades’). The conductor of electricity to the 
blades sitting in between the two power blades is the water itself flowing through the chamber. 
The blades are held in place by slots on each end, and when a blade needs replacing it will 
slide in and out of the chamber for quick replacement and little interruption of the treatment 
process. To make EC even less dependent on electricity from primary sources of energy (i.e., 
fossil fuels), renewable energy sources (e.g., solar panels) could be incorporated into future 
designs.  
 Many water treatment processes utilizing artificial light sources, such as photocatalytic 
reactions or photolysis, are energy intensive and therefore costly (Gultekin and Ince 2007). 
Activated carbon treatment depends on the powdered dose or the granular replacement, which 
is a continual cost. Similarly, membrane filtration processes (microfiltration, ultrafiltration, 
nanofiltration and reverse osmosis) consume a significant amount of energy (due to pressure 
requirements) and are further complicated by membrane fouling, degradation and membrane 
replacement (Silva et al. 2012). This is where EC has a distinct advantage in being lower-cost, 
easily manageable and effective compared with other treatment processes.  
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3.3.4 Additional considerations 
Integrating an EC unit into existing WWTPs is an important advantage because it can be 
done without extensive reorganization of the plant’s structure and design. The equipment is 
simple and the design can be sized to meet a specific flow need. The lack of moving parts 
requires less maintenance (Mollah et al. 2001), and the unit can be inserted into any point in the 
WWTP process, especially since EC can work on raw water whereas other treatments (e.g., 
ozonation and filtration) require clean, particle-free water to perform well. Because the 
effectiveness of EC for removing EDCs does not seem to depend on the matrix (water) type, the 
integration of the EC process into established WWTPs will depend on the existing processes at 
the plant. For plants that utilize tertiary treatments like ozonation or filtration, EC would act 
favorably as an additional pre-cleaning step before tertiary treatment. The effect of EC on water 
(e.g., removing metal ions, heavy metals, colloids, oil wastes, dyes, suspended particles, etc.) 
would produce an effluent amenable to tertiary treatment and should reduce the time to fouling 
of these latter steps (Canizares et al. 2007, Murthy and Parmar 2011). For plants with 
secondary treatment (and low sludge retention time), the EC process can be used to coagulate 
the raw sewage before going into the existing plant clarification unit. Not only would it assist in 
reducing COD, turbidity and many contaminants (Gamage and Chellam 2011), but it would also 
have the added benefit of EDC removal. For plants which utilize conventional chemical 
coagulation, EC can replace this process entirely in that it reduces the direct handling of 
corrosive chemicals and does not produce any secondary pollution caused by added chemical 
substances (Akbal and Camcı 2011, Gamage and Chellam 2011).  
Regarding sludge production, EC is a low-sludge producing technique, and the sludge 
formed tends to be readily settable and easy to de-water (Mollah et al. 2001). The amount of 
sludge produced is a result of the metal precipitates from the sacrificial blades, the total 
suspended solids in the water and the dissolved components that precipitate out and then 
coagulate. The coagulated solids can be separated from the water with clarification, filtration or 
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decant methods. Because the coagulated solids are composed of aluminum oxides, they meet 
government discharge standards (i.e., the leach test) and can be disposed of without special 
handling (Powell 2003). 
In a commercial setting, the EC unit is drained periodically and the blades are cleaned 
by an acid wash (10 – 15% acid solution) that can be recycled until the acid’s pH increases to a 
point where it is no longer useful. Common acids include sulfuric, hydrochloric, phosphoric or 
nitric. The blades soak in the acid wash for approximately ten minutes until the oxide film is 
removed and, once the acid is drained and removed from the unit, EC treatment can resume.  
Without question, in the future of wastewater treatment, a multi-tiered approach will be 
most successful in the removal of micropollutants (EDCs) (Snyder 2007), and EC is a cost-
effective method that can be easily integrated into current infrastructure.  
 
3.4. Conclusions 
 The electrocoagulation of wastewater (WWTP raw influent and tertiary-treated effluent) 
spiked with six estrogenic EDCs was tested for removal efficiency using a laboratory-scale unit. 
EC, with the optimal operating parameters determined in this study, enabled statistically 
significant removal of all EDCs in both WWTP raw influent (56.2% - 80.5% removal) and 
tertiary-treated effluent (42% - 98.2% removal). The main mechanism of removal is proposed to 
be adsorption onto the amorphous aluminum hydroxide flocs, thereby allowing the contaminants 
to be easily separated by filtration. These flocs, termed “sweep flocs”, have large surface areas 
which promote rapid adsorption of soluble organic compounds (Attour et al. 2014). In this study, 
all samples were spiked to challenge the EC instrument with contaminant removal. Future 
testing will include environmentally-relevant concentrations in WWTP influent and effluent. 
Since these concentrations, especially for the natural and synthetic estrogens, are on the order 
of low ng/L, detection limits of analytical instruments will need to be on the order of pg/L. 
Bioassays will be an important corroborative tool in future testing due to the fact that pollutants 
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rarely occur as isolated compounds in environmental matrices, but rather in complex mixtures. 
Pollutants in mixtures can act synergistically, antagonistically or additively. Chemical analyses 
quantify the amounts of pre-selected compounds, and bioassays can support this by detecting 
final estrogenicity of the sample. In anticipation of future regulations regarding EDC discharge, a 
multi-barrier approach with comprehensive treatment technologies will be most successful in the 
removal of micropollutants, including EDCs (Auriol et al. 2006, Snyder et al. 2007). EC has the 
advantage of being low-cost, effective against EDCs, easily manageable and able to be 
integrated into current infrastructure.  
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CHAPTER FOUR: DETERMINATION OF THE BINDING FREE ENERGY OF AN 
ESTRADIOL-HUMAN ESTROGEN RECEPTOR ALPHA (E2-hERα) COMPLEX: A 
COMPUTATIONAL APPROACH  
 
4.1 Introduction 
 
Hormones, a crucial part of animal biology, have vastly different roles, different 
structures and different time scales of action. They are the fundamental components of the 
endocrine systems of humans and other animals, including a variety of marine species such as 
invertebrates, fish and marine mammals. Hormones are constantly at work to regulate 
physiological processes. Estrogens are naturally-occurring steroid hormones involved in the 
growth, development and maintenance of a diverse range of tissues (Brzozowski et al. 1997, 
van Lipzig et al. 2004, Sarath Josh et al. 2013). While there are three major natural estrogens in 
women, 17β-estradiol (E2) is the principal endogenous estrogen manufactured by the ovaries 
during the active reproductive years (Sarath Josh et al. 2013). E2 is formed from testosterone 
following aromatization of the A-ring (Figure 4.1), and is the most potent and ubiquitous of the 
natural estrogens (McCarthy 2008).   
 
 
Fig. 4.1. Production of the steroid hormone estradiol after aromatization of testosterone. 
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Hormone receptors are large proteins which noncovalently bind a hormone. For virtually 
all hormones, the first step in eliciting a physiological response is binding of the hormone to a 
receptor in its target tissue (Hedge et al. 1987). The estrogen receptor (ER) is a ligand-inducible 
intracellular (nuclear) transcription factor which mediates the physiological effects of estrogens 
at the level of gene regulation (Brzozowski et al. 1997, Kumar et al. 2011). The human estrogen 
receptor (hER) has two genetically distinct isoforms to date: alpha (hERα) and beta (hERβ) 
(McDonnell and Norris 2002). hERα (Figure 4.2) has a molecular weight of just over 66,000 
Daltons and is composed of 595 amino acids. 
 
 
Figure 4.2. Complete structure of human estrogen receptor alpha. 
 
Along with other members of the nuclear hormone receptor family, hERα has three major 
functional domains: the N-terminal domain, the central DNA-binding domain and the ligand-
binding domain (LBD) (Figure 4.3) (Kumar et al. 2011).  
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Figure 4.3. Diagram of the two human estrogen receptors, ERα and ERβ. The six functional 
domains are illustrated, including the DNA-binding domain (DBD), the ligand-binding domain 
(LBD), and the activation functions AF1 and AF2. Figure from Shao and Brown 2004. 
Permission granted by the original publisher of the figure, BioMed Central. 
 
 
The action of the ER revolves around three components—the receptor, its ligands and its 
coregulator proteins (Katzenellenbogen et al. 2000). Once estrogen binds to the LBD of the ER 
(Figure 4.4), a conformational change occurs, enabling the receptor to homodimerize (van 
Lipzig et al. 2004). The dimer allows recruitment of additional coregulators (coactivators or 
corepressors) that determine the course of interaction with DNA (Schmieder et al. 2003). Two 
activation functions, AF-1 and AF-2 (Figure 4.3), are responsible for interacting with the 
coregulators. The hormone-bound ER binds to specific DNA sequences termed estrogen 
response elements (EREs) and regulates transcription by up- or downregulating the expression 
of target genes (Kumar et al. 2011). ERs mediate estrogen signaling in both reproductive 
tissues and non-reproductive tissues including the brain, lungs, colon, prostate, heart, bone and 
intestines (McDonnell and Norris 2002, Shanle and Xu 2011). The 2 receptor isoforms (hERα 
and hERβ) have a similar affinity for E2, but display distinct tissue distributions and exhibit both 
unique and overlapping physiological roles in mediating estrogen signaling (Takeuchi et al. 
2005, Kumar et al. 2011, Shanle and Xu 2011).  
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Fig. 4.4. Estradiol molecule in the ligand binding pocket of the estrogen receptor. The left pane 
shows a dimerized estrogen receptor with two estradiol molecules in the ligand binding pockets. 
The right pane shows a close-up of the estradiol molecule in the ligand binding pocket. Figure 
from VMD of our estradiol-hERα model.  
 
An endocrine-disrupting compound, or EDC, is an exogenous (i.e., from environment or 
diet) chemical that can interfere with any aspect of hormone action (Zoeller et al. 2012). 
Although EDCs can interfere with any group of hormones (e.g., androgens, progestins, thyroid 
hormones), the most frequently reported endocrine action of EDCs involves disruption of the 
estrogen axis (Guillette et al. 2000, Jobling et al. 2004). These estrogenic EDCs can disrupt 
hormone action by interfering with estrogen synthesis, transport, metabolism or elimination, but 
many directly impact estrogen signaling by competing with endogenous estrogen and binding to 
the ER. The ligand binding pocket of hERα is significantly larger than the E2 molecule (the 
pocket size is around 450 angstroms compared to E2’s molecular volume of 245 angstroms) 
which unfortunately allows a wide assortment of molecules to access it (Shanle and Xu 2011). 
The ER is notorious for its accommodation of a wide variety of non-steroidal ligands, and this 
fact has rendered the ER “promiscuous” and is the primary argument underlying estrogen-
targeted endocrine disruption (Anstead et al. 1997, Schmieder et al. 2003).  
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Molecular modeling methods offer an efficient way to preliminarily test a ligand without 
the expense, time and use of animals in laboratory-based methods, including in vitro and in vivo 
studies. They are an important first step in the prediction of possible interactions of ligands with 
target receptors (Sarath Josh et al. 2013). Computational studies have been used for the 
development of novel ligands in pharmaceutical research (Katzenellenbogen et al. 2000) and 
can also be used as a relevant component of testing the safety and/or risk of chemicals that are 
already on the market (De Wever et al. 2012). In order to approach toxicity testing for chemical 
safety assessments in the 21st century, the current system of testing needs revising (Hartung 
2009). In the U.S. today, there are over 84,000 chemical substances registered in commerce. 
Many of these chemicals have not been assessed for significant toxicologic (including 
endocrine-disrupting) effects, and current approaches to toxicity characterization make getting 
through this extensive list of chemicals a challenging task. Because of this need to gather 
accurate and significant toxicity data on a wide range of environmental chemicals, databases as 
well as screening and prioritization programs have become an important development in 
organizations responsible for protecting public health (e.g., EPA, NIH, FDA). The overreaching 
goal is to create a toxicity profile, as efficiently as possible, for a large set of chemicals in order 
to determine potential to cause human or ecological harm as well as to support regulatory action 
(Judson et al. 2009). Developments and advances in bioinformatics and in silico (i.e., computer-
based) modelling will contribute to informational databases which can then be integrated with 
data from other life science areas (Hartung 2009). Benefits of in silico techniques include 
reducing cost, reducing animal resources, and the ability to test compounds which are not 
amenable to in vitro testing (e.g., insoluble, highly volatile, or cytotoxic) (Takeuchi et al. 2005, 
Knudsen et al. 2011). Further, because experimental systems involving humans are untenable, 
computational methods offer an important approach to studying endocrine disruption in humans 
(Falconer et al. 2006). 
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In the current study, molecular dynamic (MD) simulations were performed to yield a 
binding free energy value (ΔGbind) for the interaction of E2 with hERα. The binding free energy 
was calculated based on the MD trajectories. The goal was to build a reliable computational 
model where MD simulations resulted in a binding free energy comparable with published 
results in the literature of an equivalent ligand-receptor (E2-hERα) complex. By developing a 
successful estrogen receptor model based on human physiology, we set the stage for further 
development of analogous models for different species, including marine species that are 
prominent in the Tampa Bay area.   
 
4.2 Materials and Methods 
The RCSB protein data bank (PDB) supplied the crystal structure of hERα complexed 
with the E2 ligand, PDB code 1A52 (http:///www.rcsb.org/pdb/). The protein and ligand were 
separated via computer software and subsequently prepared individually.  
 
4.2.1 Protein preparation  
The ER protein structure was prepared utilizing the following procedures: 1. The co-
crystallized ligand and structural water molecules were removed from the crystal structure. 2. 
Hydrogen atoms were added to the protein. 3. Atom charges were assigned to the protein 
atoms utilizing AMBER (Assisted Model Building with Energy Refinement) version 12.0 (Case et 
al. 2005). The Antechamber program (program of AMBER) determined the force field (i.e., intra- 
and intermolecular forces) parameters of the protein and created topology files. The PDB format 
was maintained for this final structure and used for MD simulations.  
 
4.2.2 Ligand preparation  
The 3-dimensional structure of the E2 molecule was constructed using AMBER. The 
partial charges of the ligand were determined by AMBER, and Antechamber determined 
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missing force field parameters and supplied reasonable substitutes. Topology files for E2 were 
also created through Antechamber.  
 
4.2.3 System preparation  
Once the preparation for the protein and ligand was completed, they were joined to form 
one system of the E2-hERα complex. Sodium ions were added to bring the total unperturbed 
charge of the system to zero. The system was solvated in a cubic box of TIP3BOX (v 8.0) water 
molecules with a dimension of 83.6 Å (x-axis) by 109 Å (y-axis) by 92 Å (z-axis) (Figure 4.5).  
 
4.2.4 Equilibration 
 The solvated system was then equilibrated by a series of steps prior to the molecular 
dynamic (MD) simulations: 1.The energy minimum was obtained. 2. The temperature of the 
system was gradually increased from 0 to 300K. 3. Density equilibration was carried out on the 
complex. 4. The whole system underwent constant pressure equilibration at 300K. The 
equilibration process was run for 2 nanoseconds on a 10-node cluster. Verification of system 
equilibration was performed by plotting temperature, density and total energy against the 
equilibration time (Figure 4.6). Since the plots had all converged by the end of the equilibration 
period, the system was verified to be equilibrated and ready for MD simulation.  
 
4.2.5 MD simulations  
In order to obtain the binding free energy, four MD simulations were performed on the 
E2-hERα complex (total of 2 nanoseconds) with coordinate recordings every 10 picoseconds. 
The MD simulations were performed with Sander, a module implemented in AMBER. The 
output files were verified for equilibration again and subsequently used to calculate the binding 
free energy of the complex. In real time, the entire experiment took twelve months to complete.  
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Figure 4.5. Illustration of the estrogen receptor solvated in a 3-dimensional water box. Figure 
from VMD of our estradiol-hERα model.  
 
 
 
Figure 4.6. Plots of temperature, density and total energy against equilibration time. 
 
 
 
99 
 
4.2.6 Post-processing calculations  
The Molecular Mechanics-Poisson Boltzmann Surface Area (MM-PBSA) approach was 
used to calculate the binding free energy (ΔGbind, kcal/mol) of the E2-hERα complex. Poisson 
Boltzmann calculations were performed on 50 complex frames using an internal PBSA solver. 
Using the 50 frames, the individual energy contributions (van der Waals, electrostatic, nonpolar 
solvation, dispersion solvation and reaction field) for the receptor, ligand and system complex 
were calculated and averaged to estimate the binding free energy. The entropy contribution was 
neglected due to the fact that its large margin of error introduces uncertainty into the final result, 
and because our goal is to compare our results against similar systems analyzed in earlier 
studies which adopted this same format. Graphical representations of the ER in this study were 
created using Visual Molecular Dynamics (Humphrey et al. 1996). 
 
4.3 Results and Discussion 
 The calculated total binding free energy of E2 bound to the ligand binding domain of 
hERα was found to be -16.85 kcal/mol +/- 4.14 SD. From the negative total binding free energy, 
we conclude that this is a favorable protein-ligand complex in pure water. It must be pointed out 
that this is an approximation since we did not estimate the entropy contribution to binding due to 
it being computationally expensive. Our value of -16.85 kcal/mol is in agreement with 
Lambrinidis et al. (2006) who obtained a binding free energy of -13.77 kcal/mol, as well as van 
Lipzig et al. (2004) who obtained a binding free energy of -12.24 kcal/mol of the same complex. 
Major contributions to the binding free energy were determined and are listed in Table 4.1. One 
can see that van der Waals, electrostatic and nonpolar solvation were the major favorable 
contributors while dispersion solvation and reaction field energies were not as favorable.  
 
 
 
 
 
100 
 
Table 4.1 Major contributions to the binding free energy 
Energy Component Average Standard Deviation 
Van der Waals -78.09                 3.84               
Coulombic/Electrostatic 
(EEL) 
-56.78                 3.73               
Nonpolar solvation 
(ENPOLAR)  
-59.11                 0.56               
Dispersion solvation 
(EDISPER) 
101.48                 0.66               
Reaction field (EPB) 75.65                 2.33               
 
Different compounds yield different binding free energies when complexed with the 
estrogen receptor. van Lipzig et al. (2004) outline the binding free energies calculated for 
nineteen estrogenic ligands bound to hERα by MD simulations. The range of values is from -
4.41 kcal/mol to -13.74 kcal/mol. The more negative the binding free energy, the stronger the 
binding affinity with the estrogen receptor. Molecular models can therefore be used to identify 
estrogenic compounds which have a binding free energy more negative than endogenous 
estradiol. Because EDCs with a stronger relative binding affinity will compete with (and 
potentially outcompete) estradiol for the estrogen receptor, these particular compounds will be 
more of concern with regards to endocrine disruption in humans.  
 
4.3.1 Study limitations  
One potential limitation of this study is that the simulation looked across the entire ER 
surface, not specifically the LBD. Future work will include the incorporation of the specific amino 
acid sequence of the LBD in order to attain a more precise measurement of the binding free 
energy. Another limitation is the fact that the MD simulation of the current study was run with 10 
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processors, whereas adding more processing power will indeed reduce the time required to 
complete a similar simulation.  
 
4.3.2 Future directions  
With verification that the model is sound and returning favorable results regarding E2, 
future goals are actually twofold: 1. Expand the current model relative to endocrine disruption in 
humans, and 2. Apply the methods of the current model to develop similar models relevant to 
marine species.  
With regards to the current model, a next step is to use the model to test other well-
documented EDCs (e.g., bisphenol-A, 17α-ethinyl estradiol, diethylstilbestrol) individually, and 
later to expand the model to include multiple EDCs concurrently in order to elucidate relative 
binding affinities (RBAs). Chemicals are not usually found alone in environmental matrices—
rather, they are part of complex mixtures and it is vital to have information on how compounds 
might act when part of such a mixture. Effects of chemicals in combination may be antagonistic, 
additive or even synergistic, which forms the basis for the argument against testing chemicals 
individually (Depledge and Billinghurst 1999). Laboratory tests have confirmed that individual 
compounds at low doses may not produce an estrogenic response, but when combined, a fully 
estrogenic response can be created (Silins and Hogberg 2011). Only one compound will bind to 
any ER at one time, and typically the compound with the highest RBA will out-compete the other 
compounds and bind to the receptor. Beyond this, the subsequent goal is to develop a model of 
corresponding human hormone receptors, beginning with hERβ. EDCs can simultaneously act 
as agonists and/or antagonists via one or more hormonal receptors, and some EDCs differ in 
their ability to bind to hERα and hERβ (Strunck et al. 2000). Also, hERβ has distinct tissue 
distributions and physiological functions, some of which differ from hERα. Therefore, a better 
estimation of the estrogenicity of chemicals requires data concerning their effects on both hERα 
and hERβ (Takeuchi et al. 2005). One has to keep in mind, though, that not all estrogen effects 
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are strictly ER-mediated, and many EDCs can act not only through receptors, but other 
signaling pathways as well (Shanle and Xu 2011). A more complete estimation of estrogenicity 
will take into account all of these pathways—receptor binding, modulation of other transcription 
factors, modulation of coactivators and corepressors, modification of estrogen synthesis, 
metabolism and/or transport.  
Although the current research project focused on the human estrogen receptor, all 
animal phyla have endocrine systems where estrogen signaling is mediated by an ER. The very 
fact that the same environmental EDCs have effects on humans and other mammals, birds, 
reptiles, amphibians, fish and invertebrates means that there has been conservation in the 
evolution of the ER (van Lipzig et al. 2004). There is distinct variability in the amino acid 
sequence of the ER structure in different species, and this variability may affect the differential 
preferences and RBAs of the EDC ligands. In fact, studies have shown that estrogenic EDCs 
may exhibit such differing characteristics with regards to ERs from different species (Matthews 
et al. 2000). For these reasons, the next step will be to develop analogous models for species 
relevant to the Tampa Bay area in order to examine any inter-species differences in ligand 
preference or binding affinities.  
   
4.4 Conclusions 
Because EDCs are a critical part of modern human health issues, it is important to 
develop methods to rapidly test different compounds for endocrine-disrupting potential. 
Legislation concerning EDCs is potentially on the horizon, and until then the EPA will continue 
to address the issues of endocrine disruption through its Endocrine Disruptor Screening 
Program (EDSP). Even though the EDSP was established in 1998, the EPA is only now 
finishing its initial review of 52 chemicals under Tier 1 of the program (Bergeson et al. 2015). In 
2012, the EPA released a list of nearly 10,000 unique chemicals which may be considered by 
the EDSP for screening and testing. Fortunately, the EPA has invested significant resources 
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into CompTox (Computational Toxicology Research Program), a program which addresses the 
challenge of screening a long list of chemicals for prioritization purposes (Judson et al. 2009, 
Bergeson et al. 2015). Computational techniques are integrated into the CompTox effort, which 
highlights the importance of in silico methods for current and future management of chemical 
safety.  
Information from this study will serve as a foundation for expanding this work to include 
additional human models that encompass not only total estrogenicity, but more complete 
endocrine action. Further, the methods utilized in building the current model will be applied to 
analogous models in marine species. In order to improve understanding of the specific binding 
mechanisms involved in ligand-receptor relationships, structure-activity studies will also become 
an important tool in determining which types of molecular structures could be predicted to have 
endocrine-disrupting potential. Docking programs would be a useful addition to future studies 
focused on structure-activity relationships, as they find favorable interactions and positions 
between the ligand and the receptor.  
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CHAPTER FIVE: CONCLUSIONS AND RECOMMENDATIONS 
 
5.1 Final Conclusions 
A number of studies have been recently published on the occurrence of EDCs in sewage 
(influent and effluent), marine sediments, marine waters and marine organisms (Braga et al. 
2005, Porte et al. 2006, Noppe et al. 2007, Pojana et al. 2007, Yu and Wu 2012). The fact that 
numerous studies have been able to quantify similar EDCs in different wastewater and marine 
systems around the world shows that EDCs and the associated endocrine disruption are global 
issues. The threat of this specific type of contamination is insidious, as the harm is at times not 
immediate nor obviously expressed (Colborn et al. 1993, 1996).  
The results of the three projects detailed in this dissertation serve to complement the 
existing body of EDC literature. Chapter 2 quantified the concentrations of six estrogenic EDCs 
in Tampa Bay area sewage, sediment and water. The prevalence of all six compounds supports 
the findings of other studies which focused on similar environmental matrices as well as 
sewage. Using risk assessment data outlined in other studies (Hutchinson et al. 2000, Touraud 
et al. 2011, Manickum and John 2014), the EDC concentrations in the Tampa Bay area are 
sufficiently high to cause concern as to adverse impacts on local marine life. The Tampa Bay 
estuary provides critical habitats for a wide array of invertebrates (e.g., shellfish), fish (including 
commercial fish), reptiles, birds and mammals, all of which are susceptible to the effects of 
endocrine disruption (Schmidt et al. 2004).   
Chapter 3 explored the potential to ameliorate the basic problem discussed in Chapter 2. 
Since the primary route of transport to the marine environment is through effluent discharge 
from area wastewater treatment plants, this particular project tested a laboratory-scale 
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instrument which has a commercial-sized counterpart that can be integrated (without much 
difficulty or reorganization) into the infrastructure of existing WWTPs. In the present study, the 
removal method significantly reduced spiked concentrations of six EDCs and has the potential 
to act as one of the following: 1. A primary step for WWTPs with no/limited secondary treatment, 
2. A polishing step for plants with secondary treatment only, 3. A post-secondary effluent 
cleansing step for plants with tertiary treatments involving filters or UV light, 4. A complete 
replacement for plants utilizing chemical coagulation processes. The excretion of natural 
hormones and pharmaceutical estrogens will continue to be a critical component of domestic 
sewage, while industry will continue to produce waste with many EDC components as well. For 
this reason, it is crucial to find removal methods that can significantly reduce the amount of 
EDCs from the final effluent. Presently, a multi-tiered approach is recommended as the best 
approach to managing a wide array of contaminants (including EDCs), as no single technique 
has been shown to consistently produce an effluent with zero-effect level (Snyder et al. 2007).  
Chapter 4 outlined the development of a molecular model, built for the purpose of testing 
the binding free energy for different EDC compounds in humans. The development of this model 
can be applied to other species, including those that are relevant to the Tampa Bay area. The 
binding free energy (and, therefore, the binding affinity) of EDCs may change across species 
due to inter-species differences in the structure of the hormone receptors. In silico techniques 
are advantageous as they allow quick, efficient and inexpensive testing without utilizing animal 
resources. Computational techniques are already being utilized by many organizations 
(government and non-government) focused on protecting ecosystem and public health.  
 Because the prevalence and persistence of EDCs in the environment is a global issue, 
this research can be expanded in many important ways. Chemically, this work would benefit 
from expanding the list of hormones to include androgen, thyroid or adipose tissue disruptors. 
Geographically, this work could be broadened by expanding outside the Tampa Bay area to 
include other Florida systems including coastal and pelagic marine systems, surface freshwater 
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systems and groundwater matrices. Drinking water sources are of particular interest, as the 
incomplete removal of EDCs also occurs after drinking water treatment (which leads to a source 
of exposure for humans). Incorporation of bioassays will enhance the chemical analyses, as the 
predictions of estrogenicity from measured compound concentrations (i.e., EEQ) can differ from 
bioassay results. This alludes again to the complexity of mixtures, and how analytical 
instruments (e.g., GCMS) can only test for pre-determined compounds, while bioassays reveal 
the estrogenicity (or similar response) of the entire sample, without a priori knowledge of what is 
included.  
 Because the EC unit described in Chapter 3 for the removal of EDCs was a laboratory-
scale design, further work should include monitoring wastewater at a plant which has integrated 
the commercial scale unit at their site. Currently, a power-generation plant in El Paso, Texas 
utilizes a commercial EC unit for the cooling tower blowdown water, and the EC-generated floc 
feeds into an ultra-filtration clarification tank. Additionally, the Santa Clara Waste Water 
company (California) utilizes EC to treat wastewater streams from both industrial and septic 
system waste. This would provide real-world data on how EC functions at this scale, and what 
effect it has on chemical parameters including EDCs. 
 The computational model of the human estrogen receptor will benefit from expansions to 
the EDCs tested as well as the hormone systems represented. Additionally, the methods for 
model development will be applied to marine species important to the Tampa Bay estuary. In 
silico techniques are a vital and efficient component of the prioritization and identification 
process, especially since regulatory action is anticipated with regards to EDCs and other 
potentially toxic chemicals.  
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CHAPTER SIX: ADDITIONAL CONSIDERATIONS AND FUTURE DIRECTIONS  
 
6.1 EDCs and Nonmonotonicity 
A monotonic dose-response curve will increase or decrease over the entire range of 
doses (Conolly and Lutz 2004). In a nonmonotonic dose-response curve, the slope changes 
from positive to negative, or vice-versa (Myers et al. 2009). Because of the role receptors play in 
mediating hormone effects, the shape of the dose-response curves induced by hormones will 
typically be either nonlinear or nonmonotonic. Figure 6.1a illustrates a monotonic, linear dose-
response curve where an increase in dose corresponds to an increase in response. Figure 6.1b 
illustrates a monotonic dose-response curve typical of hormones, where a small change in 
hormone concentration at the low end of the curve will have a much greater effect on the 
response than a similar change in hormone concentration at the high end of the curve (Zoeller 
et al. 2012). This curve has a sigmoidal shape, yet it still retains monotonicity since a monotonic 
curve is allowed to flatten out (notice the slope does not reverse direction). Finally, Figure 6.1c 
illustrates a nonmonotonic dose-response curve where a change in slope direction is seen and 
the curve takes on an inverted “U” shape. This phenomenon is also known as chemical 
hormesis, characterized by low-dose stimulation and high-dose inhibition. For a toxic substance, 
stimulation occurs in cells at low concentrations while distinct toxicity occurs at higher 
concentrations (Radosevic et al. 2011). For hormones, this type of dose-response can occur 
when high concentrations of a hormone down-regulate the receptor (Jobling et al. 2004, Zoeller 
et al. 2012).   
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Figure 6.1. Monotonic (A,B) and nonmonotonic (C) dose-response curves. 
 
Nonmonotonicity is generally characteristic of endogenous hormones, hormonally-active 
pharmaceuticals and environmental EDCs (Myers et al. 2009). Several studies have shown that 
EDCs do indeed produce nonmonotonic dose-response curves (Conolly and Lutz 2004, 
Andrade et al. 2006, Vandenberg et al. 2013).  
Traditional regulatory toxicology relies on chemical testing strategies where the core 
assumption is linear relationships (i.e., high doses will reveal consequences of low doses). 
These chemical testing strategies are furthermore used to establish human health standards 
and acceptable levels of chemical exposure, including EDCs (Andrade et al. 2006, Myers et al. 
2009). The implications of this are as important as they are troubling (Saal and Hughes 2005, 
Zoeller et al. 2012):  
 EDCs cannot be evaluated as if they are general toxins because they do not behave like 
classic toxins. 
 The effect of an EDC at a high dose may not predict the effect of the EDC at a low dose, 
so it cannot be assumed that high doses can reveal information relevant to low-dose 
exposures. 
 Certain EDC effects can be completely overlooked if only testing high-dose ranges. 
 Since a low level (i.e., ppt) of endogenous hormones is the normal bioactive range in an 
individual, small additions to this level by exogenous EDCs will have a significant impact. 
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Patterns of nonmonotonicity highlight the liability in assuming that low-dose effects from an 
environmental EDC can be extrapolated from high-dose effects of the compound (Vandenberg 
et al. 2013). The risk assessment of EDCs must be evaluated keeping in mind the fundamental 
principles of endocrinology, not classic toxicology (Myers et al. 2009, Zoeller et al. 2012).  
 
6.2 Prenatal Exposures and Latency of Exposure  
When the synthetic estrogen diethylstilbestrol (DES) was administered to pregnant 
women (from the 1940s through the 1970s) to treat threatened and habitual abortions, both 
male and female offspring showed reproductive tract abnormalities, but only after they reached 
early adulthood (Giusti et al. 1995). Many laboratory studies confirmed that when DES was 
given to pregnant mice during critical developmental periods, the offspring also developed 
comparable genital tract changes (McLachlan et al. 1975, Newbold 1995, McLachlan 2006). 
Experimental tests were later conducted with nonylphenol, BPA and phthalates (known to be 
estrogenic EDCs), and the exposures of pregnant rats to these compounds also had significant 
effects on the offspring. Importantly, the reduced sperm production did not occur until the animal 
reached adulthood (latency of exposure). This lag between the exposure and the appearance of 
disease (or disruption) adds an extra layer of complexity with regards to endocrine disruption.  
The critical windows of development are those in which developing systems are especially 
sensitive to hormonal or other disruptions (Selevan et al. 2000, Rochester 2013). Exposures 
during these periods can lead to permanent damage which may not surface until childhood, 
adulthood or even later in life (Houlihan et al. 2005). It is not that adults are not at risk from 
environmental exposure to EDCs, but the developing fetus is more susceptible due to the 
following important factors (Houlihan et al. 2005, Schug et al. 2011): 
 Chemicals can cross the placenta and enter the womb. 
 Inherent protective mechanisms (e.g., blood-brain barrier and integumentary system) are 
immature in the developing fetus. 
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 The rapid growth and organization of development make the fetus vulnerable to 
chemical insults. 
 Chemical exposures are greater pound for pound than those of adults. 
 Detoxification and excretion processes are not fully developed.  
 Lower levels of serum-binding proteins are circulating, resulting in a greater fraction of 
chemical being unbound and therefore biologically active.  
 In order to assess human prenatal exposure to EDCs, studies have been conducted on 
amniotic fluid (Foster et al. 2000, Geer et al. 2015), umbilical cord blood (Houlihan et al. 2005, 
Chen et al. 2008), placental tissue (Vilahur et al. 2014), fetal and newborn tissue (Cappiello et 
al. 2014). The findings of these studies were important to rule out air, food and drink (e.g., 
breast milk) as a newborn’s first exposure, and to confirm that exposures were indeed taking 
place while in the womb. Quantifiable amounts of multiple EDCs have been found in all of these 
samples.  
There has been a change in disease incidence over the past 40-50 years—an increased 
rate of certain types of diseases that cannot be explained by genetic changes/mutations alone. 
Early life exposures to EDCs are suspected in the relatively recent increases in diseases such 
as prostate and breast cancer, polycystic ovarian syndrome, sperm count decrease, infertility, 
miscarriage, earlier onset of puberty, hypospadias, thyroid disorders, metabolic syndrome, 
obesity, diabetes, autoimmune disease and neurobehavioral disorders like ADHD and autism 
(Colborn et al. 1993, Meeker et al. 2009, Legler et al. 2011, Skinner et al. 2012). 
 
6.3 EDCs and Epigenetics 
The trans-generational concept refers to how an individual passes something on to the 
next generation. This can occur through genetic mutations, but it can also occur through 
epigenetic mutations. Epigenetics is defined as molecular factors or components that exist 
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physically around the DNA, and which regulate how DNA functions (i.e., which genes get 
expressed). Epigenetic modifications are completely independent of the DNA sequence, and 
are mitotically stable (Berger et al. 2009). The environment (e.g., exposure to chemicals) has 
the ability to determine which genes function normally and which do not through epigenetic 
mechanisms (Saal and Hughes 2005). DNA methylation is one type of epigenetic modification 
where a methyl group is placed on a DNA nucleotide in response to an exposure. This methyl 
group is an epigenetic mark and can actually change how DNA functions.  As the cells begin to 
grow and divide, the DNA sequence is replicated, and the new strand of DNA will also be 
methylated. Through the maintenance of these epigenetic marks, an exposure to an 
environmental factor (including EDCs) early in life can cause disease at a later time. (Skinner 
2007). A second epigenetic mechanism involves modification of the histone proteins around 
which DNA wraps. If the histone modifications are such that the DNA wraps more tightly around 
the proteins, then certain genes may become trapped within the condensed chromatin and are 
effectively silenced since transcription of the gene cannot take place (Goldberg et al. , Berger et 
al. 2009). 
 
6.4 EDC Regulation 
Current regulations are not effective when it comes to protecting human populations 
from EDCs (Gore et al. 2013). Out of the nearly 80 - 100,000 chemicals in use in the U.S. today, 
only a small number have been thoroughly tested for toxicity. What is worse, these chemicals 
were typically tested at high doses for the probability that they could cause either immediate 
harm (acute toxicity), obvious birth defects (mutagenicity) or cancer (carcinogenicity) (Colborn et 
al. 1993). They were not tested for disturbances during critical developmental periods which 
then lead to diseases that might not appear until childhood, puberty or even later in life.  
The Toxic Substances Control Act (TSCA) was passed in 1976. Its job is to regulate all 
chemicals in United States commerce (TSCA 1976). There are about 84,000 compounds 
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registered, however 63,000 chemicals were grandfathered in and presumed safe. The law does 
not require any health or safety studies before a new chemical is allowed on the market. In the 
history of TSCA, only 5 chemicals have been banned or restricted. Under TSCA, the burden is 
on the EPA to show that an industrial chemical is unsafe. An attempt to ban asbestos was made 
by the EPA in 1990 when it issued a final rule, citing Section 6 of TSCA, which effectively 
banned asbestos. However, asbestos manufacturers challenged the EPA’s ban and took its 
appeal to court. The court sided with the manufacturers, claiming that the EPA had presented 
insufficient evidence (including risk information) to justify its asbestos ban (Lowell Center for 
Sustainable Production 2003). This burden of proof needs to shift to the chemical industry. 
TSCA has not been updated since 1976, but many agree that the Act must be revisited and 
reformed in order to appropriately address chemical exposures and health risks. Recently, bills 
have been sponsored (e.g., S.1009, Chemical Safety Improvement Act) which address this 
issue, but they have not made it to the House or Senate for a vote.  
Although TSCA was passed in the 1970s for the purpose of regulating toxic substances, 
it was not until the 1990s that the issue of EDCs and endocrine disruption really emerged. The 
Food Quality Protection Act of 1996 mandated that the U.S. EPA develop a screening program 
(the Endocrine Disruptor Screening Program, EDSP) in order to determine whether certain 
chemicals may have endocrine-disrupting effects. As a result, the Endocrine Disruptor 
Screening and Testing Advisory Committee (EDSTAC) was established that same year to 
advise the EPA on methods of screening and testing individual chemicals for endocrine-
disrupting activity. The final report of the EDSTAC, published in 1998, recommended the EDSP 
have a 2-tiered system to screen chemicals for potential endocrine-disrupting activity. Tier 1 is 
similar to a first line of defense which involves assays, both in vitro and in vivo, to identify 
chemicals that may interfere with estrogen, androgen, or thyroid hormone action. If a chemical 
is identified as an EDC, it would require additional testing in Tier 2 in order to determine the 
degree of risk to human and wildlife health. If a chemical is not identified as an EDC, it will not 
116 
 
be studied further. Because of time concerns with Tier 1 screening, the current EDSP is 
developing a new strategy of using high throughput in vitro assays that would be faster and 
more efficient. (Falconer et al. 2006, Zoeller et al. 2012).  
Because of the lack of legislation regarding EDCs, the government has initiated a 
number of voluntary programs to mitigate some of these issues. The use of alkylphenol 
polyethoxylates (of which 80 – 85% are nonylphenol polyethoxylates, NPEs) was banned in 
domestic cleaning products in the U.S. in the late 1990s, yet only restrictions have been placed 
on their use in industrial detergents and cleaners (Janex-Habibi et al. 2009, U.S. Environmental 
Protection Agency 2010). Under anaerobic sewage treatment conditions, nonylphenol 
polyethoxylates degrade to NP, a more toxic and hydrophobic compound (Lee et al. 2004, 
Janex-Habibi et al. 2009). Because of its widespread release to the environment and its 
biorefractory nature, the EPA is pursuing, with the cooperation of industry, a voluntary phase-
out of the use of NPEs in industrial applications (U.S. Environmental Protection Agency 2010). 
As a way to encourage this, the EPA’s Design for the Environment program created the 
voluntary Safer Detergents Stewardship Initiative in 2007. Businesses are recognized if they 
commit to replacing the use of NPEs with safer alternatives. In 2010, a NP Action Plan was 
published by the EPA which recognized and listed 8 safer alternatives that are comparable in 
cost and effectiveness to NP. Safer alternatives include alcohol ethoxylates, sorbitan esters and 
sodium lauryl sulfates.  
The U.S. has made progress eliminating BPA from infant products, but not countless 
other consumer products. The baby bottle and sippy cup ban actually lagged behind several 
state, county and city bans. Although France just banned BPA from food packaging effective 
January 1st, 2015, the U.S. FDA (which has jurisdiction over food packaging) recently reinforced 
their support for the use of BPA in food contact applications, reiterating their position that BPA is 
safe in the low doses that occur in foods (U.S. Food and Drug Administration 2014). Free BPA 
is released into food under increased temperature, acidic or basic conditions. Repeated 
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washings of BPA containers will also release BPA into anything stored in that container (Saal 
and Hughes 2005). The EPA has determined that 50 µg/kg/day is the acceptable daily intake for 
BPA in humans, yet adverse health effects in the general population can be seen at BPA levels 
much lower than this (Rochester 2013). The CDC found that 93 to 95% of adult tissue samples 
are contaminated with BPA, even though the half-life is only 6 hours (Saal and Hughes 2005, 
Rochester 2013). Since BPA is NOT a persistent chemical (it is easily absorbed, metabolized, 
excreted and does not accumulate in fatty tissues), the exposure must be widespread and 
chronic since it is detected in such a large portion of the population.   
A ban of EE2 is untenable, and endogenous hormones will always be a part of human 
waste that travels to the WWTP. Human excretion of natural hormones and EE2 must be taken 
into account when addressing the endocrine-disrupting potential of natural and synthetic 
estrogens. Essentially, the elimination of these compounds at the level of the WWTP needs to 
continue to be improved (Weber et al. 2004).  
The prerequisites for assessing an environmental or human health risk include exposure 
assessment and evidence of hazard (Touraud et al. 2011). Additional important factors include 
dose-response assessment and risk characterization (Beronius et al. 2009, Marx-Stoelting et al. 
2011, Meeker and Ferguson 2011). Moving forward, a revised risk assessment process for risk 
management must be agreed upon and implemented by U.S. regulating authorities (Hartung 
2009). The process will need to include low-dose, chronic exposures which are not included in 
the current testing system (Knudsen et al. 2011). Appropriate endocrine-sensitive endpoints 
need to be included, not just those of cancer, birth defects or death (Colborn et al. 1993). 
Additionally, it must be kept in mind that by-products of organic contaminants include 
metabolites and degradation intermediates (transformation products) which may have 
endocrine-disrupting potential as well. Most current testing focuses on the parent product, but 
the occurrence, fate and health effects of by-products are also highly important (Mompelat et al. 
2009). For ecological risk assessment, regulatory tests for EDCs should be applicable to a 
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variety of wildlife species, as the current approach is limited to a few species in the vertebrate 
and invertebrate taxa (Jobling et al. 2004). Several societies recently published a statement 
asking government agencies and other decision makers to rely upon their collective scientific 
expertise when revising the current system (The American Society of Human Genetics et al. 
2011).   
 
6.5 Future Considerations  
Now that there is weight-of-evidence regarding EDC occurrence and risk assessments, it 
is recommended that future work focus on acknowledging and correcting the problem. Some 
issues to consider:  
 Surrogate compounds. The compound-by-compound approach is much too time-
consuming and costly, and surrogate compounds can be used as a 
representative for a group of EDC compounds (e.g., phenol for phenolic 
compounds). 
 Mixtures. Contaminants do not exist as individual compounds in the environment, 
and mixture toxicity is an important part of ecotoxicology. 
 Environmentally-relevant concentrations. This is especially important with 
regards to removal methods. Because most micropollutant contaminants exist in 
trace concentrations (ng/L to ug/L), it will be critical to incorporate quantitative 
instruments with ever-decreasing method detection limits. 
 Bio-monitoring.  Detection of EDC ‘hotspots’ with mobile bio-monitoring devices 
is one avenue to be explored—assays that can be taken to the field to monitor for 
EDCs in situ. As an example, the use of fluorescence could be utilized as a 
qualitative method of characterizing EDCs in certain samples. Utilizing an 
Aqualog (Horiba Scientific), we have analyzed our estrogenic EDC standards 
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and captured excitation-emission matrices (EEMs) which could potentially serve 
as a type of fluorescent fingerprint.  
It should be recognized that the issue of EDCs and endocrine disruption is not just of 
importance to scientists. This is a broader issue affecting domestic households, politicians, 
regulatory agencies and generations to come. Substantial data exist regarding the exposures 
and health risks associated with EDCs in humans and wildlife on a global scale. Although 
momentum is pushing global climate change to the forefront of environmental concerns, it is 
important that mitigating the effects of EDCs not be overlooked, as this will be an important and 
collaborative responsibility of many organizations in the near future. The health of humans and 
wildlife depends on it.  
 
6.6 References 
Andrade, A.J.M., Grande, S.W., Talsness, C.E., Grote, K. and Chahoud, I. (2006) A Dose–
Response Study Following in Utero and Lactational Exposure to Di-(2-Ethylhexyl)-Phthalate 
(Dehp): Non-Monotonic Dose–Response and Low Dose Effects on Rat Brain Aromatase 
Activity. Toxicology 227(3), 185-192. 
Berger, S.L., Kouzarides, T., Shiekhattar, R. and Shilatifard, A. (2009) An Operational Definition 
of Epigenetics. Genes & Development 23(7), 781-783. 
Beronius, A., Rudén, C., Hanberg, A. and Håkansson, H. (2009) Health Risk Assessment 
Procedures for Endocrine Disrupting Compounds within Different Regulatory Frameworks in the 
European Union. Regulatory Toxicology and Pharmacology 55(2), 111-122. 
Cappiello, A., Famiglini, G., Palma, P., Termopoli, V., Lavezzi, A.M. and Matturri, L. (2014) 
Determination of Selected Endocrine Disrupting Compounds in Human Fetal and Newborn 
Tissues by Gc-Ms. Analytical and Bioanalytical Chemistry 406(12), 2779-2788. 
Chen, M.L., Chang, C.C., Shen, Y.J., Hung, J.H., Guo, B.R., Chuang, H.Y. and Mao, I.F. (2008) 
Quantification of Prenatal Exposure and Maternal-Fetal Transfer of Nonylphenol. Chemosphere 
73(1 Suppl), S239-245. 
Colborn, T., vom Saal, F.S. and Soto, A.M. (1993) Developmental Effects of Endocrine-
Disrupting Chemicals in Wildlife and Humans. Environmental Health Perspectives 101(5), 378-
384. 
120 
 
Conolly, R.B. and Lutz, W.K. (2004) Nonmonotonic Dose-Response Relationships: Mechanistic 
Basis, Kinetic Modeling, and Implications for Risk Assessment. Toxicological Sciences 77(1), 
151-157. 
Falconer, I.R., Chapman, H.F., Moore, M.R. and Ranmuthugala, G. (2006) Endocrine-Disrupting 
Compounds: A Review of Their Challenge to Sustainable and Safe Water Supply and Water 
Reuse. Environmental Toxicology 21(2), 181-191. 
Foster, W., Chan, S., Platt, L. and Hughes, C. (2000) Detection of Endocrine Disrupting 
Chemicals in Samples of Second Trimester Human Amniotic Fluid. Journal of Clinical 
Endocrinology and Metabolism 85(8), 2954-2957. 
Geer, L.A., Pycke, B.F.G., Sherer, D.M., Abulafia, O. and Halden, R.U. (2015) Use of Amniotic 
Fluid for Determining Pregnancies at Risk of Preterm Birth and for Studying Diseases of 
Potential Environmental Etiology. Environmental Research 136(0), 470-481. 
Giusti, R.M., Iwamoto, K. and Hatch, E.E. (1995) Diethylstilbestrol Revisited: A Review of the 
Long-Term Health Effects. Ann Intern Med 122(10), 778-788. 
Goldberg, A.D., Allis, C.D. and Bernstein, E. Epigenetics: A Landscape Takes Shape. Cell 
128(4), 635-638. 
Gore, A.C., Balthazart, J., Bikle, D., Carpenter, D.O., Crews, D., Czernichow, P., Diamanti-
Kandarakis, E., Dores, R.M., Grattan, D., Hof, P.R., Hollenberg, A.N., Lange, C., Lee, A.V., 
Levine, J.E., Millar, R.P., Nelson, R.J., Porta, M., Poth, M., Power, D.M., Prins, G.S., Ridgway, 
E.C., Rissman, E.F., Romijn, J.A., Sawchenko, P.E., Sly, P.D., Soder, O., Taylor, H.S., Tena-
Sempere, M., Vaudry, H., Wallen, K., Wang, Z., Wartofsky, L. and Watson, C.S. (2013) Policy 
Decisions on Endocrine Disruptors Should Be Based on Science across Disciplines: A 
Response to Dietrich Et Al. Endocrinology 154(11), 3957-3960. 
Hartung, T. (2009) Toxicology for the Twenty-First Century. Nature 460(7252), 208-212. 
Houlihan, J., Kropp, T., Wiles, R., Gray, S. and Campbell, C. (2005) Body Burden: The Pollution 
in Newborns, pp. 1-85, Environmental Working Group, Oakland, CA. 
Janex-Habibi, M.-L., Huyard, A., Esperanza, M. and Bruchet, A. (2009) Reduction of Endocrine 
Disruptor Emissions in the Environment: The Benefit of Wastewater Treatment. Water Research 
43(6), 1565-1576. 
Jobling, S., Casey, D., Rogers-Gray, T., Oehlmann, J., Schulte-Oehlmann, U., Pawlowski, S., 
Baunbeck, T., Turner, A.P. and Tyler, C.R. (2004) Comparative Responses of Molluscs and 
Fish to Environmental Estrogens and an Estrogenic Effluent. Aquatic Toxicology 66(2), 207-222. 
Knudsen, T.B., Kavlock, R.J., Daston, G.P., Stedman, D., Hixon, M. and Kim, J.H. (2011) 
Developmental Toxicity Testing for Safety Assessment: New Approaches and Technologies. 
Birth Defects Res B Dev Reprod Toxicol 92(5), 413-420. 
121 
 
Lee, H.-B., Peart, T.E. and Chan, J. (2004) Occurrence of Endocrine-Disrupting Chemicals in 
Sewage and Sludge Samples in Toronto, Canada. Water Quality Research Journal of Canada 
39(1), 57-63. 
Legler, J., Hamers, T., van Eck van der Sluijs-van de Bor, M., Schoeters, G., van der Ven, L., 
Eggesbo, M., Koppe, J., Feinberg, M. and Trnovec, T. (2011) The Obelix Project: Early Life 
Exposure to Endocrine Disruptors and Obesity. American Journal of Clinical Nutrition 94(6 
Suppl), 1933S-1938S. 
Lowell Center for Sustainable Production (2003) The Promise and Limits of the United States 
Toxic Substances Control Act, Lowell Center for Sustainable Production, Lowell, MA. 
Marx-Stoelting, P., Pfeil, R., Solecki, R., Ulbrich, B., Grote, K., Ritz, V., Banasiak, U., Heinrich-
Hirsch, B., Moeller, T., Chahoud, I. and Hirsch-Ernst, K.I. (2011) Assessment Strategies and 
Decision Criteria for Pesticides with Endocrine Disrupting Properties Relevant to Humans. 
Reproductive Toxicology 31(4), 574-584. 
McLachlan, J.A. (2006) Commentary: Prenatal Exposure to Diethylstilbestrol (Des): A 
Continuing Story. International Journal of Epidemiology 35(4), 868-870. 
McLachlan, J.A., Newbold, R.R. and Bullock, B. (1975) Reproductive Tract Lesions in Male 
Mice Exposed Prenatally to Diethylstilbestrol. Science 190(4218), 991-992. 
Meeker, J.D. and Ferguson, K.K. (2011) Relationship between Urinary Phthalate and Bisphenol 
a Concentrations and Serum Thyroid Measures in Us Adults and Adolescents from the National 
Health and Nutrition Examination Survey (Nhanes) 2007-2008. Environmental Health 
Perspectives 119(10), 1396. 
Meeker, J.D., Sathyanarayana, S. and Swan, S.H. (2009) Phthalates and Other Additives in 
Plastics: Human Exposure and Associated Health Outcomes. Philos Trans R Soc Lond B Biol 
Sci 364(1526), 2097-2113. 
Mompelat, S., Le Bot, B. and Thomas, O. (2009) Occurrence and Fate of Pharmaceutical 
Products and by-Products, from Resource to Drinking Water. Environment International 35(5), 
803-814. 
Myers, J.P., Zoeller, R.T. and vom Saal, F.S. (2009) A Clash of Old and New Scientific 
Concepts in Toxicity, with Important Implications for Public Health. Environmental Health 
Perspectives 117(11), 1652-1655. 
Newbold, R. (1995) Cellular and Molecular Effects of Developmental Exposure to 
Diethylstilbestrol: Implications for Other Environmental Estrogens. Environmental Health 
Perspectives 103 Suppl 7, 83-87. 
Radosevic, K., Tonkovic, T., Slivac, I., Kniewald, Z. and Gaurina Srcek, V. (2011) Comparison 
of Cytotoxicity Induced by 17alpha-Ethynylestradiol and Diethylstilbestrol in Fish Cco and 
122 
 
Mammalian Cho-K1 Cell Lines. Bulletin of Environmental Contamination and Toxicology 86(3), 
252-257. 
Rochester, J.R. (2013) Bisphenol a and Human Health: A Review of the Literature. 
Reproductive Toxicology 42(0), 132-155. 
Saal, F.S.v. and Hughes, C. (2005) An Extensive New Literature Concerning Low-Dose Effects 
of Bisphenol a Shows the Need for a New Risk Assessment. Environmental Health 
Perspectives 113(8), 926-933. 
Schug, T.T., Janesick, A., Blumberg, B. and Heindel, J.J. (2011) Endocrine Disrupting 
Chemicals and Disease Susceptibility. The Journal of Steroid Biochemistry and Molecular 
Biology 127(3–5), 204-215. 
Selevan, S.G., Kimmel, C.A. and Mendola, P. (2000) Identifying Critical Windows of Exposure 
for Children's Health. Environmental Health Perspectives 108 Suppl 3, 451-455. 
Skinner, M.K. (2007) Endocrine Disruptors and Epigenetic Transgenerational Disease Etiology. 
Pediatr Res 61(5 Pt 2), 48R-50R. 
Skinner, M.K., Manikkam, M., Haque, M.M., Zhang, B. and Savenkova, M.I. (2012) Epigenetic 
Transgenerational Inheritance of Somatic Transcriptomes and Epigenetic Control Regions. 
Genome Biol 13(10), R91. 
The American Society of Human Genetics, The American Society for Reproductive Medicine, 
The Endocrine Society, The Genetics Society of America, The Society for Developmental 
Biology, The Society for Pediatric Urology, The Society for the Study of Reproduction and The 
Society for Gynecologic Investigation (2011) Assessing Chemical Risk: Societies Offer 
Expertise. Science 331(6021), 1136. 
Touraud, E., Roig, B., Sumpter, J.P. and Coetsier, C. (2011) Drug Residues and Endocrine 
Disruptors in Drinking Water: Risk for Humans? International Journal of Hygiene and 
Environmental Health 214(6), 437-441. 
TSCA (1976) Toxic Substances Control Act of 1976. 15 U.S.C 2601 et seq. (Public Law), 94 - 
469. 
U.S. Environmental Protection Agency (2010) Nonylphenol (Np) and Nonylphenol Ethoxylates 
(Npes) Action Plan, pp. 1-13, U.S. EPA. 
U.S. Food and Drug Administration (2014) Bisphenol a (Bpa): Use in Food Contact Application, 
FDA, www.fda.gov  
Vandenberg, L.N., Colborn, T., Hayes, T.B., Heindel, J.J., Jacobs Jr, D.R., Lee, D.-H., Myers, 
J.P., Shioda, T., Soto, A.M., vom Saal, F.S., Welshons, W.V. and Zoeller, R.T. (2013) 
123 
 
Regulatory Decisions on Endocrine Disrupting Chemicals Should Be Based on the Principles of 
Endocrinology. Reproductive Toxicology 38(0), 1-15. 
Vilahur, N., Bustamante, M., Byun, H.M., Fernandez, M.F., Santa Marina, L., Basterrechea, M., 
Ballester, F., Murcia, M., Tardon, A., Fernandez-Somoano, A., Estivill, X., Olea, N., Sunyer, J. 
and Baccarelli, A.A. (2014) Prenatal Exposure to Mixtures of Xenoestrogens and Repetitive 
Element DNA Methylation Changes in Human Placenta. Environment International 71, 81-87. 
Weber, S., Gallenkemper, M., Melin, T., Dott, W. and Hollender, J. (2004) Efficiency of 
Nanofiltration for the Elimination of Steroids from Water. Water Science and Technology 50(5), 
9-14. 
Zoeller, R.T., Brown, T.R., Doan, L.L., Gore, A.C., Skakkebaek, N.E., Soto, A.M., Woodruff, T.J. 
and Vom Saal, F.S. (2012) Endocrine-Disrupting Chemicals and Public Health Protection: A 
Statement of Principles from the Endocrine Society. Endocrinology 153(9), 4097-4110. 
 
124 
 
 
 
 
 
 
APPENDIX A 
 
Table A1 
Sites and GPS coordinates of sampling stations 
Site Station Latitude Longitude 
Tampa Active discharge plume 27°54'37.68"N 82°26'25.01"W 
 T1 27°54'38.40"N 82°26'25.09"W 
 T2 27°54'39.07"N 82°26'25.43"W 
 T3 27°54'39.70"N 82°26'26.16"W 
 T4 27°54'38.04"N 82°26'25.50"W 
 T5 27°54'38.45"N 82°26'26.27"W 
 T6 27°54'38.70"N 82°26'26.99"W 
 T7 27°54'37.16"N 82°26'25.08"W 
 T8 27°54'36.40"N 82°26'25.60"W 
 T9 27°54'35.89"N 82°26'26.33"W 
 T10 27°54'37.10"N 82°26'24.53"W 
 T11 27°54'36.52"N 82°26'24.05"W 
 T12 27°54'35.69"N 82°26'23.51"W 
St. Petersburg Remnant discharge 27°45'46.61"N 82°37'20.42"W 
 S1 27°45'46.90"N 82°37'20.17"W 
 S2 27°45'47.35"N 82°37'21.02"W 
 S3 27°45'47.94"N 82°37'21.66"W 
 S4 27°45'46.29"N 82°37'20.60"W 
 S5 27°45'45.70"N 82°37'21.30"W 
 S6 27°45'45.09"N 82°37'21.98"W 
 S7 27°45'46.27"N 82°37'20.21"W 
 S8 27°45'45.85"N 82°37'19.38"W 
 S9 27°45'45.12"N 82°37'18.94"W 
 S10 27°45'47.01"N 82°37'20.31"W 
 S11 27°45'47.75"N 82°37'19.87"W 
 S12 27°45'48.40"N 82°37'19.27"W 
Clearwater Active discharge plume 27°58'55.22"N 82°47'11.88"W 
 C1 27°58'55.16"N 82°47'11.72"W 
 C2 27°58'55.30"N 82°47'11.96"W 
 C3 27°58'55.48"N 82°47'11.86"W 
 C4 27°58'55.33"N 82°47'11.66"W 
 C5 27°58'57.78"N 82°47'15.11"W 
 C6 27°58'57.65"N 82°47'15.20"W 
 C7 27°58'57.57"N 82°47'15.35"W 
 C8 27°59'0.32"N 82°47'18.22"W 
 C9 27°59'1.53"N 82°47'19.20"W 
 C10 27°59'10.52"N 82°47'27.56"W 
 C11 27°59'12.07"N 82°47'29.27"W 
 C12 27°59'19.11"N 82°47'34.46"W 
 C13 27°59'21.34"N 82°47'37.73"W 
Reference Site R 27°35'35.00"N 82°45'25.00"W 
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APPENDIX B 
 
Table B1 
Percent dry weight of sediment samples. 
Site Campaign Station % Dry weight 
Tampa April 2012 2 62.53 
Tampa April 2012 3 77.85 
Tampa April 2012 4 57.05 
Tampa April 2012 5 72.93 
Tampa April 2012 7A 29.76 
Tampa April 2012 7B 26.40 
Tampa April 2012 7C 28.36 
Tampa April 2012 8 27.55 
Tampa April 2012 9 32.63 
Tampa April 2012 10 24.50 
Tampa April 2012 11 39.61 
Tampa April 2012 12 19.20 
Tampa October 2012 5A 78.55 
Tampa October 2012 5B 78.86 
Tampa October 2012 5C 73.24 
Tampa October 2012 6 28.87 
Tampa October 2012 8 22.91 
Tampa October 2012 9A 69.51 
Tampa October 2012 9B 64.39 
Tampa October 2012 9C 40.35 
Tampa October 2012 10 30.31 
Tampa October 2012 11 30.04 
Tampa June 2013 1 77.61 
Tampa June 2013 2 63.61 
Tampa June 2013 3 46.84 
Tampa June 2013 4 79.00 
Tampa June 2013 5 55.51 
Tampa June 2013 6 36.08 
Tampa June 2013 7A 28.79 
Tampa June 2013 7B 30.41 
Tampa June 2013 7C 23.88 
Tampa June 2013 8 20.32 
Tampa June 2013 9 23.67 
Tampa June 2013 10 28.30 
Tampa June 2013 11 21.25 
Tampa June 2013 12 20.63 
St. Petersburg April 2012 1 78.12 
St. Petersburg April 2012 2 78.43 
St. Petersburg April 2012 3 78.99 
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Table B1 (continued) 
St. Petersburg April 2012 4 80.36 
St. Petersburg April 2012 5A 78.86 
St. Petersburg April 2012 5B 78.07 
St. Petersburg April 2012 5C 78.44 
St. Petersburg April 2012 6 78.59 
St. Petersburg April 2012 7 77.17 
St. Petersburg April 2012 8 77.37 
St. Petersburg April 2012 9 78.04 
St. Petersburg April 2012 10 78.94 
St. Petersburg April 2012 11 76.87 
St. Petersburg April 2012 12 79.47 
St. Petersburg October 2012 1A 78.34 
St. Petersburg October 2012 1B 77.53 
St. Petersburg October 2012 1C 77.42 
St. Petersburg October 2012 2 73.76 
St. Petersburg October 2012 3A 74.50 
St. Petersburg October 2012 3B 77.91 
St. Petersburg October 2012 3C 78.60 
St. Petersburg October 2012 4 77.68 
St. Petersburg October 2012 5 76.30 
St. Petersburg October 2012 6 73.75 
St. Petersburg October 2012 7 76.45 
St. Petersburg October 2012 8 77.62 
St. Petersburg October 2012 9 79.13 
St. Petersburg October 2012 10 78.43 
St. Petersburg October 2012 11 79.64 
St. Petersburg October 2012 12 77.90 
St. Petersburg June 2013 1 78.98 
St. Petersburg June 2013 2 74.97 
St. Petersburg June 2013 3 78.28 
St. Petersburg June 2013 4 79.33 
St. Petersburg June 2013 5A 76.84 
St. Petersburg June 2013 5B 79.35 
St. Petersburg June 2013 5C 77.86 
St. Petersburg June 2013 6 77.53 
St. Petersburg June 2013 7 79.29 
St. Petersburg June 2013 8 79.14 
St. Petersburg June 2013 9 78.03 
St. Petersburg June 2013 10 78.25 
St. Petersburg June 2013 11 78.89 
St. Petersburg June 2013 12 78.65 
Clearwater April 2012 1A 78.48 
Clearwater April 2012 1B 78.56 
Clearwater April 2012 1C 81.10 
Clearwater April 2012 2 82.33 
Clearwater April 2012 3 81.72 
Clearwater April 2012 4 75.31 
Clearwater April 2012 5 76.05 
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Table B1 (continued) 
Clearwater April 2012 6A 79.79 
Clearwater April 2012 6B 70.98 
Clearwater April 2012 6C 76.93 
Clearwater April 2012 7 79.10 
Clearwater April 2012 8 72.84 
Clearwater April 2012 9 79.72 
Clearwater April 2012 10 71.80 
Clearwater April 2012 11 49.90 
Clearwater April 2012 12 63.88 
Clearwater October 2012 1A 79.88 
Clearwater October 2012 1B 81.72 
Clearwater October 2012 1C 82.14 
Clearwater October 2012 2 80.16 
Clearwater October 2012 3 75.83 
Clearwater October 2012 4 81.53 
Clearwater October 2012 5 74.90 
Clearwater October 2012 6A 77.24 
Clearwater October 2012 6B 74.04 
Clearwater October 2012 6C 76.75 
Clearwater October 2012 7 58.88 
Clearwater October 2012 8 81.12 
Clearwater October 2012 9 81.01 
Clearwater October 2012 10 69.68 
Clearwater October 2012 11 47.56 
Clearwater October 2012 12 74.94 
Clearwater October 2012 13 28.26 
Clearwater June 2013 1A 74.01 
Clearwater June 2013 1B 80.39 
Clearwater June 2013 2 80.63 
Clearwater June 2013 3 75.52 
Clearwater June 2013 4 75.97 
Clearwater June 2013 5 79.53 
Clearwater June 2013 6 68.66 
Clearwater June 2013 7 74.33 
Clearwater June 2013 8 73.30 
Clearwater June 2013 9 79.96 
Clearwater June 2013 10 71.13 
Clearwater June 2013 11 35.15 
Clearwater June 2013 12 44.09 
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APPENDIX C 
 
Table C1 
Mean influent and effluent concentrations of six estrogenic endocrine-disrupting compounds 
(EDCs) determined across four wastewater treatment plant (WWTP) study locations over 
fourteen months. 
EDC WWTP 
ID 
Campaign Mean 
influent 
conc. 
(ng/L) 
Mean 
effluent 
conc. 
(ng/L)  
Test 
Statistic 
p-value Significance % 
reduction 
E1 HFC Apr-12 107.0 1.8 t = 14.20 <.0001 Significant 98.3 
E2 HFC Apr-12 42.7 3.4 t = 10.40 0.0001 Significant 92.1 
EE2 HFC Apr-12 7.7 2.9 t = 8.25 <.0001 Significant 62.7 
E3 HFC Apr-12 51.7 1.5 t = 10.36 0.0001 Significant 97.1 
NP HFC Apr-12 858.1 13.5 t = 3.20 0.0241 Significant 98.4 
BPA HFC Apr-12 48537.4 9.7 t = 9.78 0.0002 Significant 100.0 
EEQ HFC Apr-12 85.2 7.4 t = 18.83 <.0001 Significant 91.3 
E1 SCB Apr-12 55.9 1.9 t = 7.06 <.0001 Significant 96.6 
E2 SCB Apr-12 71.8 3.8 S = 
155.0000 
<.0001 Significant 94.8 
EE2 SCB Apr-12 9.2 2.2 t = 8.80 <.0001 Significant 76.4 
E3 SCB Apr-12 53.7 1.5 t = 10.95 <.0001 Significant 97.2 
NP SCB Apr-12 134.9 9.9 S = 
155.0000 
<.0001 Significant 92.6 
BPA SCB Apr-12 21276.7 16.8 S = 
155.0000 
<.0001 Significant 99.9 
EEQ SCB Apr-12 100.2 6.9 S = 
155.0000 
<.0001 Significant 93.1 
E1 SSP Apr-12 78.2 5.4 S = 
155.0000 
<.0001 Significant 93.1 
E2 SSP Apr-12 34.3 1.9 t = 6.71 <.0001 Significant 94.6 
EE2 SSP Apr-12 4.4 2.4 S = 
132.0000 
0.043 Significant 45.7 
E3 SSP Apr-12 27.7 1.8 S = 
155.0000 
<.0001 Significant 93.6 
NP SSP Apr-12 76.3 30.8  S = 
147.0000 
0.0007 Significant 59.6 
BPA SSP Apr-12 7367.4 44.5 S = 
155.0000 
<.0001 Significant 99.4 
EEQ SSP Apr-12 60.4 6.2 t = 8.94 <.0001 Significant 89.7 
E1 Man Apr-12 33.5 23.8 S = 
112.0000 
0.6305 Not 
significant 
28.8 
E2 Man Apr-12 36.4 4.1 t = 8.17 <.0001 Significant 88.7 
EE2 Man Apr-12 5.8 4.1 t = 2.30 0.0336 Significant 29.2 
E3 Man Apr-12 36.2 1.9 S = 
155.0000 
<.0001 Significant 94.8 
NP Man Apr-12 63.5 26.6 S = 
152.0000 
<.0001 Significant 58.1 
BPA Man Apr-12 6323.5 49.5 S = 
155.0000 
<.0001 Significant 99.2 
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Table C1 (continued) 
EEQ Man Apr-12 52.9 15.2 t = 7.53 <.0001 Significant 71.3 
E1 HFC Oct-12 86.3 18.3 t = 3.29 0.0301 Significant 78.8 
E2 HFC Oct-12 28.5 18.5 S = 
26.0000 
0.8413 Not 
significant 
34.9 
EE2 HFC Oct-12 6.3 1.0 S = 
40.0000 
0.0079 Significant 84.1 
E3 HFC Oct-12 52.1 14.7 t = 2.64 0.0563 Not 
significant 
71.8 
NP HFC Oct-12 194.5 87.5 t = 2.95 0.0414 Significant 55.0 
BPA HFC Oct-12 179.2 179.2 S = 
20.0000 
0.1508 Not 
significant 
0.0 
EEQ HFC Oct-12 58.2 24.5 t = 1.87 0.1337 Not 
significant 
57.9 
E1 SCB Oct-12 54.5 19.0 t = 6.17 0.0034 Significant 65.1 
E2 SCB Oct-12 22.3 4.4 t = 3.97 0.0163 Significant 80.2 
EE2 SCB Oct-12 9.8 1.0 t = 7.61 0.0016 Significant 89.8 
E3 SCB Oct-12 153.9 17.6 t = 7.61 0.0014 Significant 88.6 
NP SCB Oct-12 138.8 70.1 t = 6.93 0.0014 Significant 49.5 
BPA SCB Oct-12 356.0 72.1 t = 2.79 0.0482 Significant 79.7 
EEQ SCB Oct-12 49.1 10.5 t = 7.88 0.0014 Significant 78.6 
E1 SSP Oct-12 63.3 16.8 t = 7.35 0.0017 Significant 73.5 
E2 SSP Oct-12 20.5 1.9 t = 9.21 0.0006 Significant 90.4 
EE2 SSP Oct-12 6.0 1.0 t = 3.19 0.0332 Significant 83.4 
E3 SSP Oct-12 17.4 38.5 S = 
15.0000 
0.0079 Significant -122.0 
NP SSP Oct-12 851.4 44.2 t = 1.95 0.1224 Not 
significant 
94.8 
BPA SSP Oct-12 117.0 95.1 t = 0.94 0.3929 Not 
significant 
18.7 
EEQ SSP Oct-12 44.0 7.7 S = 
40.0000 
0.0079 Significant 82.6 
E1 Man Oct-12 75.9 13.1 t = 3.85 0.018 Significant 82.7 
E2 Man Oct-12 24.7 7.2 t = 1.74 0.1554 Not 
significant 
70.9 
EE2 Man Oct-12 8.0 1.0 t = 3.80 0.0191 Significant 87.5 
E3 Man Oct-12 311.9 57.7 t = 5.11 0.0067 Significant 81.5 
NP Man Oct-12 328.8 72.2 t = 5.40 0.0056 Significant 78.0 
BPA Man Oct-12 1591.5 372.2 S = 
40.0000 
0.0079 Significant 76.6 
EEQ Man Oct-12 55.5 12.3 t = 3.05 0.0377 Significant 77.8 
E1 HFC Jun-13 192.2 15.1 t = 12.96 0.0001 Significant 92.1 
E2 HFC Jun-13 40.6 11.8 t = 5.39 0.0007 Significant 70.9 
EE2 HFC Jun-13 7.2 3.5 t = 2.88 0.0206 Significant 51.9 
E3 HFC Jun-13 640.8 5.9 t = 11.18 0.0015 Significant 99.1 
NP HFC Jun-13 220.9 24.1 S = 
40.0000 
0.0079 Significant 89.1 
BPA HFC Jun-13 1108.9 16.1 t = 1.97 0.1197 Not 
significant 
98.5 
EEQ HFC Jun-13 100.8 20.0 t = 12.20 <.0001 Significant 80.2 
E1 SCB Jun-13 48.7 11.8 t = 10.89 <.0001 Significant 75.8 
E2 SCB Jun-13 33.5 13.5 t = 14.07 <.0001 Significant 59.7 
EE2 SCB Jun-13 7.7 3.6 t = 4.65 0.0016 Significant 52.7 
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E3 SCB Jun-13 83.1 3.9 S = 
40.0000 
0.0079 Significant 95.3 
NP SCB Jun-13 170.5 13.7 t = 2.08 0.1062 Not 
significant 
92.0 
BPA SCB Jun-13 3095.5 17.6 S = 
40.0000 
0.0079 Significant 99.4 
EEQ SCB Jun-13 56.2 21.0 t = 14.55 <.0001 Significant 62.6 
E1 SSP Jun-13 175.9 2.0 t = 18.79 <.0001 Significant 98.9 
E2 SSP Jun-13 28.7 1.0 t = 9.88 0.0006 Significant 96.5 
EE2 SSP Jun-13 4.1 1.0 t = 5.29 0.0061 Significant 75.6 
E3 SSP Jun-13 157.3 3.0 t = 9.26 0.0008 Significant 98.1 
NP SSP Jun-13 79.6 2.0 t = 4.67 0.0095 Significant 97.5 
BPA SSP Jun-13 1542.4 1.0 t = 20.06 <.0001 Significant 99.9 
EEQ SSP Jun-13 78.9 2.8 t = 14.63 0.0001 Significant 96.5 
E1 Man Jun-13 157.1 38.6 t = 6.79 0.0025 Significant 75.4 
E2 Man Jun-13 23.2 19.8 t = 1.31 0.2591 Not 
significant 
14.7 
EE2 Man Jun-13 5.4 4.3 t = 1.59 0.1869 Not 
significant 
20.8 
E3 Man Jun-13 662.5 7.6 S = 
15.0000 
0.1 Not 
significant 
98.9 
NP Man Jun-13 161.9 25.6 t = 2.54 0.1263 Not 
significant 
84.2 
BPA Man Jun-13 2480.2 40.5 t = 19.74 0.0024 Significant 98.4 
EEQ Man Jun-13 73.5 34.8 t = 6.00 0.0039 Significant 52.7 
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APPENDIX D 
 
Table D1 
Concentrations of six estrogenic EDCs and total estrogenicity in marine aqueous samples. 
Concentrations are in ng/L. ‘ns’ = no sample.  
Station Site Campaign E1 E2 EE2 E3 BPA NP EEQ 
1 St. 
Petersburg 
Apr-12 3.8 4.0 4.0 4.2 9452.0 13.3 11.1 
2 St. 
Petersburg 
Apr-12 3.0 1.0 0.5 1.3 4051.2 11.7 2.9 
3 St. 
Petersburg 
Apr-12 2.9 1.4 0.5 1.5 2917.4 11.0 3.1 
4 St. 
Petersburg 
Apr-12 5.7 1.0 0.5 1.9 1893.2 11.7 3.2 
5 St. 
Petersburg 
Apr-12 1.0 4.4 0.5 1.5 3643.9 19.4 5.7 
6 St. 
Petersburg 
Apr-12 3.3 2.6 1.2 1.5 2652.0 32.5 5.2 
7 St. 
Petersburg 
Apr-12 ns ns ns ns ns ns 0.0 
8 St. 
Petersburg 
Apr-12 8.1 4.3 0.5 4.2 1584.3 20.6 7.2 
9 St. 
Petersburg 
Apr-12 7.0 6.8 2.0 6.9 3325.8 87.7 11.5 
10 St. 
Petersburg 
Apr-12 8.7 0.5 1.8 0.6 1414.3 69.7 5.1 
11 St. 
Petersburg 
Apr-12 4.6 5.7 0.5 0.4 1584.9 9.2 7.6 
12 St. 
Petersburg 
Apr-12 4.3 3.5 0.5 1.5 1134.3 22.8 5.3 
1 St. 
Petersburg 
Oct-12 ns ns ns ns ns ns 0.0 
2 St. 
Petersburg 
Oct-12 12.3 9.5 5.5 1.5 32380.6 30.1 23.4 
3 St. 
Petersburg 
Oct-12 13.2 10.4 3.1 1.5 26031.2 25.0 20.6 
4 St. 
Petersburg 
Oct-12 12.6 8.6 4.0 1.5 21058.9 29.1 19.3 
5 St. 
Petersburg 
Oct-12 9.0 10.1 2.8 1.5 19938.7 37.8 18.2 
6 St. 
Petersburg 
Oct-12 10.1 14.6 2.6 1.5 15939.8 30.2 22.4 
7 St. 
Petersburg 
Oct-12 6.2 3.8 2.4 1.5 27352.2 28.3 11.7 
8 St. 
Petersburg 
Oct-12 9.4 4.3 3.2 1.5 30617.1 32.2 14.3 
9 St. 
Petersburg 
Oct-12 9.0 5.0 2.9 1.5 19756.2 38.9 13.3 
10 St. 
Petersburg 
Oct-12 10.5 6.5 2.9 1.5 17303.8 36.0 14.8 
11 St. 
Petersburg 
Oct-12 18.8 4.9 2.4 1.5 17431.8 34.6 14.7 
12 St. 
Petersburg 
Oct-12 9.0 6.4 2.9 1.5 18499.7 27.1 14.5 
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Table D1 (continued)  
1 St. 
Petersburg 
Jun-13 29.1 16.0 0.5 70.8 2598.9 4.1 24.6 
2 St. 
Petersburg 
Jun-13 14.7 4.7 0.5 41.1 2310.3 5.0 9.5 
3 St. 
Petersburg 
Jun-13 10.0 2.5 0.5 17.0 1798.1 5.0 5.9 
4 St. 
Petersburg 
Jun-13 5.6 2.1 0.5 1.5 2620.6 8.7 4.4 
5 St. 
Petersburg 
Jun-13 4.7 1.5 0.5 4.9 2154.2 4.7 3.6 
6 St. 
Petersburg 
Jun-13 5.3 1.9 0.5 18.3 3696.0 5.4 4.4 
7 St. 
Petersburg 
Jun-13 2.2 1.6 0.5 4.7 2319.9 2.3 3.1 
8 St. 
Petersburg 
Jun-13 7.8 2.0 0.5 1.5 1706.3 11.2 4.8 
9 St. 
Petersburg 
Jun-13 6.8 1.3 0.5 10.9 1783.5 3.8 3.9 
10 St. 
Petersburg 
Jun-13 6.2 1.1 0.5 3.0 1936.1 4.3 3.5 
11 St. 
Petersburg 
Jun-13 4.6 1.8 0.5 8.5 1689.1 4.8 3.8 
12 St. 
Petersburg 
Jun-13 11.0 1.6 0.5 7.0 1870.7 4.1 5.3 
1 Tampa Apr-12 4.3 5.9 6.2 11.8 11760.6 5.7 16.2 
2 Tampa Apr-12 5.1 6.2 8.4 9.5 7263.6 5.2 18.9 
3 Tampa Apr-12 2.9 1.6 0.6 3.2 5393.0 5.3 3.7 
4 Tampa Apr-12 2.5 2.2 0.5 5.3 3194.9 4.2 3.9 
5 Tampa Apr-12 3.0 6.3 0.5 6.6 5355.1 21.3 8.3 
6 Tampa Apr-12 3.8 1.2 0.5 2.2 4044.4 8.9 3.3 
7 Tampa Apr-12 3.3 1.6 0.5 1.5 3119.0 6.6 3.4 
8 Tampa Apr-12 4.2 1.9 0.5 1.3 3099.9 10.5 3.9 
9 Tampa Apr-12 0.9 2.2 0.5 0.8 1663.9 2.7 3.3 
10 Tampa Apr-12 5.5 4.0 0.5 1.5 5153.5 4.8 6.6 
11 Tampa Apr-12 4.9 1.2 1.8 1.6 2842.3 5.3 5.1 
12 Tampa Apr-12 3.9 0.5 0.5 1.5 2082.0 10.9 2.4 
1 Tampa Oct-12 21.3 16.1 6.6 1.5 41511.9 28.2 34.7 
2 Tampa Oct-12 15.2 7.8 7.5 1.5 50940.7 38.9 27.2 
3 Tampa Oct-12 19.5 23.4 8.0 1.5 36732.8 37.7 42.7 
4 Tampa Oct-12 17.3 8.1 4.2 1.5 37217.7 31.5 22.2 
5 Tampa Oct-12 23.9 18.5 6.4 1.5 26213.6 38.0 35.6 
6 Tampa Oct-12 1.0 17.4 9.4 1.5 61030.6 45.1 36.7 
7 Tampa Oct-12 15.2 9.3 4.6 1.5 32214.7 37.9 22.7 
8 Tampa Oct-12 14.0 9.1 4.9 1.5 27043.4 37.3 22.1 
9 Tampa Oct-12 25.2 11.3 9.8 1.5 26814.9 37.8 33.1 
10 Tampa Oct-12 19.4 9.2 5.3 1.5 25876.2 39.5 23.8 
11 Tampa Oct-12 14.8 8.0 5.1 1.5 24233.4 43.0 21.0 
12 Tampa Oct-12 9.5 7.8 5.4 1.5 22224.0 30.3 19.7 
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Table D1 (continued)  
1 Tampa Jun-13 16.8 1.9 4.1 1.5 2263.3 8.7 11.5 
2 Tampa Jun-13 15.7 2.3 1.3 1.5 2628.8 6.4 8.2 
3 Tampa Jun-13 26.6 2.7 1.4 1.5 2399.4 2.9 11.4 
4 Tampa Jun-13 16.4 1.6 0.9 1.5 2723.3 4.4 7.2 
5 Tampa Jun-13 6.7 2.8 0.5 1.5 2674.2 2.5 5.4 
6 Tampa Jun-13 14.5 1.6 0.9 1.5 3108.5 3.5 6.8 
7 Tampa Jun-13 18.8 1.8 1.0 1.5 3473.7 2.6 8.2 
8 Tampa Jun-13 11.6 1.6 0.5 1.5 2626.6 3.5 5.5 
9 Tampa Jun-13 9.9 2.0 0.8 1.5 3179.6 3.8 5.9 
10 Tampa Jun-13 13.1 3.6 4.4 1.5 7951.5 4.7 13.3 
11 Tampa Jun-13 21.4 1.4 1.5 1.5 3257.6 5.8 9.0 
12 Tampa Jun-13 6.5 1.6 0.5 1.5 3490.8 2.3 4.3 
1 Clearwater Apr-12 ns ns ns ns ns ns 0.0 
2 Clearwater Apr-12 8.2 3.3 6.4 9.6 5691.7 201.9 14.2 
3 Clearwater Apr-12 7.4 3.9 18.4 9.6 12304.4 187.9 30.3 
4 Clearwater Apr-12 1.0 21.6 0.5 59.7 6396.4 18.0 23.6 
5 Clearwater Apr-12 5.3 3.0 9.5 8.7 8035.3 119.8 17.2 
6 Clearwater Apr-12 8.3 3.1 9.5 3.8 5762.9 18.5 17.8 
7 Clearwater Apr-12 3.6 3.2 9.5 9.1 4720.7 147.0 16.5 
8 Clearwater Apr-12 6.1 1.2 1.1 3.1 6084.3 42.5 4.9 
9 Clearwater Apr-12 5.6 4.7 17.0 8.3 6228.9 25.1 28.1 
10 Clearwater Apr-12 4.7 1.7 4.5 4.9 7580.2 28.0 9.5 
11 Clearwater Apr-12 4.3 2.0 3.9 5.0 5284.2 11.1 8.6 
12 Clearwater Apr-12 ns ns ns ns ns ns 0.0 
13 Clearwater Apr-12 3.5 0.8 3.0 0.8 3205.1 17.2 5.9 
1 Clearwater Oct-12 38.4 18.7 9.3 1.5 24233.1 38.4 42.8 
2 Clearwater Oct-12 36.7 18.3 8.5 1.5 22482.7 36.2 40.8 
3 Clearwater Oct-12 23.3 15.9 5.3 1.5 27907.9 36.5 31.7 
4 Clearwater Oct-12 33.0 13.9 3.9 1.5 15899.9 34.7 28.9 
5 Clearwater Oct-12 27.5 12.3 3.9 1.5 16778.3 31.6 26.1 
6 Clearwater Oct-12 22.9 11.5 3.7 1.5 18501.3 25.8 24.1 
7 Clearwater Oct-12 16.6 5.0 3.9 1.5 20026.8 7.1 16.4 
8 Clearwater Oct-12 22.4 10.6 4.2 1.5 81560.3 22.0 31.2 
9 Clearwater Oct-12 33.2 14.5 3.2 1.5 41616.3 32.9 31.9 
10 Clearwater Oct-12 13.1 5.1 2.5 1.5 24511.4 7.0 14.4 
11 Clearwater Oct-12 20.8 9.5 3.6 1.5 25492.9 22.9 22.2 
12 Clearwater Oct-12 9.2 8.0 2.2 1.5 10229.9 11.0 14.3 
13 Clearwater Oct-12 8.9 9.2 0.5 1.5 17556.6 13.5 14.2 
1 Clearwater Jun-13 5.2 5.0 2.3 6.3 3630.6 5.7 9.6 
2 Clearwater Jun-13 2.0 0.9 0.5 1.5 0.5 1.0 2.1 
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Table D1 (continued)  
3 Clearwater Jun-13 5.0 1.4 1.6 5.3 3126.5 4.8 5.0 
4 Clearwater Jun-13 2.6 0.9 1.4 2.7 2182.5 3.3 3.5 
5 Clearwater Jun-13 5.4 3.6 2.5 4.4 2197.1 8.2 8.3 
6 Clearwater Jun-13 4.7 1.3 0.5 4.0 2851.7 8.7 3.4 
7 Clearwater Jun-13 4.8 2.0 1.5 6.2 2782.0 8.7 5.5 
8 Clearwater Jun-13 5.5 1.5 1.8 5.5 2923.1 10.8 5.5 
9 Clearwater Jun-13 5.0 1.6 0.5 4.0 3195.9 6.4 3.9 
10 Clearwater Jun-13 2.6 0.9 0.5 1.5 2653.6 4.8 2.5 
11 Clearwater Jun-13 3.1 0.6 0.5 1.5 2877.2 4.9 2.3 
12 Clearwater Jun-13 3.7 0.9 0.5 3.3 3334.6 7.3 2.9 
13 Clearwater Jun-13 1.5 0.5 0.5 2.1 0.5 0.6 1.5 
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APPENDIX E 
 
Table E1 
Concentrations of six estrogenic EDCs and total estrogenicity in marine sediment samples. 
Concentrations are in ng/g. ‘ns’ = no sample.  
Station  Site Campaign E1 E2 EE2 E3 BPA NP EEQ 
1 St. 
Petersburg 
Apr-12 6.7 0.7 1.5 1.5 3.3 3.5 4.2 
2 St. 
Petersburg 
Apr-12 ns ns ns ns ns ns  
3 St. 
Petersburg 
Apr-12 7.5 0.9 1.1 1.5 3.5 0.8 4.1 
4 St. 
Petersburg 
Apr-12 0.9 0.5 1.1 1.5 3.0 0.7 2.1 
5 St. 
Petersburg 
Apr-12 4.9 0.8 1.1 1.5 2.4 1.1 3.4 
6 St. 
Petersburg 
Apr-12 5.5 0.7 1.5 1.5 2.0 0.7 4.0 
7 St. 
Petersburg 
Apr-12 9.2 1.3 2.8 1.5 4.4 2.0 7.1 
8 St. 
Petersburg 
Apr-12 8.0 0.8 1.2 1.5 3.6 3.2 4.3 
9 St. 
Petersburg 
Apr-12 7.2 0.4 0.7 1.5 1.9 1.5 3.1 
10 St. 
Petersburg 
Apr-12 4.8 0.6 0.9 1.5 1.7 0.7 2.9 
11 St. 
Petersburg 
Apr-12 8.0 1.1 2.2 1.5 3.9 6.5 5.8 
12 St. 
Petersburg 
Apr-12 11.0 1.1 1.7 1.5 5.0 4.6 6.1 
1 St. 
Petersburg 
Oct-12 4.9 11.1 2.2 1.5 28.1 7.7 15.0 
2 St. 
Petersburg 
Oct-12 4.5 9.0 1.6 12.5 19.9 4.8 12.2 
3 St. 
Petersburg 
Oct-12 9.1 13.6 1.4 26.9 38.6 4.4 17.8 
4 St. 
Petersburg 
Oct-12 5.7 15.7 0.5 15.4 25.6 10.4 17.9 
5 St. 
Petersburg 
Oct-12 5.6 13.5 0.7 20.0 24.7 8.2 16.0 
6 St. 
Petersburg 
Oct-12 8.6 18.7 0.5 27.1 40.2 12.1 21.7 
7 St. 
Petersburg 
Oct-12 7.7 47.2 0.5 21.5 38.1 9.5 49.9 
8 St. 
Petersburg 
Oct-12 5.9 23.3 0.5 15.5 28.8 10.1 25.5 
9 St. 
Petersburg 
Oct-12 7.4 9.6 1.0 19.3 33.2 9.5 12.8 
10 St. 
Petersburg 
Oct-12 3.9 10.7 0.8 11.1 25.7 10.9 12.7 
11 St. 
Petersburg 
Oct-12 7.0 28.7 1.0 19.4 35.8 7.1 31.9 
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Table E1 (continued) 
12 St. 
Petersburg 
Oct-12 16.5 35.0 0.9 47.6 70.8 39.8 40.5 
1 St. 
Petersburg 
Jun-13 4.3 6.3 1.2 1.5 3.4 2.9 8.9 
2 St. 
Petersburg 
Jun-13 5.4 6.4 0.9 1.5 3.3 2.8 8.9 
3 St. 
Petersburg 
Jun-13 5.2 5.6 1.0 1.5 6.9 2.2 8.1 
4 St. 
Petersburg 
Jun-13 5.6 8.0 0.6 1.5 3.2 2.8 10.1 
5 St. 
Petersburg 
Jun-13 3.6 6.2 0.8 1.5 4.6 4.9 8.1 
6 St. 
Petersburg 
Jun-13 3.4 6.4 0.7 1.5 2.9 3.0 8.2 
7 St. 
Petersburg 
Jun-13 3.2 5.6 0.6 1.5 3.1 2.9 7.1 
8 St. 
Petersburg 
Jun-13 5.0 14.3 0.5 1.5 0.5 14.5 16.2 
9 St. 
Petersburg 
Jun-13 2.0 5.9 0.7 1.5 5.2 2.7 7.3 
10 St. 
Petersburg 
Jun-13 4.9 15.6 0.8 1.5 4.5 7.2 17.8 
11 St. 
Petersburg 
Jun-13 2.4 10.3 0.5 1.5 4.7 3.8 11.5 
12 St. 
Petersburg 
Jun-13 6.0 8.0 0.5 1.5 1.8 2.8 10.2 
1 Tampa Apr-12 ns ns ns ns ns ns  
2 Tampa Apr-12 19.7 5.5 3.0 2.9 18.7 2.7 14.2 
3 Tampa Apr-12 15.7 2.6 1.0 3.4 86.7 7.7 7.7 
4 Tampa Apr-12 12.3 2.0 1.9 2.6 37.2 2.5 7.5 
5 Tampa Apr-12 1.7 1.7 0.5 1.5 12.4 0.3 2.8 
6 Tampa Apr-12 ns ns ns ns ns ns  
7 Tampa Apr-12 26.2 3.7 3.7 3.9 94.1 7.4 14.9 
8 Tampa Apr-12 ns ns ns ns ns ns  
9 Tampa Apr-12 21.2 2.8 2.2 1.5 82.1 3.4 10.8 
10 Tampa Apr-12 55.7 26.8 6.1 1.5 19.7 20.6 48.4 
11 Tampa Apr-12 10.6 3.2 2.7 1.5 9.8 4.3 9.2 
12 Tampa Apr-12 63.8 25.6 8.5 1.5 23.4 28.8 52.1 
1 Tampa Oct-12 ns ns ns ns ns ns  
2 Tampa Oct-12 ns ns ns ns ns ns  
3 Tampa Oct-12 ns ns ns ns ns ns  
4 Tampa Oct-12 ns ns ns ns ns ns  
5 Tampa Oct-12 10.9 2.9 2.0 12.5 42.7 11.4 8.3 
6 Tampa Oct-12 41.5 16.0 29.1 27.0 194.3 22.8 62.9 
7 Tampa Oct-12 11.3 2.7 0.5 9.5 14.5 4.3 6.2 
8 Tampa Oct-12 17.9 10.5 7.4 30.5 8.7 37.6 24.4 
9 Tampa Oct-12 13.7 16.2 11.5 10.9 33.7 21.9 34.1 
10 Tampa Oct-12 47.7 49.4 46.1 1.5 54.4 22.4 118.9 
11 Tampa Oct-12 53.5 54.0 53.4 1.5 65.5 27.1 134.1 
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Table E1 (continued)  
12 Tampa Oct-12 ns ns ns ns ns ns  
1 Tampa Jun-13 35.9 40.2 2.3 1.5 3.8 1.0 52.2 
2 Tampa Jun-13 1.0 2.9 0.7 1.5 5.6 1.0 4.0 
3 Tampa Jun-13 1.0 4.8 0.5 1.5 1.4 1.0 5.7 
4 Tampa Jun-13 6.2 2.7 0.5 1.5 27.5 1.0 4.9 
5 Tampa Jun-13 23.5 9.7 0.5 1.5 15.2 1.0 16.2 
6 Tampa Jun-13 6.3 7.9 2.0 1.5 0.5 99.2 12.0 
7 Tampa Jun-13 ns ns ns ns ns ns  
8 Tampa Jun-13 6.9 11.2 3.0 1.5 0.5 22.5 16.8 
9 Tampa Jun-13 ns ns ns ns ns ns  
10 Tampa Jun-13 10.2 5.8 4.9 1.5 77.9 3.3 14.5 
11 Tampa Jun-13 ns ns ns ns ns ns  
12 Tampa Jun-13 ns ns ns ns ns ns  
1 Clearwater Apr-12 14.1 2.0 0.9 1.5 64.9 4.5 6.7 
2 Clearwater Apr-12 11.1 2.6 0.9 3.3 28.2 3.7 6.6 
3 Clearwater Apr-12 11.2 1.8 0.8 2.9 40.6 6.2 5.6 
4 Clearwater Apr-12 23.4 2.6 2.9 3.0 56.1 10.7 12.1 
5 Clearwater Apr-12 19.8 2.7 0.9 2.7 69.1 18.1 8.9 
6 Clearwater Apr-12 22.1 2.7 2.7 3.1 46.3 14.1 11.6 
7 Clearwater Apr-12 14.4 2.0 1.1 2.6 89.6 9.4 7.0 
8 Clearwater Apr-12 15.7 2.3 1.6 3.2 69.8 7.5 8.3 
9 Clearwater Apr-12 20.6 3.1 1.6 1.5 48.7 5.5 10.2 
10 Clearwater Apr-12 28.3 2.5 1.7 1.5 80.4 8.4 11.7 
11 Clearwater Apr-12 26.4 3.4 0.5 3.2 28.9 33.1 10.7 
12 Clearwater Apr-12 29.3 1.9 0.5 3.2 230.4 7.6 9.8 
13 Clearwater Apr-12 ns ns ns ns ns ns  
1 Clearwater Oct-12 9.1 2.6 5.2 1.5 12.7 25.5 11.4 
2 Clearwater Oct-12 7.7 2.3 5.8 1.5 15.6 8.5 11.5 
3 Clearwater Oct-12 4.6 3.7 1.7 1.5 17.8 5.8 6.9 
4 Clearwater Oct-12 5.9 2.0 2.1 9.6 18.6 3.2 6.1 
5 Clearwater Oct-12 2.8 0.5 2.1 1.5 13.4 10.4 3.9 
6 Clearwater Oct-12 13.0 2.0 1.7 42.6 32.7 16.9 7.6 
7 Clearwater Oct-12 9.5 2.5 2.5 23.8 36.6 26.1 8.1 
8 Clearwater Oct-12 10.7 2.0 1.7 25.4 38.1 12.2 7.0 
9 Clearwater Oct-12 12.0 2.4 2.0 28.0 43.9 11.0 8.1 
10 Clearwater Oct-12 8.7 3.4 1.3 23.5 26.0 10.6 7.3 
11 Clearwater Oct-12 6.2 3.3 2.3 13.5 20.7 22.6 7.8 
12 Clearwater Oct-12 7.2 2.2 1.9 13.5 20.8 13.3 6.4 
13 Clearwater Oct-12 5.5 3.0 3.4 15.8 24.9 16.1 8.7 
1 Clearwater Jun-13 ns ns ns ns ns ns  
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2 Clearwater Jun-13 5.7 0.8 0.5 1.5 4.7 6.4 2.9 
3 Clearwater Jun-13 64.3 1.4 1.0 1.5 19.3 33.9 18.8 
4 Clearwater Jun-13 26.2 0.7 1.0 1.5 22.5 30.2 8.5 
5 Clearwater Jun-13 8.0 0.5 1.0 1.5 13.3 24.0 3.7 
6 Clearwater Jun-13 9.9 0.8 2.3 1.5 19.6 15.1 6.2 
7 Clearwater Jun-13 55.5 1.6 1.1 1.5 16.5 33.8 16.9 
8 Clearwater Jun-13 39.9 1.5 1.7 1.5 15.3 12.7 13.6 
9 Clearwater Jun-13 13.4 1.3 0.6 1.5 29.4 31.9 5.4 
10 Clearwater Jun-13 39.8 0.9 1.9 1.5 13.8 25.3 13.2 
11 Clearwater Jun-13 58.1 3.5 11.8 1.5 160.5 59.8 32.8 
12 Clearwater Jun-13 31.7 2.2 6.1 1.5 174.5 57.7 17.8 
13 Clearwater Jun-13 ns ns ns ns ns ns  
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Figure F1. Graduated-symbol map for the Clearwater site. The map illustrates the difference in 
total estrogenicity in aqueous samples from October 2012 as Stevenson Creek flows northwest. 
EEQ units = ng/L. Refer to Figure 2.3c for the discharge point. 
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Figure F2. Graduated-symbol map for the Clearwater site. The map illustrates the difference in 
total estrogenicity in aqueous samples from June 2013 as Stevenson Creek flows northwest. 
EEQ units = ng/L. Refer to Figure 2.3c for the discharge point. 
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Figure F3. Graduated-symbol map for the Clearwater site. The map illustrates the difference in 
total estrogenicity in sediment samples from October 2012 as Stevenson Creek flows northwest. 
EEQ units = ng/g. Refer to Figure 2.3c for the discharge point. 
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Figure F4. Graduated-symbol map for the Clearwater site. The map illustrates the difference in 
total estrogenicity in sediment samples from June 2013 as Stevenson Creek flows northwest. 
EEQ units = ng/g. Refer to Figure 2.3c for the discharge point. 
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Figure F5. Graduated-symbol map for the St. Petersburg site. The map illustrates the difference 
in total estrogenicity in aqueous samples from April 2012. EEQ units = ng/L. The discharge 
point is at the center of the X-shaped pattern (Figure 2.3b).  
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Figure F6. Graduated-symbol map for the St. Petersburg site. The map illustrates the difference 
in total estrogenicity in aqueous samples from October 2012. EEQ units = ng/L. The discharge 
point is at the center of the X-shaped pattern (Figure 2.3b). 
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Figure F7. Graduated-symbol map for the St. Petersburg site. The map illustrates the difference 
in total estrogenicity in aqueous samples from June 2013. EEQ units = ng/L. The discharge 
point is at the center of the X-shaped pattern (Figure 2.3b). 
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Figure F8. Graduated-symbol map for the St. Petersburg site. The map illustrates the difference 
in total estrogenicity in sediment samples from April 2012. EEQ units = ng/g. The discharge 
point is at the center of the X-shaped pattern (Figure 2.3b). 
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Figure F9. Graduated-symbol map for the St. Petersburg site. The map illustrates the difference 
in total estrogenicity in sediment samples from October 2012. EEQ units = ng/g. The discharge 
point is at the center of the X-shaped pattern (Figure 2.3b). 
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Figure F10. Graduated-symbol map for the St. Petersburg site. The map illustrates the 
difference in total estrogenicity in sediment samples from June 2013. EEQ units = ng/L. The 
discharge point is at the center of the X-shaped pattern (Figure 2.3b). 
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Figure F11. Graduated-symbol map for the Tampa site. The map illustrates the difference in 
total estrogenicity in aqueous samples from April 2012. EEQ units = ng/L. The discharge point is 
at the center of the X-shaped pattern (Figure 2.3a).  
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Figure F12. Graduated-symbol map for the Tampa site. The map illustrates the difference in 
total estrogenicity in aqueous samples from October 2012. EEQ units = ng/L. The discharge 
point is at the center of the X-shaped pattern (Figure 2.3a).  
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Figure F13. Graduated-symbol map for the Tampa site. The map illustrates the difference in 
total estrogenicity in aqueous samples from June 2013. EEQ units = ng/L. The discharge point 
is at the center of the X-shaped pattern (Figure 2.3a).  
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Figure F14. Graduated-symbol map for the Tampa site. The map illustrates the difference in 
total estrogenicity in sediment samples from April 2012. EEQ units = ng/g. The discharge point 
is at the center of the X-shaped pattern (Figure 2.3a).  
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Figure F15. Graduated-symbol map for the Tampa site. The map illustrates the difference in 
total estrogenicity in sediment samples from October 2012. EEQ units = ng/g. The discharge 
point is at the center of the X-shaped pattern (Figure 2.3a).  
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Figure F16. Graduated-symbol map for the Tampa site. The map illustrates the difference in 
total estrogenicity in sediment samples from June 2013. EEQ units = ng/g. 
The discharge point is at the center of the X-shaped pattern (Figure 2.3a).  
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APPENDIX G 
 
Table G1 
Preliminary electrocoagulation testing against six endocrine-disrupting compounds (EDCs)  
Date Blade 
type 
Pump 
setting 
RT (sec) Volts Amps Number 
of 
terminals 
Method Oxidant 
added 
Conclusion 
6/5/2012 Fe 2 32 42 1 2 one pass  EDCs not 
responsive 
6/5/2012 Fe 2 32 52 1.7 2 one pass  EDCs not 
responsive 
6/5/2012 Fe 2 32 102 2.5 - 
4 
2 one pass  EDCs not 
responsive 
6/5/2012 Fe 3 20 75 2.3 2 one pass  EDCs not 
responsive 
6/5/2012 Al  2 32 42 1 2 one pass  EDCs not 
responsive 
6/5/2012 Al  2 32 54 1.3 2 one pass  EDCs not 
responsive 
6/5/2012 Al  2 32 102 2.7-3 2 one pass  EDCs not 
responsive 
6/5/2012 Al  3 20 66 1.6 2 one pass  EDCs not 
responsive 
11/20/2012 Fe 2 32 56 13.5 3 one pass  EDCs not 
responsive 
11/20/2012 Fe 2 32 55 13.7 3 one pass H2O2 EDCs not 
responsive 
11/20/2012 Al  2 32 66 13 3 one pass  EDCs not 
responsive 
11/20/2012 Al  2 32 72 13 3 one pass H2O2 EDCs not 
responsive 
11/20/2012 Fe 6 60 60 - 
65 
13.5 - 
14 
3 recirculation   EDCs not 
responsive 
11/20/2012 Fe 7 90 55 - 
60 
14 3 recirculation   EDCs not 
responsive 
11/20/2012 Al  6 60 80 13.5 3 recirculation   EDCs not 
responsive 
11/20/2012 Al  8 120 80-
95 
13.5 3 recirculation   Removal 
obtained 
for majority 
of EDCs 
7/1/2013 Al  8 120 80-
95 
13.5 3 recirculation   Replicate 
experiment; 
optimum 
parameters 
verified 
 
